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Abstract 
 
Plasmid pBSSB1 is a 27 kb linear DNA with proteins attached at the 5’ termini. It 
encodes the H: z66 flagellar antigen in Salmonella enterica serovar Typhi (S. Typhi) 
isolated from Indonesia. Together with the H: j or H: d flagellar antigen encoded by the 
host chromosome, pBSSB1 renders expression of the flagellar antigen biphasic in S. 
Typhi. Following the discovery of pBSSB1, initial bioinformatic analyses were carried 
out. However, no genetic analysis of replication and stability functions was conducted. 
Such studies form the basis of the present work. Plasmid pBSSB2, that contains a 
kanamycin cassette inserted at position 1295 bp of pBSSB1, was used in the present 
investigation.  
 
The first objective of the work was to develop a method of purification for the linear 
plasmid. Conventional plasmid extraction methods which had been used previously 
were found to produce a very poor yield of plasmid DNA. It was shown in the present 
study that a proteinase-K treatment was essential for the removal of the linear plasmid 
terminal proteins to avoid loss of the plasmid in the phenol-chloroform-isoamylalcohol 
treatment which removes cellular proteins from the plasmid DNA. 
 
The region containing the basic replicon of pBSSB2 was identified by screening for a 
region that was able to support replication in E. coli of a ColE1-like plasmid in a polA 
host (in which it would not normally replicate). This identified a 2831 bp fragment 
encompassing nucleotides 12820 to 15649 of pBSSB2.  It was expected that this would 
encode an initiator of replication such as a Rep protein. However, mutagenesis studies 
showed that none of the annotated ORFs in this fragment was essential for replication. 
Candidate ORFs, not identified in the original annotation, have been proposed that 
remain to be tested as possible candidates for the rep encoding gene. The possibility of 
an alternative RNA primed initiation of replication has also been hypothesized. An 
adjacent region was found to exert strong incompatibility against pBSSB2, suggesting 
that it might encode a repressor of replication. The minimum region conferring 
incompatibility was 179 bp, encompassing nucleotides 10840 bp to 11018 bp of 
pBSSB2. A six base pair imperfect repeat, (G/T) (G/A) TGTT was found within this 
sequence. It is hypothesized that these imperfect repeats may function as iterons that 
titrate a Rep protein and regulate pBSSB2 replication.   
 
A 1023 bp region (nucleotides 7236 to 8258 of pBSSB2) was found to confer stability 
in E. coli upon an otherwise unstable circular plasmid. Mutational analysis showed that 
an annotated ORF within this region (ORF09) was required for plasmid stabilisation. 
When expressed independently from an expression vector ORF09 killed host cells. It is 
proposed that the stability function acts as a toxin-antitoxin system, although the 
antitoxin has not yet been identified. A candidate promoter for a putative 
countertranscript and two potential ORFs as candidates for encoding the antitoxin   
have been suggested for future work to identify the antitoxin.  
 
The preliminary functional characterization of pBSSB2 has contributed to our general 
understanding of the replication and stability functions of linear plasmids. However, 
further work will be required to achieve a complete understanding of the molecular 
basis of these functions in pBSSB2.    
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1.1 Salmonella Typhi: the causative agent of typhoid fever  
Salmonella enterica serovar Typhi is the causative agent of typhoid fever in humans. 
Unlike most other Salmonella serotypes, S. Typhi is restricted to the human host (Parry 
et al., 2002). Typhoid fever continues to be a major public health concern, particularly 
in developing countries. Every year, 12-33 million cases of typhoid fever occur 
worldwide (Pang et al., 1995; DeRoeck, 2007).  
In Salmonella flagella play an important role in motility (Flan and Macnab, 1996; Walz 
and Caplan, 2000). Most Salmonella enterica serovars are biphasic and can express 
either of two flagellin antigens. These are expressed from phase-1 and phase-2 genes 
named fliC and fljB, located at different locations in the Salmonella enterica 
chromosome (Flan and Macnab, 1996). fljA is the genetic determinant of the repressor 
(FljA) of fliC and is cotranscribed with fljB (Bonifield and Hughes, 2003; Yamamoto 
and Kutsukake, 2006). Switching of flagellin antigen expression (Figure 1.1) is 
mediated by the product of a DNA sequence, hin, flanked by two inverted repeats 
(Johnson and Simon, 1985) and located upstream of the fljBA operon (Henderson et al., 
1999; Kelly, 2004; Kutsukake et al., 2006). Binding of Hin recombinase to the inverted 
repeats, hix, leads to a site-specific recombination event that inverts the promoter for 
fljBA. In one orientation, the promoter of fljB faces away from it. Hence, fliC is 
expressed in the absence of FljA repressor (Figure 1.1, B) (Zieg et al., 1977; Zieg and 
Simon, 1980; Simon et al., 1980). Under conditions when hin reverses its direction by 
site-specific recombination, the promoter of fljB is in its right orientation, enabling 
expression of fljB as well as fljA, which prevents expression of fliC (Figure 1.1, A). The 
process of hin inversion, known as ‘phase variation’, is reversible, thereby enabling 
either of the flagellar antigens, FliC or FljB to be expressed at a given time. 
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Figure 1.1: Site-specific recombination mediated by Hin recombinase involved in 
Salmonella flagellar antigenic phase variation. (Source: Bonifield et al., 2003) 
 
Salmonella enterica serovar Typhi is not capable of phase variation and normally 
expresses only one antigen, FliC (Frankel et al., 1989). The chromosomal fliC gene 
codes for H:d (d) flagellin antigen. Salmonella Typhi is responsible for high incidence 
of typhoid in Indonesia, where the disease is endemic (Ivanoff, 1997). Some S. Typhi 
strains from Indonesia express an atypical flagellar antigen called H:j (j) instead of H:d 
(d) (Frankel et al., 1989). Antigen j is coded by a truncated form of fliC. The truncated 
gene carries a 251bp deletion in the central region (Frankel et al., 1989). Isolates of 
Salmonella Typhi that are motile but do not express either j or d antigen have also been 
reported (Guinee et al., 1981). These strains were found to express a novel antigen, H: 
z66 (z66). Unlike other Salmonella enterica serovars, FliC is not the default antigen in 
these strains. When these strains are incubated with anti-z:66 antiserum, they express 
antigens j or d, depending on whether fliC or its deletion derivative is present in the 
chromosome. However, strains expressing the FljB (z66) antigen preferentially express 
the fliC gene (Baker et al., 2008). It was previously assumed that these strains are 
biphasic like most other S. enterica serovars. However, the d or j positive S. Typhi 
strains do not revert to z66 expression when induced with anti-j or anti-d antiserum 
(Tamura et al., 1988).  
 
A 
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The gene encoding z66 was reported to be located in a linear plasmid, pBSSB1 (27kb) 
by Baker et al. (2007b). A fljAB-like operon was identified in the linear plasmid (Baker 
et al., 2007b). There is 45% DNA sequence homology between the fljAB
z66
 region of S. 
Typhi z66+ strains with the fljAB locus of S. Typhimurium. About 70% similarity has 
been reported between the amino acid sequence of the product of the fljA-like gene in S. 
Typhi with the FljA of S. Typhimurium LT2 (Huang et al., 2004). No hin-like gene 
capable of site-specific recombination has been detected upstream of the fljAB locus in 
z66+ strains.  
Recently, the expression of a new flagellin protein, Ind, has been reported for S. Typhi 
strains isolated from Indonesia. The sequence of Ind shows close homology to that of 
z66 and H:d at its amino and carboxy termini conserved sequences. On the other hand, 
a part of its conserved domain and the heterologous domains show homology to the 
FliC flagellin protein of Serratia marcescens. All of the isolates that were positive for 
Ind were also positive for H:d fliC. Whether Ind represents a phase 1 or a phase 2 
flagellin has not yet been investigated (Hatta et al., 2011).  
 
1.2 The linear plasmid, pBSSB1  
The plasmid, pBSSB1, was originally identified by Baker et al. (2007b). Linearity of 
pBSSB1 has been proved by restriction digestion by these authors. Linear plasmids 
belong to one of two structural categories: one in which the end is closed by a hairpin 
loop and another in which a protein is attached covalently at the 5’ ends. Baker et al. 
(2007b) demonstrated that pBSSB1 was resistant to S1 nuclease and lambda 
exonuclease but was sensitive to degradation by 3’-5’ exonuclease III.  The linear 
plasmid, pBSSB1, therefore, belongs to the second category. Plasmid pBSSB1 is 
27,037bp in length with terminal inverted repeats (TIRs) of about 1230bp. There are 33 
annotated ORFs in pBSSB1, of which ORF031 codes for phase II flagellar antigen 
(Baker et al., 2007b). The sequences of 22 ORFs have no similarity to the sequences in 
the public databases. The genetic map of pBSSB1 is shown in figure 1.2. The GC% of 
the linear plasmid is about 36.6 (Baker et al., 2007b). Based on GC skew (G-C/G+C), 
the origin of replication lies upstream of ORF017. No direct repeats or iterons have 
been detected in the region predicted to contain the origin of replication. The right 
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terminal inverted repeat has been shown not to be essential for replication (Baker et al., 
2007a).  
A kanamycin resistance cassette has been inserted at 1295 bp by Baker et al. (2007b) to 
give rise to pBSSB2 (indicated by the cross in Figure 1.2).  The linear plasmid, 
pBSSB2, was transformed into E. coli Top10 (Invitrogen) to create a strain designated 
SGB33 (Baker et al., 2007b). SBG33 has been used in all experimental procedures in 
the present investigation as a source of pBSSB2.  
 
 
 
 
 
 
Figure 1.2. The genetic map of pBSSB1. The arrows indicate ORFs, the yellow arrows 
indicate ORFs with known functions, red arrows represent ORFs with sequences 
similar to other ORFs in the public database and blue arrows indicate ORFs with 
unknown function. The terminal inverted repeats, tirs, are indicated by light blue boxes 
with one pointed end. The restriction digestion map of pBSSB1 is shown underneath 
the ORF map. The cross indicates the site of insertion of the kanamycin cassette. The 
GC skew is indicated by the asterisk. The figure was taken from Baker et al., (2007b). 
 
1.3  Plasmid replication and its control 
1.3.1 Replication of circular plasmids  
Plasmids are extrachromosomal DNA molecules capable of autonomous replication. 
Typically, plasmids encode factors necessary for initiation of replication and use host 
specific elements for continuation of replication (reviewed by Actis et al., 1999). The 
basic replicon of a plasmid is defined as the smallest region of the plasmid that is able 
to replicate on its own with its wild-type copy number (Kollek et al., 1978). In most 
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plasmids it is about 4 kb in length (Actis et al., 1999). The basic replicon generally 
includes the origin of replication (ori), an initiator protein (Rep) or an initiator RNA 
and sequences involved with regulation of replication. Primer RNAs generally act in 
cis, whereas Rep proteins can act either in cis or in trans (reviewed by Actis et al., 
1999).  
The replication of circular plasmids has been reviewed by del Solar et al. (1998). 
Replication occurs by one of two common mechanisms. In theta type replication, 
replication is initiated by synthesis of a primer RNA (pRNA) at the origin. Elongation 
of plasmid replication is generally carried out by the host DNA polymerase III 
holoenzyme (HE), DnaB helicase and DnaG primase. Termination of plasmid 
replication generally involves DNA-protein interactions. Some plasmids replicate by 
rolling-circle replication in which Rep protein introduces a sequence-specific nick that 
generates a free 3’-OH end that acts as a primer for replication. The end-products are a 
double-stranded DNA and a single stranded DNA molecule. The latter DNA is 
converted to a double-stranded form by discontinued synthesis of Okazaki fragments 
using a single strand origin sequence for initiation.  
Plasmids maintain themselves at a particular copy number in a given host under 
specific conditions. Copy number is regulated by sequences involved in control of 
initiation of replication. Control of plasmid replication is achieved by one of two 
mechanisms. In one mechanism, direct DNA repeats designated iterons, located close 
to ori, control the rate of initiation of replication through binding of Rep proteins. In 
some plasmids e.g. P1 (Pal and Chattoraj, 1988; Abeles and Austin, 1991; Abeles et al., 
1995) binding of Rep protein at low concentration allows replication. At high 
concentrations of Rep, due to an increased copy number of the plasmid, Rep proteins 
couple or handcuff origins of different plasmid molecules, hence limiting the 
availability of origins to initiate replication. In the other control mechanism, one or 
more antisense RNAs bind to pre-primer RNAs or to transcripts that encode the Rep 
protein and control the rate of initiation of plasmid replication (Kues and Stahl, 1989; 
Novick, 1987).  
In this section the replication and control mechanisms of the iteron-regulated P1 
replicon and the antisense RNA regulated replicons of ColE1 and pT181 will be used to 
illustrate copy-number control mechanisms of circular plasmids.  
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1.3.1.1 Replication and control of P1 replication 
 
The lysogenic form of bacteriophage P1 can replicate autonomously in E. coli (Abeles 
et al., 1984). The minimum region required for P1 replication is about 1.5 kb in length 
(Figure 1.3). A 959bp region codes for the 32 kD RepA protein (Chattoraj et al., 1985). 
An incompatibility locus, incC, consisting of five 19bp iteron repeats, located about 53 
bases upstream from the repA ORF (Chattoraj et al., 1985), is essential for replication 
and is the binding site of RepA (Abeles et al., 1984). The promoter and the operator of 
repA is present within incC and production of RepA is autoregulated (Chattoraj et al., 
1985). A region containing 67% A+T lies 50bp to the left of the RepA binding sites. A 
second incompatibility locus, incA, containing nine identical 19bp repeats is involved in 
P1 copy number control (Abeles et al., 1985). The origin lies in a region about 245bp 
(Abeles et al., 1984). Two DnaA boxes occur to the left of the origin and three more 
DnaA boxes are present about 200 bp from these, within the leader region of the repA 
gene (Abeles et al., 1990). There is a group of five 7bp direct repeats, of which four 
contain nested GATC sequences, that are the substrates for E. coli DNA deoxyadenine 
methylase (Hattman et al., 1978). These sites are separated from incC by a 39bp GC 
rich (62%) clamp sequence (Brendler et al., 1991). A host protein, the product of seqA, 
recognizes the GATC methylation sites in the replicon and binds to them when 
hemimethylated. Hemimethylated DNA is formed immediately after replication when 
newly replicated DNA strands are non-methylated (Brendler et al., 1995).  
 
 
 
Figure 1.3 Schematic diagram showing the P1 replicon. ‘R’ represents DnaA box, the 
7bp repeats contain the substrates for methylation, G represents the GC rich clamp, 
incC and incA contain iterons, repA encodes the RepA protein. The figure, not drawn to 
scale, is adapted from Brendler et al., 1991. 
 
RepA is essential for P1 replication (Abeles et al., 1984). An amber mutation in the 
repA gene blocks replication of a mini P1 plasmid (Sternberg and Austin, 1981; Abeles 
    R  R   7bp repeats   G                 incC                 R  R  R         repA             incA (9 iterons)  
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et al., 1984). RepA is activated by the host-encoded heat-shock proteins, DnaJ, DnaK 
and GrpE, in the presence of ATP. These cause conformational changes in dimeric 
RepA that convert the dimer into active iteron-binding monomers (Dibbens et al., 
1997). RepA binds to the origin incC locus (Abeles et al., 1989) and induces a bend in 
the DNA (Mukhopadhyay and Chattoraj, 1993). Melting of the DNA strands at the 
origin by RepA binding is stimulated by DnaA and HU (Hansen and Yarmolinsky, 
1986; Ogura et al., 1990). DnaA binding also aids loading of DnaB helicase (Bramhill 
and Kornberg, 1988; Abeles et al., 1990; Wickner et al., 1990). Once the DNA strands 
in the P1 origin of replication have separated, host-encoded DnaB helicase, RNA 
polymerase, DNA Polymerase III HE and gyrase are used to initiate elongation of DNA 
and formation of daughter strands (Wickner and Chattoraj, 1987). 
The copy number of P1 is modulated by the incA incompatibility locus. Constructs that 
do not contain the incA locus have higher copy number than the parental plasmid 
(Chattoraj et al., 1984). On the other hand, extra copies of incA on a second plasmid, or 
in the host chromosome, inhibit P1 replication and reduce the copy number (Austin et 
al., 1982). When RepA binds to the incA repeats, the concentration of free RepA 
available to initiate replication is reduced, thereby limiting replication (Chattoraj et al., 
1984). This is known as the ‘titration model’ (Chattoraj et al., 1984; Tsutsui et al., 
1983). The low level of initiator is maintained by autoregulation of RepA expression 
(binding of RepA to its own promoter prevents binding by RNA polymerase and hence 
prevents synthesis of more RepA).  
RepA dimerization in combination with autorepression and handcuffing have been 
proposed to be the mechanisms underlying the ability of plasmid P1 to regulate its 
replication (Das et al., 2005). The ability of RepA to bind simultaneously to incC and 
incA (Chattoraj et al., 1988) enables pairing of two P1 plasmids. This is known as the 
‘handcuffing model’ (Abeles and Austin, 1991; Pal and Chattoraj, 1988). The 
‘handcuffing model’ results in steric hindrance whereby RepA is unable to bind to the 
origin to initiate replication (Park et al., 2001; Pal and Chattoraj, 1988). Increase in cell 
volume lowers the copy number of P1 below the steady-state value (Pal and Chattoraj, 
1988). Under these conditions, the concentration of active RepA is also reduced. As 
such, handcuffing of plasmids becomes reversible and the concentration of active RepA 
is increased. This allows saturation of origin iterons and replication can proceed. 
Replication also frees RepA bound to the RepA promoters enabling transcription of 
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RepA to occur (Mukhopadhyay and Chattoraj, 2000). Replication induced transcription 
and RepA activation by chaperones ensures a sufficient supply of RepA for replication 
to occur and helps to overcome handcuffing of coupled plasmids.  
 
1.3.1.2 RNA mediated replication of ColE1  
 
Replication of plasmid ColE1 is initiated by formation of an RNA primer and is 
independent of a plasmid-encoded Rep protein (Itoh and Tomizawa, 1980). Replication 
proceeds unidirectionally and can take place in extracts from cells of E. coli 
(Sakakibara and Tomizawa, 1974). The RNA transcript that is processed to form the 
primer of ColE1 replication, RNAII, is about 700 nucleotides and is synthesized from 
approximately 555 bp upstream of the origin (Itoh and Tomizawa, 1980) (Figure 1.4, 
Section A step:1). It forms an RNA-DNA hybrid with the complementary DNA at the 
replication origin (Masukata and Tomizawa, 1984) (Figure 1.4, Section A step: 3). 
Formation of the stable RNAII-DNA hybrid requires an interaction between a G-rich 
region in RNAII, 265 nucleotides upstream of the 3' end and a C- rich segment of the 
complementary DNA, 20bp from the origin (Masukata and Tomizawa, 1990). The 
RNA component of this stable hybrid is processed into a primer by RNaseH (Itoh and 
Tomizawa, 1978) (Figure 1.4, Section A step: 5). The 3'-OH group of the processed 
RNA is used to prime leading-strand synthesis by DNA polymerase I (Itoh and 
Tomizawa, 1980) (Figure 1.4, Section A step: 6). As leading-strand synthesis 
continues, the template DNA unwinds exposing a primosome assembly site on the 
leading strand (Zavitz and Marians, 1991). About 40bp must be unwound after which 
DnaB helicase can be loaded. DnaB helicase and DnaG primase then work to initiate 
lagging-strand synthesis discontinuously with the aid of short primers (Bramhill and 
Kornberg, 1988). DNA polymerase I is replaced on the leading strand by DNA 
polymerase III gradually over about 1.3kb. DNA polymerase I processes about 20 
nucleotides of the Okazaki fragments on the lagging strand (Allen et al., 2011). 
Transition from primer RNA to DNA occurs in a region with five adenine residues. 
Both sides of this region are rich in G and C residues (Tomizawa et al., 1977).  
 
If RNaseH is absent, transcription continues to a point about 190 nucleotides 
downstream of the origin in a dA rich region (Selzer and Tomizawa, 1982). Replication 
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of ColE1 has however been found to occur in both RNaseH-deficient mutants (Naito et 
al., 1984) and in DNA polymerase I mutants (Kogoma, 1984). It is possible that the 
formation of the RNAII-DNA hybrid unwinds the DNA (Dasgupta et al., 1987; 
Tomizawa and Masukata, 1987) and enables loading by DnaB helicase (Bramhill and 
Kornberg, 1988).  
 
Since binding of the RNAII pre-primer to the template DNA leads to initiation of 
leading strand synthesis, this step also is the target for control of copy number of ColE1 
(Figure 1.4, section B). Formation of the active primer is inhibited by a second RNA, 
RNAI (Hashimoto-Gotoh and Timmis, 1981). RNAI is transcribed in a direction 
opposite to that of RNAII (-553 to -445bp region relative to the origin of ColE1, Figure 
1.4 Section B, step: 1) (Morita and Oka, 1979). RNAI is complementary to the 5' end of 
the RNAII primer over 100 nucleotides (Selzer et al., 1983). The RNAI-bound version 
fails to form a stable hybrid with the origin DNA (Tomizawa et al., 1981) (Figure 1.4, 
Section B, step 3). Both RNAI and RNAII form three prominent stem-loop structures 
(Tomizawa and Itoh, 1982). Single-stranded loops of RNAI interact with 
complementary sequences in RNAII (Tomizawa, 1990). This initial interaction called 
‘kissing’ becomes stronger and eventually RNAI is completely hybridized with RNAII 
(Tomizawa, 1984) (Figure 1.4, Section B, step: 5). However, for effective inhibition by 
RNAI there is a specific conformation-dependent ‘window of susceptibility’ (Wong 
and Polisky, 1985) and RNAI must bind to RNAII when the latter is between 100-360 
nucleotides long (Tomizawa, 1986). The initial complex between RNAI and RNAII is 
unstable (Tomizawa, 1990). This unstable intermediate can be converted to a more 
stable complex that is resistant to RNase A in the loop region (Tomizawa, 1990) by a 
plasmid-encoded protein called Rom (RNA one modulator) (Tomizawa and Som, 
1984). Rom is a 63 amino acid protein encoded by the rom gene (Tomizawa and Som, 
1984), located approximately 600 nucleotides downstream of the origin of replication 
(Cesareni, 1982). The concerted action of RNAI and Rom negatively regulates 
initiation of replication and is central to copy number control of ColE1.  
 
 
 
 
 
Replication and stability of the linear plasmid pBSSB2                                          Chapter 1: Introduction 
 
11 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4. Schematic representation of ColE1 replication (adapted from Tomizawa and 
Itoh, 1982) 
 
1.3.1.3 Rolling-circle replication of pT181  
pT181 is a 4.4kb plasmid isolated from Staphylococcus aureus (Iordanescu and 
Basheer, 1991). Over many years, it has served as the paradigm for the study of Rolling 
Circle Replication. The basic replicon of pT181 is about 1200 bp within which a 50bp 
region binds the initiator protein (Khan et al., 1982). Replication requires a plasmid-
encoded 314 amino acid (Chang et al., 2000) protein RepC (Novick et al., 1982, 
Carleton et al., 1984) that drives unidirectional (Khan et al., 1982) and semi-
conservative (Khan et al., 1981) replication of the plasmid. Replication of pT181 is said 
to be asymmetric as synthesis of the leading and lagging strands are not coupled 
(Thomas et al., 1990).  
 
RepC exists as a monomer in solution but acts as a dimer during replication (Zhao et al. 
1998). This dimer is designated RepC/RepC (Rasooly et al., 1994b). Replication starts 
with binding of RepC to the dso region of the plasmid (Figure 1.5). RepC has sequence-
specific DNA binding, topoisomerase-like activities and endonuclease activity (Koepsel 
et al., 1986). Residues 267-270 of RepC are involved in sequence-specific recognition 
 
A B 
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of the origin (Dempsey et al., 1992; Wang et al., 1992). The RepC binding site includes 
an inverted repeat element IRIII and the right arm of a second inverted element, IRII. 
Binding by RepC bends the DNA and forms a cruciform structure containing the IRII 
repeat element (Koepsel and Khan, 1986; Noirot et al., 1990). RepC cleaves this 
structure between nucleotides 70 and 71 (Koepsel et al., 1985) with its active tyrosine 
residue, Tyr-191 (Chang et al., 2000) (Figure 1.5, A).  A tyrosine residue of RepC 
exerts a nucleophilic attack on the phosphodiester bond of a dinucleotide 5’-AT-3’ 
within the nic region of dso (Rasooly et al., 1994a). One of the monomers of the 
RepC/RepC dimer becomes covalently linked to the 5'-end of the nick through a 
phosphotyrosine bond (Koepsel et al., 1985; Thomas et al., 1988) (Figure 1.5, B). The 
3'-OH end acts as a primer for elongation of the leading strand (Koepsel et al., 1985). 
Host factors are used for the synthesis of the leading strand including DNA polymerase 
III that polymerizes DNA from the 3'-OH end, single-strand DNA binding protein 
(SSB) that protects the displaced single stranded DNA from nucleolytic attack, and 
DNA helicase that unwinds the DNA. After the replisome reaches the nic site, 
elongation of the leading strand continues for about 10 nucleotides to regenerate the dso 
region (Figure 1.5, C). The RepC subunit of the dimer not bound to DNA then cleaves 
the newly synthesized nic site through its active tyrosine residue. This leads to binding 
of 10-12 nucleotides of the 3' half of the nic region to the RepC subunit (Rasooly and 
Novick, 1993) (Figure 1.5, D). The dimeric RepC-RepC now contains an active RepC 
that initiated replication and a RepC inactivated by oligonucleotide attachment, termed 
RepC* (Rasooly and Novick, 1993). This heterodimer RepC/RepC* can bind DNA but 
cannot relax plasmid DNA. As a result, it is inactive as an initiator of replication 
(Rasooly and Novick, 1993, Rasooly et al., 1994b). Following completion of leading 
strand synthesis, the products are a single-stranded DNA (the displaced parental strand) 
and a double-stranded DNA that has a newly synthesized leading strand and a parental 
strand. The latter is supercoiled by DNA gyrase (te Rielle et al., 1986) (Figure 1.5, E).  
 
The single-stranded DNA intermediate is converted to double-stranded DNA through 
lagging-strand synthesis. This initiation occurs from the sso region of the plasmid, 
located within a noncoding region capable of forming secondary structures (Khan, 
1997). Replication of lagging strand is believed to be initiated by RNA polymerase. 
Elongation of lagging strand is achieved by host DNA polymerase III. Finally the host 
DNA polymerase I removes the primer RNA (Espinosa et al., 1995) (Figure 1.5, F).  
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Figure 1.5. Schematic representation of pT181 replication. Source: Khan, 2005. 
 
Replication of pT181 is regulated by anti-sense RNA that controls synthesis of RepC 
(Kumar and Novick, 1985). The antisense RNA or counter-transcript transcribed from 
the cop region (Rasooly et al., 1994a) is complementary to the leader region of RepC-
mRNA. It is capable of forming extensive secondary structures that contain hairpin 
regions (Novick et al., 1989). It initially binds with the unpaired regions of RepC 
mRNA. This initial binding is converted to a linear duplex between the 
countertranscribed RNA and RepC mRNA (Novick et al., 1989). Binding of ctRNA 
with RepC mRNA inhibits translation of the latter (Rasooly et al., 1994a). The ctRNA 
is synthesized constitutively. Consequently, full-length Rep mRNA is synthesized in 
limited concentrations. Lower level of Rep mRNA expression reduces the 
concentration of the Rep initiator. This leads to lower replication rates and thereby 
regulates replication (Novick et al., 1989).  
 
1.3.2 Replication of linear plasmids  
Linear plasmids belong to one of two structural categories: those with proteins attached 
at 5’ termini (e.g. Streptomyces linear plasmids) and those that have covalently closed 
ends (Borrelia linear plasmids). Although the components of the replicons of several 
Streptomyces linear plasmids have been studied in the past (Section 1.3.2.1 to follow), 
the mechanism of replication, particularly replication at the ends, is still a mystery. 
 
A B
D
C
E F
Replication and stability of the linear plasmid pBSSB2                                          Chapter 1: Introduction 
 
14 
 
Limited studies have been conducted on replication of Borrelia burgdorferi linear 
plasmid lp17 and mechanism for telomere resolution proposed (Section 1.3.2.2).  
 
1.3.2.1 Replication of linear plasmids with terminal proteins  
Replication of protein-capped linear plasmids occurs bidirectionally from an internal 
origin (Chang and Cohen, 1994). The autonomously replicating sequence of 
Streptomyces linear plasmids generally contains an origin of replication and one or 
more genes required for replication (Huang et al., 2003). These genes are located near 
the origin and may be subsidiary in some cases (Hiratsu et al., 2000). Replication 
generates a 3' leading-strand overhang at the telomeres (Figure 1.6). The lagging strand 
is about 280bp short at its 5' terminus (Chang and Cohen, 1994). It is proposed that end 
patching occurs by one of two mechanisms: the first (Figure 1.6 A) assumes that 
pairing of palindromes in the 3’ overhang causes it to fold back such that the terminal 
protein is anchored near the base of the overhang. The terminal protein (TP) acts as a 
primer and helps to fill the gap (Qin and Cohen, 1998). In the second model (Figure 1.6 
B), TP acts as a nickase and nicks the template strand and attaches covalently to the 5' 
end. The gap is filled by DNA polymerase (Qin and Cohen, 1998). Streptomyces 
chromosomes are linear (Lin et al., 1993) and contain telomeres similar to those present 
on Streptomyces linear plasmids. They replicate bidirectionally and it is suggested that 
telomeres are patched in similar manner as their linear plasmids (Chen, 1996; Huang et 
al., 1998; Qin and Cohen, 1998). The product of the tpg gene is required for 
Streptomyces rochei chromosomal replication (Bao and Cohen, 2001).  
 
In linear plasmid pSLA2, the autonomously replicating sequence lies near the centre of 
the plasmid. It contains two 21-mer iterons followed by a series of CT and AG residues 
within the rep1 gene that codes for the Rep1 DNA binding protein which promotes 
plasmid replication (Huang et al., 2003). Another gene downstream of rep1, rep2, 
encodes a protein with a helicase-like activity. Additional genes necessary for pSLA2 
replication are the tpgs, terminal protein genes (Bao and Cohen, 2001), tap, the gene for 
a terminus associated protein (Bao and Cohen, 2003) loci required for linear replication 
(rlrA/rorA) (Qin et al., 2003).  The presence of rlrA
pSLA2
 in a circular derivative is 
inhibitory to its replication. The presence of rlrA
pSLA2
 is not however inhibitory for 
replication in the linear form (Qin et al., 2003). The inhibitory effect of rlrA
pSLA2
 in the 
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circular derivative can be overcome by another locus, rorA
pSLA2
 (Kendall and Cohen, 
1987; Stein et al., 1989). Copurification of DNA polymerase I (PolA) and a 
topoisomerase I with the Tap protein suggests a role in replication. However, DNA 
polymerase I has not been found to be essential for Streptomyces linear plasmid 
replication (Tsai et al., 2008). Tap has been demonstrated to possess reverse 
transcriptase activity (Bao and Cohen, 2004).  
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Figure 1.6. Models for replication of linear plasmids containing 5' terminal proteins 
(Taken from Phillips, G. and Funnell, B.G. (2004) Plasmid Biology. 1
st
 Edition, ASM 
Press.) 
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In the linear plasmid SCP1, the minimum replicon is within a 5.4kb region that contains 
an A+T rich region and two ORFs. One of these codes for a protein that has similarity 
to the primase repA gene of Acidianus ambivalens and the helicase-like protein of 
Sulfolobus islandicus (Redenbach et al., 1999). The A+T rich region may facilitate 
melting of the double-stranded DNA to initiate DNA replication. The autonomously 
replicating sequence (ARS) of linear plasmid SLP2 is located within approximately 5 to 
10kb sequence from the left end. The ARS contains the tpg gene, the dnaB-like gene 
and two DnaA boxes (T/C) (T/C) (A/G/C) TCCACA (Jakimowicz et al., 1998). One of 
these DnaA boxes is located within the tpg coding sequence and the other with the 
dnaB-like coding sequence. The minimal replicon of SCP1 contains an ORF (ORF 
SCP1.196) that codes a putative primase/helicase and a second overlapping ORF (ORF 
SCP1.197) that codes for a hypothetical protein and direct repeats (Redenbach et al., 
1999). SCP1 lacks tpg and tap homologues.   
The basic replicon of plasmid pSCL1 is similar in configuration to that of pSLA2 (Wu 
and Roy, 1993). In the case of the linear plasmid SLP2, efficient replication as a 
circular derivative requires a 47bp sequence upstream of 23-mer iterons. Inclusion of 
these sequences increased the transformation efficiency by about 1000 fold (Xu et al., 
2006). This region is not transcribed as shown by RT PCR and hence may contain 
regulatory factor(s) that act in cis (Xu et al., 2006). SLP2 contains two tpg homologues 
– tpg SLP2 and a putative pseudogene on the right arm. SLP2 requires tpgL gene 
product for replication (Lee et al., 2003). SLP2 lacks a rep gene (Huang et al., 2003). It 
possibly requires a host DNA polymerase for DNA replication. It has been proposed 
(Huang et al., 2003) that the origin of replication of the plasmid lies close to the tpg 
gene, and the DnaA boxes.  
 
A Rep-iteron structure is also found in the minimal replicon of plasmid pSHK1 of 
Streptomyces sp. HK1 (Zhang et al., 2009). The gene for a putative Rep protein and 
adjacent noncoding sequences (ncs) form the basis of the basic replicon in the linear 
plasmids pSLA2-L from Streptomyces rochei (Hiratsu et al., 2000), pSCL2 from S. 
clavuligerus (Wu et al., 2006), pRL1 from Streptomyces sp. 44030, pRL2 from 
Streptomyces sp. 44414, and pFRL2 from Streptomyces sp. FR1 (Zhang et al., 2009).  
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Unlike any other linear plasmid reported so far, two origins of replication have been 
identified in the linear plasmid pFRL1 from Streptomyces sp. FR1 (Zhang, 2010). One 
of these, rep1A-ncs1, lies adjacent to the telomere and the other, rep2A-ncs2, lies about 
10kb away from it. The first origin can propagate both in linear and circular modes, but 
the latter requires an additional locus, rlrA-rorA, for propagation in the linear mode. 
The Rep1A protein binds to the sequence ncs1 in vitro. The proteins Rep1A and Rep2A 
were transcribed at different levels at different times and each dominated at different 
points of time (Zhang et al., 2010).  
 
Rep-iteron structure is also found in Mycobacterium celatum linear plasmid pCLP. The 
basic replicon is a 2.8kb fragment comprising of a putative Rep gene and a putative 
origin of replication consisting of 18bp iterons and an AT-rich region (Picardeau et al., 
2000). Linear plasmid pRHL3 from Rhodococcus jostii (McLeod et al., 2006) minimal 
replicon is also similar to that of pCLP. It contains two ORFs: RHL3.237 encoding 
Rep1 (Rep protein) and RHL3.235 that codes for a protein homologous to a ParA 
protein from R. erythropolis (De Mot et al., 1997). In this plasmid, iterons are present 
as control mechanisms. An approximately 40% AT-rich 600bp region is found 
upstream of rep1 (Warren et al., 2004). 
 
1.3.2.2 Replication of linear plasmids with closed ends  
 
Borrelia linear plasmids contain covalently closed ends. Replication of Borrelia linear 
plasmids initiates from an internal origin and proceeds bidirectionally (Picardeau et al., 
1999) (Figure 1.7). A head-to-head dimer in which the telomere is duplicated is 
generated. The duplicated telomere is recognized by a telomere resolvase, ResT 
(Chaconas and Kobryn, 2010; Chaconas, 2005; Kobryn and Chaconas, 2005), which 
resolves the dimer into two covalently closed linear plasmids. ResT causes breakage of 
DNA, causes a conformational change by which the 5'-OH group of the DNA and the 
3'-phosphate of a tyrosine residue in ResT are juxtaposed. The 5'-OH group exerts a 
nucleophilic attack on the 3'-phosphate group leading to the formation of a 
phosphodiester bond. This structure stabilizes the hairpin ends.  
In Borrelia burgdorferi linear plasmid, lp17, the basic replicon is 1.8kb in length and 
contains one ORF designated BBD14 (Casjens et al., 2000) as well as adjacent non-
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coding sequences, 311bp and 360bp to the left and right, respectively. Expression of 
ORF BBD14 is required for replication (Beaurepaire and Chaconas, 2005). However, 
no iterons or DnaA boxes were detected in lp17 basic replicon. The exact location of 
the origin is not known. The gene for ResT in Borrelia burgdorferi is not located on a 
linear plasmid but on a 26-kb circular plasmid (Kobryn and Chaconas, 2002). ResT 
recognizes the 25kb inverted repeats for its function. It has been shown that circular 
plasmids of B. burgdorferi can replicate as linear derivatives when telomeres are added 
to the termini (Chaconas et al., 2001). Conversely, linear plasmids have also been 
demonstrated to replicate as circular derivatives in circular vectors (Stewart et al., 
2003).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.7. Bidirectional replication of Borrellia linear plasmid from a central origin. L 
and R indicate left and right telomeres, respectively. L' and R' are replication-generated 
telomeres. ResT resolves the telomeres and generates two monomer plasmids. The 
figure has been taken from Chaconas and Kobryn, 2010. 
 
The basic replicon of the linear prophage N15 is 5.2kb and can drive replication of 
linear or circular derivatives. An ORF, repA, which codes for a protein with similarity 
to primase is required for replication (Rybchin and Svarchevsky, 1999). ResT of E. coli 
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prophage N15 is encoded by the telN gene located adjacent to its recognition site 
(telRL) (Deneke et al., 2004, 2002, 2000). 
 
1.4  General features of plasmid stability 
 
Plasmid replication ensures plasmid duplication in the host but for efficient distribution 
to occur to daughter cells at cell division, plasmids also encode mechanisms for their 
proper partitioning to daughter cells at division. The basic replicon of a plasmid 
carrying the stability cassette is inherited more stably and with a much greater 
frequency than when the basic replicon is on its own (Gerdes et al., 1985). 
  
1.4.1 Random distribution of high copy number plasmids 
Most high copy number plasmids are assumed to be distributed randomly to daughter 
cells. The probability that one daughter cell will not receive a particular plasmid is 0.5. 
If the copy number of the plasmid is ‘n’, then for all plasmids this probability becomes 
(0.5)
n
. As two daughter cells are produced upon cell division, the probability that either 
one of them will not receive any plasmid is 2(0.5)
n
=2
(1-n)
 (Summers, 1991). For high 
copy number plasmids, this probability becomes very small which means that each 
daughter cell is likely to receive at least one copy of the plasmid (Summers, 1996).  
Factors that reduce copy number, viz. plasmid metabolic load, plasmid clustering and 
oligomer formation, reduce the number of independent plasmids that can be segregated 
and hence affect plasmid stability.  
 
1.4.1.1 Plasmid loss and metabolic load 
The loss of a plasmid from a cell can be due to either structural instability or 
segregational instability. When a plasmid is structurally instable, loss or rearrangement 
of its sequence takes place (Summers, 1991).  Loss of part of the plasmid DNA, or of 
part or the entire foreign gene inserted in the plasmid can occur owing to metabolic 
load (Harrington et al., 1986).  The cell with reduced load gets selective advantage. 
Metabolic load can decrease the rate of host cell growth after introduction of the 
plasmid (Summers, 1991; Kyslik et al., 1993). Plasmid metabolic load on its host takes 
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place since the plasmid requires energy and resources for its maintenance. Both the size 
and the copy number of a plasmid affect the metabolic load imposed on the host. 
Metabolic load can be defined as the portion of the host cell’s resources required for the 
maintenance of the plasmid. Resources can include energy in the form of ATP or GTP, 
or cellular biomolecules such as nucleotides and amino acid. The larger the size of the 
plasmid, the greater is the proportion of cellular energy and resources required for its 
maintenance (Cheah et al., 1987; Ryan et al., 1989; Khosravi et al., 1990).  
Copy number affects metabolic load in a similar way to plasmid size. The higher the 
copy number of the plasmid, the greater the proportion of energy and resources 
required to maintain the plasmid (Seo and Bailey, 1985; Birnbaum and Bailey, 1991).  
 
1.4.1.2 Plasmid clustering 
Plasmids have been reported to cluster within host cells (Eliasson et al., 1992). 
Clustering of plasmids would be expected to affect their proper distribution to daughter 
cells. This is because the number of plasmid clusters has been found to be less than the 
copy number of the plasmid (Gordon et al., 2004; Pogliano et al., 2001; Weitao et al., 
2000). A model has been proposed to resolve this problem by Nordstrom and Gerdes 
(2003) (Figure 1.8). It is suggested that one plasmid is recruited at a time from a cluster 
to the centre of the host cell where the replication factory is present (Figure 1.8, A). 
Recruitment will therefore decluster plasmids. After replication (Figure 1.8, B-C), the 
daughter plasmids are able to diffuse freely in the cell cytoplasm, increasing the 
probability that each daughter cell receives a plasmid (Figure 1.8, D). Thus it is not the 
plasmid cluster that is the unit of segregation but it is the individual plasmid copies.   
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Figure 1.8: Plasmid clustering. The ultimate fate of plasmids in the cluster will vary 
between Par
+
 and Par
-
 cells (Adapted from Nordstrom and Gerdes, 2003) 
 
1.4.1.3 Plasmid oligomer formation and resolution 
 
Plasmid dimers are less stable than monomers (Summers and Sherratt, 1984). 
Oligomers arise as a result of recombination (Patient and Summers, 1993). An oligomer 
of the order of n has a copy number 1/n times the copy number of the monomer 
(Summers, 1996). This means that there are fewer plasmid entities to be distributed by 
random distribution. Moreover, since plasmid replication control elements count 
origins, dimers are considered as two plasmids instead of one (Summers and Sherratt, 
1984). This means that dimers quickly out-replicate monomers in a cell. The low copy 
number of dimers means the rate of plasmid loss increases significantly. This 
phenomenon is known as ‘dimer catastrophe’ (Summers et al., 1993). Multimer 
containing cells grow slowly, giving cells the time to overcome the issue through 
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+
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multimer resolution systems. Many plasmids possess oligomer resolution sites 
including ColE1 (Summers and Sherratt, 1984) and pMB1 (Summers and Sherratt, 
1988; Greene et al., 1981). In ColE1, the oligomer resolution site is known as cer and is 
240 bp in length. Site-specific recombination at this site converts oligomers to 
monomers (Summers and Sherratt, 1984). Oligomer resolution requires the products of 
four genes: argR (the repressor of arginine biosynthesis; Stirling et al., 1988), pepA 
(aminopeptidase A; Stirling et al., 1989), xerC (Colloms et al., 1990) and xerD 
(Blakely et al., 1993). XerC and XerD form a heterodimeric recombinase that mediates 
strand exchange resulting in resolution of oligomers.  
Although necessary, multimer resolution is not sufficient for plasmid stability. 
Inactivation of the promoter of a short transcript, Rcd that lies within the cer site 
reduces ColE1 stability (Patient and Summers, 1993). Upon formation of plasmid 
dimers, Rcd is expressed that inhibits cell division (Patient and Summers, 1993) 
allowing dimers to be converted to monomers by site-specific recombination before the 
cell divides. The expression of Rcd is then reduced enabling cell division to occur and 
normal growth to resume (Summers, 1996).   
 
1.4.2 Low copy number plasmids 
Unlike high copy number plasmids, random distribution is not sufficient to ensure 
proper segregation of plasmids with fewer than approximately 20 copies in the dividing 
cell (Summers, 1996). Low copy number plasmids have developed dedicated functions 
that ensure their maintenance in the host population. One common mechanism is active 
(i.e. energy-consuming) partitioning of plasmids to both daughter cells at division. 
Another ensures that plasmid-free cells are killed so that they do not proliferate and 
take over the population. 
 
1.4.2.1 Plasmid partitioning 
The P1 plasmid which has been the subject of detailed investigation is used here as a 
representative low copy number plasmid that employs active partitioning for 
segregation to daughter cells. The idea that P1 is a low copy number plasmid may need 
revising, however, after the publication of a recent paper by Sengupta et al. (2010). 
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The P1 partitioning locus is known as par. This contains information for two proteins, 
ParA (598aa), ParB (333 aa) (Surtees and Funnell, 2003; Hayes and Barilla, 2006) and 
a centromere-like site, parS (Figure 1.9).  
 
                                                     parA             parB        parS 
Figure 1.9. A schematic diagram of the P1 partition site. (Taken from Hao and 
Yarmolinsky, 2002)  
The parS site is approximately 80 bp in length and is located downstream of the parAB 
operon (Austin and Abeles, 1983). parS contains two recognition sites for ParB (Davis 
et al., 1990; Fung et al., 2001). A schematic diagram of the molecular architecture that 
develops at the P1 parS site is shown in figure 1.10. The parS sequence motifs are 
arranged around an E. coli Integration Host Factor (IHF) binding site (Funnell, 1988, 
1991). IHF increases the affinity of ParB for parS (Funnell, 1991). Initially IHF binds 
to the parS site and induces a bend in DNA that enables ParB binding (Funnell, 1991; 
Funnell and Gagnier, 1993).  
ParB binds as a dimer (Funnell, 1991; Bouet, et al., 2000) through recognition of the 
inverted repeats within parS (Lobocka and Yarmolinsky, 1996; Surtees and Funnell, 
2001). It contains a DNA-binding region at its C-terminus that recognizes sequences 
within the parS. The region of ParB that is required for recognition of ParA lies close to 
the N-Terminus of ParB (Surtees and Funnell, 2001).  
ParA is an ATPase (Davis et al., 1992). Binding of ATP and its hydrolysis are 
important for partitioning to take place (Bouet and Funnell, 1999; Davis et al., 1996; 
Fung et al., 2001). It autoregulates its own expression by binding to its own promoter 
(Davis et al., 1992). The presence of parS decreases expression from the par promoter.   
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Figure 1.10: A schematic diagram showing the molecular assembly at the P1 parS site. 
IHF (purple) binds to the parS region and induces a bend in the DNA. ParB (Green) 
then binds the heptameric (red) and hexameric (blue) repeats located in the opposite 
arms of the parS region. ParA-ATP (pink) then binds to ParB. The figure is taken from 
Hayes and Barilla, 2006. 
 
ParA comes into action following binding of ParB at parS. It interacts with ParB in the 
presence of ATP (Bouet and Funnell, 1999). However, ADP is a better cofactor for 
ParA binding than ATP (Davey and Funnell, 1994). Alternatively, it has been proposed 
that ParA alters conformation of ParB such that the host interaction domain of ParB is 
exposed for function (Philips and Funnell, 2004). ParB stabilizes the ADP-bound form 
of ParA by converting ParA-ATP to ParA-ADP (Philips and Funnell, 2004).  
An interpretation of how P1 plasmid partitioning takes place is shown in Figure 1.11 
(Sengupta et al., 2010). When P1 replicates, the partitioning sites are paired through 
ParB (Figure 1.11, b). ParA separates two paired plasmids through filaments using the 
energy from ATP hydrolysis (Figure 1. 11, c). The plasmids are finally widely 
separated by diffusion (Figure 1. 11, e). When multiple copies of P1 are produced, 
pairing and separation events ensure that plasmids are evenly distributed throughout the 
cytoplasm (Figure 1. 11, f-k).  
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Figure 1.11. Interpretation of the mechanisms of P1 partitioning (Sengupta et al., 2010). 
The green dots indicate parS sites with bound ParB. The red arrows represent ParA 
filaments.   
 
1.4.2.2 Plasmid stabilization through the toxin antitoxin system  
Plasmid stability systems involving toxin and antitoxin components ensure selective 
killing of cells that fail to retain the plasmid following cell division (Jaffe et al., 1985; 
Gerdes et al., 1986). Unlike a plasmid partitioning system, the toxin-antitoxin system 
stabilizes a plasmid through the inhibition of growth or killing of cells rather than 
through ensuring equal distribution of plasmids to daughter cells prior to cell division 
(Gerdes, 1988). The term ‘Postsegregational killing’ is derived from Gerdes (1986).  
 
Toxin-antitoxin systems kill host cells from inside rather than from the outside and are 
thus distinct from the operation of colicins (Nomura, 1964). The names 
postsegregational cell killing (PSK) and addiction systems are sometimes used 
interchangeably with the term toxin-antitoxin system (Hayes, 2003). Restriction-
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modification systems are also considered as part of postsegregational stability systems, 
in which the restriction enzyme acts as the toxin (Kobayashi, 2001).  
 
Toxin-antitoxin loci in bacteria belong to seven two-component gene families and one 
three-component system (reviewd by Gerdes, 2005). In some host-killing gene 
cassettes, the gene for the antitoxin overlaps the gene for the toxin and their synthesis is 
autoregulated. In others, the gene for the antitoxin alone regulates production of the 
toxin. In yet other systems, the product of a third gene is necessary for regulation 
(Engelberg-Kulka and Glaser, 1999; Gerdes, 2000). Toxins belonging to the 
postsegregational killing systems are usually stable proteins. The antitoxin may be 
either a labile protein or an untranslated counter-transcript. In Type I postsegregational 
killing system the countertranscript binds to the toxin mRNA and prevents translation 
of the toxin. In Type II systems, the protein antitoxin binds specifically with the toxin 
and prevents it from exerting any toxic effect on the host (reviewed by Hayes, 2003).  
Toxin-antitoxin systems have been proposed to provide competitive advantage of 
plasmids with (TA+) and without (TA-) systems when co-infection of the same host 
takes place (Cooper and Heinemann, 2000, 2005). Cells that inherit the TA+ plasmid 
are protected from the toxin owing to the continued production of the antitoxin by the 
plasmid. Cells in which only the TA- plasmid is present are killed by the presence of 
the toxin produced by the TA+ plasmid (Cooper and Heinemann, 2005).  Many 
plasmids have multiple toxin-antitoxin systems. A well-known example is plasmid R1 
which contains the hok-sok system (Gerdes et al., 1986) and the kis-kid system (Bravo 
et al., 1987). Multiple toxin-antitoxin systems in the same plasmid have been suggested 
to increase the chances that one plasmid will have one system that its competitor does 
not. Hence, it increases fitness of the cell containing the plasmid with the multiple 
toxin-antitoxin systems (Cooper and Heinemann, 2010).  
If a daughter cell fails to receive the plasmid owing to an error in replication of the 
plasmid or owing to any defect in the plasmid stability system, the toxin causes death of 
the host or inhibits cell growth. The toxin remains longer in the host cell because it is 
degraded relatively slower when compared to the antitoxin. The labile antitoxin is 
degraded by host enzymes. As long as the plasmid is present, more antitoxin continues 
to be synthesized. This leads to the maintenance of only those cells that still retain the 
plasmid and hence contain both the toxin and its antidote.  
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The toxin-antitoxin system of plasmid R1 has been studied in detail. The toxin-
antitoxin locus of plasmid R1 is about 580 bp in length and contains three genes, hok 
(host killing), mok (modulator of killing) and sok (suppressor of killing) (Gerdes et al., 
1985, 1997; Gerdes, 1986) (Figure 1.11, A). The hok gene expresses a small, 
hydrophilic polypeptide of 52 amino acids (Rasmussen et al., 1987). The sok gene lies 
upstream of hok, is 100bp long and is transcribed in a direction opposite to that of the 
hok toxin gene (Figure 1.11, A). The antisense RNA, sok, is trans-acting and its 3' end 
is necessary for proper function (Gerdes, 1988). It forms a single stem-loop structure 
(Dam and Gerdes, 1997).  
Translation of the polypeptide mediator, Mok, is coupled with that of Hok (Figure 1.12, 
A) and the translation of mok mRNA is tightly regulated by sok RNA (Thisted and 
Gerdes, 1992). The single mRNA that codes for Hok and Mok is initially folded at its 3' 
end such that the Shine-Dalgarno sequence for mok (SDmok) is not available to initiate 
translation of mok (Figure 1.12, B). This closed structure is known as fbi (Fold-back 
inhibition). Consequently, neither mok nor hok is translated. In plasmid containing 
cells, this is where the suppressor of killing, sok, comes into play. sok is complementary 
to sokT, a sequence that is located close to SDmok. When the sok-mok mRNA refolds 
as a result of 3' end processing, sok can bind to sokT in the mok-hok transcript (Figure 
1.12, C). The double-stranded RNA formed as a result of sok-mok binding is processed 
by RNaseIII leading to its decay. Thus, hok is not translated and cell death is prevented 
(Gerdes, 1988; Franch et al., 1997). In plasmid free cells, partial processing of the 3' 
end changes the folding pattern that exposes the SDmok (Figure 1.1, D). Translation of 
hok and its mediator, mok, results in the production of Hok toxin (Thisted et al., 1995, 
1994; Franch and Gerdes, 1996) that can potentially kill cells through collapse of the 
cell membrane potential and inhibition of respiration (Gerdes, 1988).  
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Figure 1.12: The parB post-segregational killing system of plasmid R1. Source: De La 
Cueva-Mendez and Pimentel, 2007. 
 
A. The mok-hok-sok parB postsegregational system. B. mok-hok mRNA initially folds 
into a secondary structure in which the target of sok antisense RNA, sokT, is hidden. 
Processing of the 3' end of this structure exposes sokT. C. In cells containing R1, sok 
binds to sokT of mok-hok mRNA and induces RNase III decay of the resultant double-
stranded RNA. D. In cells lacking R1, hok expresses toxin leading to host cell death. 
SD = Shine Dalgarno sequence, mok = mediator of killing, hok = host killing and sok= 
suppressor of killing. 
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1.5 Aims and objectives of the present investigation 
The linear plasmid, pBSSB1, was identified from S. Typhi (Baker et al., 2007b). Since 
its initial identification, only basic characterization based on bioinformatic approaches 
has been carried out. Based on such approaches, the putative origin of replication has 
been determined and ORFs identified. No laboratory based approach has yet been 
conducted to study the replication and stability functions of pBSSB1. The aim of the 
present study is to characterize regions involved with these functions in the linear 
plasmid.  
An initial objective of the study is also to develop a method for the purification of the 
linear plasmid, based on the fact that no standard protocol for the purification of linear 
plasmids in general is available in the literature. Another objective is to identify the 
basic replicon (the minimum region required for replication of the linear plasmid). 
Finally, I will seek to identify regions necessary for stabilization of the plasmid. 
pBSSB1 has been shown to replicate and to be stably maintained in E. coli. To simplify 
the experimental approach I will attempt, in the first instance, to identify regions of 
pBSSB1 which confer competence for replication and stable maintenance upon circular 
E. coli plasmids.   
Investigation of replication and stability functions of pBSSB1 can help in 
understanding the biology of linear plasmids in general. Results from the present work 
can form the basis for future work for a better understanding of specific mechanisms 
involved in these functions in pBSSB1. Development of a method for the purification 
of pBSSB1 can introduce a routine method for the extraction of linear plasmids in 
general.  
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Materials and methods 
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2.1 Solutions 
All solutions were prepared using sterile distilled water. Unless otherwise stated, 
chemicals were purchased from Sigma-aldrich (www.sigmaaldrich.com/united-
kindgdom.html).  
 
100 mM CaCl2 
Anhydrous CaCl2 (1.11g) was dissolved in 100 ml sterile distilled water. The solution 
was filter sterilized using Millipore type VS 0.025 m filter disc before use.  
 
0.5 M EDTA 
Disodium ethylenediaminetetraacetate dehydrate (186.12g) was added to 800 ml of 
distilled water. While stirring, the pH was adjusted to 8.0 by adding sodium hydroxide 
pellets. The final volume was adjusted to 1L and the solution was autoclaved at 121°C 
at 15 p.s.i for 20 min. 
 
3 M Sodium acetate (pH 5.2) 
Sodium acetate (246.09g) was dissolved in sterile 800 ml dH2O. The pH was adjusted 
to 5.2 by using glacial acetic acid. The final volume was adjusted to 1L using dH2O.  
 
Glucose (20%) 
D-Glucose (2g) was dissolved in 10ml dH2O. Once prepared, the solution was sterilized 
by passing through a 0.2 µm filter (Millipore Type VS 0.025 m) 
 
Arabinose (20%)  
Arabinose (2g) was dissolved in 10ml dH2O. Once prepared, the solution was sterilized 
by passing through a 0.2 µm filter (Millipore Type VS 0.025 m). 
 
Ethidium bromide (10mg/ml) 
Ethidium bromide tablets were dissolved in sterile dH2O to prepare 10mg/ml solution. 
200 µl of this was added to 2L of 1X TAE for staining gels.  
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2.2 Reagents 
dNTP (10mM) 
10 mM dNTP was prepared by mixing 100 µl of each of 100 mM dATP, 100mM 
dGTP, 100 mM dCTP and 100 mM dTTP and bringing the final volume to 1ml by 
adding sterile dH2O. 
 
Proteinase K (10mg/ml) 
25 mg lyophilized proteinase K (Roche Applied Science) was reconstituted in 2.5 ml 
sterile dH2O. Aliquots were stored at 4°C for short-term storage and at -20°C for long 
term preservation.  
 
2.3 Buffers  
Tris (0.5 M) 
Tris (hydroxymethyl) aminomethane (60.57g) was dissolved in 800 ml of dH2O. The 
final volume was adjusted to 1 L. The pH was adjusted to 8.0 using 1 M HCl.  
 
TAE (50X) 
TAE was stored as a 50X concentrate and diluted to 1X by adding dH2O. To prepare 
the concentrate, 242.2 g Tris base was dissolved in 800 ml dH2O. Glacial acetic 
(57.1ml) acid and 100 ml 0.5 M EDTA (pH 8.0) were added to this. The final volume 
was adjusted to 1L.   
 
2.4  Bacterial strains  
The bacterial strains used in this study are listed in Table 2.1.  
Table 2.1: Bacterial strains used in this study 
Strain Genotype Source 
XL1-Blue recA1 endA1 gyrA96 thi-1 hsdR17 supE44 
relA1 lac [F´ proAB lacI
q
ZΔM15 Tn10 
(Tet
r
)] 
Agilent technologies 
E. coli Top 10  (F- mcrA Δ(mrr-hsdRMS-mcrBC) 
φ80lacZΔM15 ΔlacX74 recA1 araD139 
Δ(araleu) 7697 galU galK rpsL (StrR) 
endA1 nupG) 
Invitrogen 
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Table 2.1 (contd.) 
E. coli DH5α F- φ80lacZΔM15 Δ(lacZYA-argF)U169 
deoR recA1 endA1 hsdR17(rk -, mk+) phoA 
supE44 thi-1 gyrA96 relA1 λ- 
Invitrogen 
E. coli BR825 polA::Tn10 trp Ludtke et al. 1989 
E. coli SP2  pcnB, lac, recA Podkovyrov and 
Larson, 1995 
BW25141 lacI
q
 rrnBT14 ΔlacZWJ16 ΔphoBR580 
hsdR514 ΔaraBADAH33 ΔrhaBADLD78 
galU95 endABT333 uidA(ΔMluI)  pir
+
 
recA1 
Datsenko and 
Wanner, 2000 
 
2.5  Media 
All media were prepared using milliQ water and sterilized at 121°C at 15p.s.i for 20 
minutes. When glucose was added to any medium, it was filter sterilized separately 
using a 0.2 µm filter (Millipore).  
 
Luria Bertani (LB) broth 
L-broth (Kennedy, 1971) was purchased from Merck (Merck4Biosciences, UK). The 
medium is sold as granules, which is reconstituted in milliQ water according to the 
manufacturer’s instructions. The composition of the L-broth (Miller) per litre is 5 g 
yeast extract, 10 g peptone from casein and 10 g sodium chloride. 
 
Luria Bertani (LB) agar 
To prepare L-agar, 12 g agar-agar was added to per liter of L-broth. 
 
LB agar with X-gal and IPTG 
To prepare L-agar containing X-gal and IPTG, 0.3g of 5- Bromo - 4-Chloro- 3-Indoly-
β-D-galactopyranoside (X-gal, Melford, UK) and 0.3g Isopropyl-β-D-
thiogalactopyranoside (IPTG, Sigma Aldrich, UK) were added to 1L of molten L-agar 
prior to pouring plates. 
 
SOC medium 
The recipe described in Sambrook and Russell (2001) was followed to prepare SOC. To 
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950 ml of dH2O, 5 g yeast extract, 20 g tryptone, 0.5 g NaCl, and 10 ml 250 mM KCl 
were added. The pH was adjusted to 7.0 using 10 M NaOH. The final volume was 
adjusted to 1 L. Before use, 5 ml of 2 M MgCl2 and 20 ml of 1 M glucose were added 
to per litre of the medium. 
 
2.6  Antibiotics  
The antibiotics used in this study are listed in Table 2.2. 
Table 2.2: Antibiotics used in this study 
Antibiotic Solvent Stock concentration 
(mg ml
-1
) 
Working concentration 
(μg ml-1) 
Carbenicillin Water 50 50 
Chloramphenicol Absolute ethanol 10 10 
Kanamycin Water 25 25 
 
All antibiotics were purchased from Melford laboratories (www.melford.co.uk). 
Following preparation, all antibiotics were filter sterilized (Millipore Type VS 0.025  
m)  and stored at −20 °C. 
 
2.7  Plasmids 
Plasmids used in this study are in Table 2.3.  
Table 2.3: Plasmids used in the present investigation 
Plasmid Description Reference  
pBSSB1 Linear, Kan
r
 Baker et al. 2007b 
pUC18 Cloning vector, Ap
r
 Yanisch-Perron et al.  1985  
pBAD18 Expression vector, ParaBAD promoter, 
Kan
r
 
Guzman et. al. 1995 
pFH450 P1 ori, pMB1 ori, cat Hayes, 1998 
pKD13 Template plasmid Datsenko and Wanner, 2000 
For short term storage, plasmids were kept at 4°C. Longer storage was done at -20°C. 
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2.8  Oligonucleotides used in this study 
Oligonucleotides used in the present investigation are listed in Table 2.4.  
 
Table 2.4: Details of oligonucleotides used in the present study 
Oligonucleotide 
 
Sequence 5' to 3' 
 
Oligonucleotides used for construction of linear plasmid library 
 
EcoRIRP2 AGTCGAATTCCCGTTCTGAACAGCCTGTAA 
BamHIRP2 AGTCGGATCCTCACCATCAGGGTTTATTCCA 
EcoRIRP3 TAACGAATTCAGCAATTGGTACCGTTCTGG 
BamHIRP3 TGCCGGATCCGAAAGCTATCCGCACGAAAG 
EcoRIRP4 TTTTGAATTCGGGATTTGTTGACAGGCATT 
BamHIRP4 TGATGGATCCTTTTAACGGCGGCTTATCTG 
EcoRIRP5 TGTCGAATTCTTGTGGAACAATGGCAAAAA 
BamHIRP5 ACATGGATCCACTGCATTTCGAGCAGGTCT 
EcoRIRP6 CAATGAATTCCGCACTGTTAGCCGTAATCA 
BamHIRP6 CGGCGGATCCTTCTGCCGTCTTACCTTGCT 
EcoRIRP7 CTGGGAATTCGCTTGCCCCTATCGTTATCA 
BamHIRP7 TATTGGATCCCCCTTTCATTGGGTTTCCTT 
EcoRIRP8 CTTGGAATTCATGAACAACCGGAAGGTGAG 
BamHIRP8 TGTCGGATCCTTCAGAACCCCAGGAGAATG 
EcoRIRP9 CTTAGAATTCAACCCAATGAAAGGGAAAGG 
BamHIRP9 GTAGGGATCCCAACCACGATACCCGCTACT 
EcoRIRP10 CCAAGAATTCCCGTTGCGATCAAGACAGTA 
BamHIRP10 AGAGGGATCCAGAGCCTTACAGACGGCAAA 
Oligonucleotides used for amplification of kanamycin cassette 
 
pKD13_Fwd ACGTGAATTCGTGTAGGCTGGAGCTGCTTC 
pKD13_Fwd ACGTGGATCCCTGTCAAACATGAGAATTAA 
Oligonucleotides used for construction of deletion derivatives of  RP7 
 
RP7-Fwd-A ATATATATATGAATTCATGAATGGGGAATGGCTACA                              
RP7-Fwd-B ATATATATATGAATTCAGCAAGGTAAGACGGCAGAA                              
RP7-Fwd-C ATATATATATGAATTCCCAAATCCTGCAAAACTTGTTA                           
RP7-Fwd-D ATATATATATGAATTCAAGACCTGCTCGAAATGCAG      
RP7_del_EcoRI_2 AATTAATTGAATTCCCTACGGCATGGGTGTAACT                                  
RP7_del_BamHI_2 AATTAATTGGATCCCCCATGTGAGCTTTACCATACA                           
RP7_del_EcoRI_3 AATTAATTGAATTCAATGCTGCTCATGTCGTCAC                                  
RP7_del_BamHI_3 AATTAATTGGATCCCTTGTCCAGCCACACTGAGA                              
RP7_delete_2_fwd AATTAATTGAATTCATGAACAACCGGAAGGTGAG                             
MG6_Delete_1_Fwd AATTAATTGAATTCTGCAAGCAAAGAAAAAGCAA        
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Table 2.4 (contd.) 
MG6_Delete_1_Rev AATTAATTGGATCCTGTTGTCATAAGTACCCCGTTTT   
MG6_Delete_2_Fwd AATTAATTGAATTCAGCCTCTTGCTGATGTAGCAC  
MG6_Delete_2_Rev AATTAATTGGATCCTTTCTTTTATTCTGTCCTTATTGTTG                         
Oligonucleotides used to generate deletion derivatives of RP2 
 
RP2_Min_DelA_Rev ATATATATATGGATCCCTTCCTGGACGACGAAGATT                              
RP2_Min_DelB_Rev ATATATATATGGATCCCCACAGTTTGATGACCTGGA                              
RP2_Min_DelD_Rev ATATATATATGGATCCGTGGCTCTTGCCTACACCTC                              
RP2_Min_DelE_Rev ATATATATATGGATCCAAAAGGGTAAAGGGCTTCCA                              
RP2_Min_DelF_Rev ATATATATATGGATCCCGTCCAGTTCGTGAACACTC                              
RP2_Delete_Fwd_A ATATATATATGAATTCAATTGAATGACTGCCCCTTG                              
RP2_Delete_Fwd_B ATATATATATGAATTCCAATCGCTTCCTGGTTGTTT                              
RP2_Delete_Fwd_C ATATATATATGAATTCTTTCAAGCTGTTGGGTGTTG                              
RP2_Delete_Fwd_D ATATATATATGAATTCTTCCGTATTCCGTCTGGAAC                              
RP2_Delete_Fwd_1 ATATATATGAATTCTCTGCACTGCTATGGACTGG                                   
RP2_Delete_Fwd_2 ATATATATGAATTCGCTTGCCCCTATCGTTATCA                                   
RP2_Delete_Fwd_3 ATATATATGAATTCATGAACAACCGGAAGGTGAG                                   
RP2_Delete_Rev_3 ATATATATGGATCCCTCACCTTCCGGTTGTTCAT                                 
RP2_Delete_Rev_2 ATATATATGGATCCGCCGTAGGCACGAGAGTAAG                                 
RP2_Delete_Rev_1 ATATATATGGATCCCCAGTCCATAGCAGTGCAGA                                 
RP2_RevB-I ATATATATATGGATCCTTTAACCGCTGCCGTTGTAT                              
RP2_RevB-II ATATATATATGGATCCCCAGTCCATAGCAGTGCAGA                              
RP2_RevB-III ATATATATATGGATCCGGTCATAGCTGCTACTGGTGC                             
RP2_RevB-IV ATATATATATGGATCCTGGAAGAACTTCACAATGCAA                             
RP2_FwdC-I ATATATATATGAATTCTAGTTCCGAATCCCATAGGC                              
RP2_FwdC-II ATATATATATGAATTCCATGTTGGCAATAGCTGACG                              
RP2_292_RevI ATATATATATGGATCCCGGAATCATAAAACCCCCTAA                             
RP2_292_RevII ATATATATATGGATCCCCGTCAGCTATTGCCAACAT                              
RP2_292_RevIII ATATATATATGGATCCAACTAAGGAGTTGCCTATGGGATT                         
RP2_292_FwdI ATATATATATGAATCCTAGTTCCGAATCCCATAGGC                              
RP2_292_FwdII ATATATATATGAATCCCATGTTGGCAATAGCTGACG                              
RP2_292_FwdIII ATATATATATGAATCCTTCCGTATTCCGTCTGGAAC                              
RP4_ORF1_2_fwd AAATTTGAATTCGGGATTTGTTGACAGGCATT                                    
RP4_ORF1_2_rev AAATTTGGATCCTGAAAAGCATCCTGACATGC 
Oligonucleotides used to generate deletion derivatives of RP4 
 
RP4_ORF_3_4_Fwd AAATTTGAATTCCCCCAGTAAAGGGGCTTATG                                    
RP4_ORF_3_4_Rev AAATTTGGATCCTTAAATGGGGTTCGTGGTTT                                    
RP4HindIII_del_R_2 AATTAATTGGATCCATCGATGGATTGCTTTCACC                                 
RP4HindII_del_Fwd_3 AATTAATTGAATTCTTGTCAGTTAAGCTGTGGCTATC                             
RP4Hind_del_Fwd_2 AATTAATTGAATTCATAGCCGTCTGTGAGCGATT                                 
RP4_del_fwd_A ATATATATATGAATTCCGCTGATTTGACGGCATAC                        
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Table 2.4 (contd.) 
Oligonucleotides to insert stop codon in ORFs in RP4 
 
Mutate_ORF7_RP4_Rev TCTCTATGCCATGACCGTTT 
Mutate_ORF7_RP4_ 
Complementary 
 
AAACGGTCATGGCATAGAGA 
Mutate_ORF8_RP4_Rev AGGGGAGACACCCACTACCTA 
Mutate_ORF8_RP4_ 
Complementary TAGGTAGTGGGTGTCTCCCCT 
Mutate_ORF9_RP4_Rev CGGCTTTCTACAACTGGTTC 
Mutate_ORF9_RP4_ 
Complementary GAACCAGTTGTAGAAAGCCG 
New_Mutate_ORF8_Rev CAGCTAGTGGGTGTCTCCCCT 
New_Mutate_ORF8_Fwd AGGGGAGACACCCACTAGCTG 
RP4HM_DelB_Fwd ATATATATATGAATTCCCAGTTCTGCAAGTCTTTCACT                           
BamHI_RP4HindIII AATTAATTAAGGATCCTGGGGTTCGTGGTTTTACTT                              
Oligonucleotides used to introduce stop codon in RP7 
 
RP7_Mutate_ORF18_Fwd GATTGCGGTTTAAACTGCTTTTAATGCCGGTGACTC 
RP7_Mutate_ORF18_ Rev GAGTCACCGGCATTAAAAGCAGTTTAAACCGCAATC 
RP7_ORF19_Mutate_Fwd TTCACGAGCTTGATTAACAACCGGAAGGTGAGC 
RP7_ORF19_mutate_Rev GCTCACCTTCCGGTTGTTAATCAAGCTCGTGAA 
RP7_mutate_ORF20_Fwd TCTCTTCCCGATCCTTAGTTCGTCGGCAAGCTG 
RP7_mutate_ORF20_Rev CAGCTTGCCGACGAACTAAGGATCGGGAAGAGA 
Mutate_RP7ORF1_Fwd GCTTTGGCAGCGGCTGGGATATAAGCAACGGTAAC 
Mutate_RP7ORF1_Rev GTTACCGTTGCTTATATCCCAGCCGCTGCCAAAGC 
Oligonucleotides to amplify ORF9 
EcoRI_ORF9_fwd 
 
ATATATATATGAATTCAGGAGGTTGAGATAGAGTTAAGG
GGATGAA               
PstI_ORF9_rev ATATATATATCTGCAGTCGATCAGGTCGTCAAAGAG              
Oligonucleotides used for sequence confirmation 
 
P2_INLP TTG ATG AAC AAC CGG AAG GT 
P2_INRP AAT TTC ATC TGT CGC ACC AA 
P3_INT_F ATTTCTTCCAGCCCTGCTTT 
P3_INT_R CAGCCAGCTTCCTGAATGAT 
P5_INT_F CGCACTGTTAGCCGTAATCA 
P5_INT_R AAACAACCAGGAAGCGATTG 
P6_INT_F TCTGCACTGCTATGGACTGG 
P6_INT_R GCCGTAGGCACGAGAGTAAG 
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2.9  Plasmid Extraction 
2.9.1 STET Plasmid Preparation  
The method described by Holmes and Quigley (1981) was followed. Five ml of DH5α 
containing pBSSB1 was grown overnight in L-broth media containing kanamycin 
(25µg/ml). Cells were pelleted in a table-top centrifuge at 14,000  g (Eppendorf 
minispin) for 2 min. The supernatant was poured off. Cells from 1.5ml culture were 
suspended in 110μl STET buffer (8% sucrose, 5% Triton X-100, 50 mM Tris pH 8.0, 
50 mM EDTA pH 8.0) containing lysozyme (0.5 mg/ml final concentration). The tube 
containing the cells was placed in 100°C heat block for 30 sec. The tube was 
centrifuged for 10 min at 14,000  g in a microfuge (Eppendorf minispin). The pellet 
was discarded with a sterile toothpick. Isopropanol (110 μl) was then added and the 
tube centrifuged for 10 min at 14,000  g (Eppendorf minispin). The supernatant was 
poured off. Pelleted DNA was washed briefly with 0.4 ml cold 70% ethanol. Next, the 
ethanol was poured off and the washing repeated three more times. Any remaining 
liquid was removed with a micropipette and the pellet was dried overnight at room 
temperature. Any DNA pellet was dissolved in 20μl TE buffer. Purified plasmid was 
stored at 4°C. 
 
2.9.2 Single colony final sample buffer (SCFSB) technique  
This method was obtained through personal communication with Dr. David Summers. 
In this method, 200µl of culture was mixed with 200 µl of SCFSB buffer. To prepare 
100 ml SCFSB buffer, 10 g ficoll, 0.025 g of bromophenol blue, 0.25g of orange G and 
0.5g of sodium dodecyl sulphate (SDS) were dissolved in 80ml dH2O water. The final 
volume was then adjusted to 100ml. The culture was mixed with the buffer and left at 
room temperature for 15 minutes. Cell debris was pelleted by centrifugation in a table-
top centrifuge at 13,000 rpm for 15 min. 15-20 µl of supernatant was loaded directly in 
a 1% agarose gel for electrophoresis.  
 
2.9.3 The Qiagen miniprep for plasmid extraction 
The manufacturer’s instructions outlined in the handbook at www.qiagen.com was 
followed. 
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2.9.4  Kado and Liu Method  
Fifteen ml of an overnight culture was harvested by centrifugation at 14, 000  g  in a 
table-top centrifuge (Eppendorf minispin). Cells were washed with 5 ml of E buffer. To 
prepare E buffer, 4.85 g of Tris was dissolved in 800 ml dH2O. The pH was adjusted to 
7.9 using glacial acetic acid. 0.74 g Disodium ethylenediaminetetraacetate dehydrate 
was then added to give a final concentration of 2 mM. The total volume was adjusted to 
1 L.  
 
Cells were lysed by the addition of 2ml of lysing solution. Lysing solution consisted of 
3% SDS and 50 mM Tris. The pH was adjusted to 12.6 by adding 1.6 ml of 2N NaOH 
and the final volume was adjusted to 100ml. The lysing solution was filter sterilized by 
using a membrane filter (Millipore Type VS 0.2 m) prior to use. Cells were incubated 
at room temperature under gentle agitation. They were then heated at 65°C for 20 min 
in a heated block. NaCl (0.5 ml of 4M) and twice the volume of phenol-chloroform 
solution (sigma, UK) were added. The solution was mixed gently for 30 min. It was 
then centrifuged at 14,000  g at 4°C for 15 min. The top aqueous phase was removed 
carefully using a pipette and extracted with diethyl ether. DNA in the aqueous phase 
was precipitated with ethanol. The DNA pellet was washed three times with 70% 
Ethanol and suspended in TE (10 mM Tris-HCl, 1 mM EDTA, pH 8.0). Five µl of 
sample was used for electrophoresis.   
 
 
2.10 PCR  
 
2.10.1 Routine PCR using Taq DNA polymerase from NEB (www.neb.com).  
All PCR reaction components were thawed and assembled on ice. PCRs were done in 
total volumes of either 25 µl or 50 µl. The following master mix adopted from the NEB 
website was used with the modification that DMSO was included at a final 
concentration of 5%.  The composition of the master mix used is detailed in Table 2.5. 
 
 
 
Replication and stability of the linear plasmid pBSSB2                         Chapter 2: Materials and Methods 
 
41 
 
Table 2.5: Composition of PCR master mix used for routine PCRs using Taq DNA 
polymerase 
Component 25 μl reaction 50μl reaction Final Concentration 
10X Standard Taq Reaction 
Buffer 
2.5 µl 5 μl 1X 
10 mM dNTPs 0.5 µl 1 μl 200 µM 
10 µM Forward Primer 0.5 µl 1 μl 0.2 µM  
10 µM Reverse Primer 0.5 µl 1 μl 0.2 µM  
DMSO 1.25 µl 2.5 µl 5% 
Template DNA variable variable <1,000 ng 
Taq DNA Polymerase 0.125 µl 0.25 µl 1.25 units/50 µl PCR 
Nuclease-free water to 25 µl to 50 µl   
 
The different components were mixed by pipetting up and down gently. They were then 
centrifuged briefly to collect everything to the bottom of the tube. Thermocycling 
conditions for PCR were as follows:  
Initial denaturation: 95°C   3-5 min, 35 cycles: 95°C, 30 sec, 55–65°C, 30-60 sec  
72°C 1 min per kb. Final extension: 72°C 10 min. Hold: 4°C  
 
2.10.2 Colony PCR 
A single colony was resuspended in 20µl of sterile distilled water. The cells were lysed 
by heating at 100°C for 10 min. Cellular debris were removed by spinning at 14,000  
g for 5 minutes. The supernatant (2 µl) was used as template in a routine 25 µl PCR 
reaction as detailed in section 2.10.1.  
 
2.10.3  Large amplicon and high fidelity PCR 
The MasterAmp
TM
 Extra Long DNA polymerase kit from Epicentre Biotechnologies 
(www.cambio.co.uk) was used for all large amplicon and high fidelity PCR reactions. 
PCR reaction mixes were prepared and reaction conditions were maintained according 
to the manufacturer’s instructions.  
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Briefly, the master mix was prepared as outlined in Table 2.6. 
 
Table 2.6: Reaction mix used for high fidelity PCR using MasterAmp
TM
 DNA 
polymerase 
Component Volume (µl) Final concentration 
DNA template Variable 4-5 times more template 
than standard PCR 
Sterile water To a reaction volume 
of 25 µl 
 
Forward primer 5 1 µM 
Reverse primer 5 1 µM 
MasterAmp Extra-Long DNA 
Polymerase Mix 
1 2.5 U 
MasterAmp™ Extra-Long 
PCR 2X Premix 5 
25 1X 
Total 50  
 
 
The Thermocycling conditions were:  
Initial denaturation at 98°C for 1-3 minutes followed by a three-step cycling reaction 
consisting of 35 cycles of denaturation at 1 minute, annealing at 2-5°C lower than the 
Tm of the primers for 0.5-1 min and extension at 72°C for 1min per kb of the product. 
A final extension was carried out at 72°C for 10 minutes. The samples were held at 4°C 
before further treatment.  
 
2.10.4 PCR using the Expand Long Template PCR system from Roche  
High Fidelity and long PCRs were also carried out using the Expand Long Template 
PCR system from Roche (www.roche-applied-science.com). For PCR reaction 
conditions and master mix compositions, the manufacturer’s instructions were 
followed. For a typical 50µl reaction, the master mix was as outlined in Table 2.7. 
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Table 2.7: Master mix for long template PCR 
Components Volume (µl) Final 
Concentration 
Sterile distilled water To a final volume of 
50 
- 
dNTPs (10mM) 1.75 350µM 
Forward primer (10µM) 1.5 300nM 
Reverse primer (10µM) 1.5 300nM 
10X PCR buffer with MgCl2 5 1X 
Template DNA Variable - 
Expand long template 
enzyme mix 
0.75 µl 3.75U 
 
Thermal cycling conditions were as follows:  
Initial denaturation: 94°C for 2-3 min 
35 cycles consisting of: denaturation at 94°C for 10 sec, annealing at 50-60°C for 30 
sec and extension at 68°C for 2 min+ 20sec for each successive cycle for up to 3 kb and 
4 min+ 20 sec for each successive cycle for up to 6 kb of amplicon size. 
Final extension was done at 68°C for 10 min. 
 
2.11 Purification of PCR products and digested DNA  
PCR products and digested DNAs were purified using the PCR purification kit from 
Qiagen according to the manufacturer’s instructions. The QIAquick gel extraction kit 
was used when a DNA sample needed to be purified from an agarose gel.  
 
2.12 Quantitation of DNA 
The concentration of DNA was quantified by measuring the optical density at 260 nm  
using a ND-1000 spectrophotometer (NanoDrop).  
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2.13 Restriction digestion 
Restriction enzymes were purchased from either NEB (www.neb.com) or Fermentas 
(www.fermentas.com). The manufacturers recommended reaction conditions were 
followed for digestion.  
 
2.14 Exonuclease treatment 
5’ to 3’ lambda exonuclease was purchased from NEB. Reactions were carried out 
according to the manufacturer’s instructions. 
 
2.15 Ligation using T4 DNA ligase 
Typical ligation reaction mixes were as described in Table 2.8. 
Table 2.8: Composition of ligation reaction mix 
Component Volume (µl) Final concentration 
DNA Variable Variable 
10X ligase buffer 1 1X 
T4 DNA ligase 1 400U 
Sterile distilled water To 10 µl  
Total 10  
 
Reaction mixes were incubated at 16°C for 16 hrs.  
 
2.16 Drop dialysis 
Ligated DNA samples were placed on a 0.2µm filter disc placed on sterile distilled 
water and left for about 10-15 min in order to remove excess salts prior to 
electroporation. 
  
 
2.17 Gel electrophoresis 
DNA samples were mixed with 5X loading dye (Bioline). Hyperladder I, supercoiled 
ladder or high range ladder (Bioline) was used as DNA sizing markers. Electrophoresis 
was done using 1% (w/v) agarose gels for routine purposes and 0.4% (w/v) agarose gels 
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for running linear plasmid samples. 1X TAE buffer was used for preparation of gels 
and for electrophoresis. Following electrophoresis gels were stained in 1X TAE 
containing 0.5μg ml-1 ethidium bromide, and visualized using the Gel Doc XR system 
(Biorad).  
  
2.18 Transformation 
2.18.1 Electroporation 
Ten ml of L-broth was inoculated with a single colony of the desired E. coli strain and 
incubated at 37°C overnight in an orbital shaker at 120 rpm.  Cells were harvested by 
centrifugation (MSE Harrier) at 3200 g for 10 min and washed with ice cold sterile 
distilled water. This step of harvesting and washing was repeated a total of three times. 
Cells were finally suspended in 200 µl of ice-cold sterile distilled water. Fifty µl of 
competent cells were transferred to an electroporation cuvette with a gap of 0.1cm. 
DNA to be transformed was added to the cells and mixed briefly by pipetting up and 
down. Cells were then subjected to an electric pulse of 1.6 kV, 200 Ohms in a Gene 
Pulser unit (Bio-Rad). SOC medium (450 µl) was quickly added to the cells. They were 
allowed to recover for an hour at 37°C at 120 rpm. Cells were then plated on 
appropriate medium either directly or following suitable dilution. Plates were incubated 
at 37°C overnight in a static incubator. 
 
2.18.2 Chemical transformation 
Ten ml of L-broth was inoculated with a single isolated colony of the desired E. coli 
strain and incubated at 37°C at 120 rpm. Cells were harvested by centrifugation (MSE 
Harrier) at 3200 g for 10 min. They were then washed with ice-cold 20mM CaCl2. 
The step to harvest and wash the cells was repeated two more times before the cells 
were resuspended in 200 µl of ice-cold 100mM CaCl2. When DNA polymerase I 
mutant and pcnB mutants were used, 100 µl of competent cells were used for 
transformation. DNA to be transformed was added to the competent cells and mixed 
gently. Cells were given a heat shock at 42°C for 45 sec-1min. They were then placed 
on ice for 2min. 900 µl of pre-warmed L-broth (in case of DNA polymerase I mutant)/ 
SOC (in case of pcnB mutant) was added and the cells allowed to recover pcnB mutants 
were given an hour at 120 rpm to recover before they were plated on appropriate 
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medium. Transformed DNA polymerase I mutants were allowed to recover for three 
hours at 37°C in a static incubator. They were then allowed a further overnight 
recovery by transferring the 1ml culture to 9 ml of L-broth. The suitable antibiotic was 
added to this 10ml broth. The tube was incubated overnight at 37°C once again under 
static conditions. Following incubation, cells were harvested by centrifugation and 
resuspended in 100 µl of L-broth. All cells were plated on suitable medium containing 
the appropriate antibiotic. Plates were incubated at 37°C overnight to allow growth of 
transformants.  
 
2.19 Phase contrast microscopy 
Five hundred µl of boiling 1% (w/v) agarose in SDS was quickly spread on a 
microscope slide and allowed to solidify. Between 5-10 µl of the bacterial culture to be 
observed was spread on top of the agar as soon as it had solidified. A cover slip was 
placed on top of the film and the slide was studied immediately under the microscope 
using an oil immersion objective of a phase contrast microscope (Nikon Eclipse 80i). a 
100X CFI Plan Fluor objective was used. A software known as NIS-elements F 3.0 
(Nikon) was used for image acquisition and the analysis of images was performed using 
the ImageJ software (Abramoff et al., 2004).   
 
2.20 Site-directed mutagenesis  
2.20.1 Site-directed mutagenesis by overlap extension method  
Cloned RP4 was mutated at desired sites by using mutated synthetic oligonucleotides. 
In separate PCR reactions, two mutated amplicon are generated. For each reaction, 
primer pairs were used in which one was mutated that annealed within the cloned DNA 
and one flanking primer that hybridized to one end of the target sequence was used. 
The two PCR reactions with overlapping ends were run and purified from agarose gel. 
They were mixed in equimolar proportions to act as template in a third PCR that used 
only the two flanking primers for amplification.  
 
A schematic diagram of the method is outlined in Figure 2.1. 
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The PCR reaction mixture was the same as that when the Expand Long Template DNA 
polymerase (Roche) was used (section 2.10.4).  
 
2.20.2 The QuikChange II one-day site-directed mutagenesis method (Smith, 
2007). 
pUC18 containing the desired insert (RP7) was used as template. Synthetic primers 
containing the desired mutation were used to synthesize the double stranded 
supercoiled template using PfuTurbo DNA polymerase (Stratagene).  
 
The PCR reaction mix was prepared according to the manufacturer’s recommendations 
with slight changes. The master mix described in Table 2.9 was adopted for PCR. 
 
 
 
Parental DNA 
Mutated DNA 
Figure 2.1: Schematic representation of the overlap extension method for the 
introduction of mutation. Adapted from Ho et al., 1989  
 
‘a’ and ‘d’ are non-mutated flanking primers, ‘b’  and ‘c’ are mutated complementary 
primers. AB and CD are products of amplifications using a+b and c+d primer pairs.  
Replication and stability of the linear plasmid pBSSB2                         Chapter 2: Materials and Methods 
 
48 
 
Table 2.9: Composition of amplification master mix used for site-directed 
mutagenesis 
Component Final 
concentration/amount  
Volume (μl) 
Reaction buffer 1X 5 
Double stranded DNA 
template 
50 ng 1 
Oligonucleotide primer 
1 
125 ng 1.5 
Oligonucleotide primer 
2 
125 ng 1.5 
dNTP mix 300 µM 1.5 
Sterile distilled water  To 50 μl 
PfuTurbo DNA 
polymerase 
0.05 U/ μl 
 
1  
 
The cycling parameters used were as follows: 
Denaturation: 95°C for 30 seconds 
Annealing: 55°C for 1 minute 
Extension: 68°C for 1 minute/kb of template plasmid length 
Total number of cycles: 20 
 
The product of the PCR was double-stranded mutated plasmid with nicks. The 
amplified product was purified using a QiaQuick PCR purification column (Qiagen). 
Parental DNA template in the amplified mix was then digested by DpnI (NEB) 
digestion following the manufacturer’s recommendations. The digested product was 
transformed into competent XL- 1 Blue E. coli cells which repaired the nicks in the 
mutated plasmid. Transformants which grew in LA containing appropriate antibiotic 
were then selected for screening for the presence of the mutated plasmid. Purified 
plasmids were confirmed for the presence of the mutation by sequencing. 
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2.21 DNA sequencing 
DNA sequencing was carried out by Geneservice Ltd. Using BigDye Terminator 
chemistry and a 3730 capillary sequencer (Applied Biosystems).  
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3.1 Introduction 
The first method for purification of plasmid DNA exploited its circular nature (Clewell 
and Helinski, 1970). This method depended on differential binding of the DNA 
intercalating dye, ethidium bromide, to covalently closed circular, nicked open circular 
and linear DNA fragments. During purification of plasmids from bacterial cells, 
chromosomal DNA usually undergoes shearing following cell lysis and is converted to 
smaller, linear fragments. Such linear DNA fragments and nicked open circular DNA 
bind more dye than covalently closed circular plasmids. Consequently, the latter 
undergo a smaller decrease in buoyant density and can be separated from linear DNA 
using high speed centrifugation in a caesium chloride - ethidium bromide solution. 
When the density gradient reaches equilibrium, the covalently closed circular plasmid 
settles below the chromosomal DNA band.  
Later, more rapid methods for plasmid purification were developed that also relied on 
the covalently closed circular nature of plasmids. A well-known example of these was 
designed by Birnboim and Doly (1979). The principle of this method was the 
differential alkaline denaturation and strand separation of linear chromosomal and 
circular plasmid DNA. Alkali can break down hydrogen bonds holding the nitrogenous 
bases between two polynucleotide chains. During cell lysis chromosomal DNA is 
usually sheared into linear fragments. Linear chromosomal DNA fragments and 
plasmids undergo denaturation by alkaline treatment. However, because of their 
circular structure plasmid DNA strands are only partially separated whereas sheared 
linear chromosomal DNA strands are completely separated (Warner and Rush, 1969; 
Birnboim and Doly, 1970). Upon neutralization, chromosomal DNA strands renature 
randomly and become entangled and insoluble. Circular plasmid DNA strands, which 
remain close to each other, renature rapidly. In methods employing heat for 
denaturation of DNA instead of alkaline treatment, e.g. the STET method (Holmes and 
Quigley, 1981) a similar situation arises where chromosomal DNA strands undergo 
complete separation whereas circular plasmid DNA strands remain bound together. In 
both methods randomly reannealed chromosomal DNA strands form an insoluble 
aggregate in close proximity with SDS-protein complexes and most of the RNA. This 
insoluble aggregate can be precipitated by centrifugation (Kay et al., 1952; Marko and 
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Butler, 1950; Crestfield et al., 1955). Plasmid DNA in the supernatant can then be 
recovered by ethanol precipitation. 
The extraction of linear plasmids using methods designed for circular plasmid 
purification is not appropriate. Because of their structure, linear plasmids would be 
expected to behave like sheared linear chromosomal DNA fragments. They are easily 
prone to complete denaturation of their strands and upon renaturation, become 
insoluble and be lost in the pellet of cellular debris and chromosomal fragments.  
 
Methods employed for purification of some linear plasmids must also include a 
protease treatment prior to cellular protein removal owing to the presence of the 
terminal protein at the end of the linear plasmid. Without this the linear plasmid is 
likely to be lost during the cellular protein removal step e.g. with phenol chloroform 
treatment.  
 
Caesium chloride ethidium bromide density gradient centrifugation failed to isolate the 
linear plasmid with 5´ terminal protein, SCP1, from Streptomyces coelicolor A3 (2) 
(Schrempf et al. 1975). In 1979, Hayakawa et al. used a neutral pH DNA extraction 
method for the purification of total cellular DNA which contained a linear plasmid, 
pSLA2, from Streptomyces rochei. The alkaline lysis method (Birnboim and Doly, 
1979) precipitated most of the linear DNAs and was, therefore, not suitable for the 
extraction of the linear plasmid (Chater and Kinashi, 2007).  
 
Conventional agarose gel electrophoresis has been used to separate the linear plasmids 
pSCL1 (12kb) from S. clavuligerus (Keen et al., 1988), pSRM (43kb) from S. rimosus 
(Chardon-Lauriaux, 1986), pFS1 (16kb) from Bacillus polymyxa (Seldin and Rosado, 
1993) and pMC3-2 (6kb) from Morchella conica (Meinhardt et al., 1991) from the 
respective chromosomal DNA.  
 
The purification of linear plasmids was made easier with the introduction of various 
types of pulsed-field gel electrophoresis (PFGE) (Schwartz and Cantor, 1984; Carle and 
Olson, 1984).  In this method, cells are immobilized in agarose plugs, which are treated 
successively with lysozyme, protease and detergent, before being embedded in an 
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electrophoresis gel. In this way, shearing of linear DNA is minimized. Linear plasmids 
which have been purified using PFGE are shown in Table 3.1.  
 
Table 3.1: Examples of linear plasmids extracted through use of PFGE 
Plasmid Size (kb) Source organism Reference 
SCP1 363 S. coelicolor A3(2) Kinashi et al., 1987 
pKSL 520 S. lasaliensis Kinashi and Shimaji, 1987 
pSLA2-M 100 S. rochei Kinashi et al., 1994 
pSCL1, 2 and 
3 
11.7, 120, 
460  
S. clavuligerus Kinashi et al., 1995 
pSGR1  160 S. griseus  Kinashi et al., 1995 
pSAR1and 2 300, 200 S. argenteolus Kinashi et al., 1995 
pZG101 387 S. rimosus Gravius et al., 1994 
pSA1 and 2 100, 250 S. avermitilis Evans et al., 1994 
pCLP 25 Mycobacterium 
celatum 
Picardeau and Vincent, 
1998 
pBD2 208-212 Rhodococcus 
erythropolis 
Dabrock et al., 1994 
pNC10, 20, 
30 and 40 
70, 85, 185 R. corallinus Saeki et al., 1999 
pFiD188 200 R. fascians Crespi et al., 1992 
pHG201, 202 
and 203 
270, 400, 420 Nocardia opaca Kalkus et al., 1990 
 
Borrelia linear plasmids, which differ from most other linear plasmids in that they have 
covalently closed ends, were originally extracted using caesium chloride and ethidium 
bromide density gradient centrifugation (Barbour and Garon, 1987). Subsequently, 
most Borrelia linear plasmids have been extracted through the preparation of total 
cellular DNA that was either run in low-percentage agarose (Barbour, 1988, 
Hinnebusch et al., 1996; Schwann et al., 1988; Lane, 2009) or PFGE was used to 
separate the linear plasmids (Barbour, 1989, Baril, 1989).  When necessary, the linear 
plasmid bands were electroeluted from the agarose gel.  
 
Chapter 3: Development of a method for the purification of the linear plasmid, pBSSB2 
 
54 
 
The linear plasmid pBSSB2, which is the subject of the present investigation, was 
extracted by Baker et al. (2007b) using a modification (Taghavi et al. 1994) of a 
method described originally by Kado and Liu (1981) (section 2.9.4). The method 
employs alkaline lysis of cells followed by precipitation of insoluble chromosomal 
DNA and cellular debris by salt. This is followed by treatment with phenol - 
chloroform. Plasmid DNA in the supernatant is purified by precipitation. However, this 
modified method (referred to as the Taghavi method in the present study) was found to 
give highly variable results with poor yield of the plasmid (Stephen Baker, personal 
communication). An initial objective in the present study was, therefore, to optimize a 
rapid, reliable, reproducible and efficient method for the extraction of pBSSB2 that 
could be used for routine preparation of linear plasmid DNA.  
 
3.2 Use of conventional plasmid extraction methods for pBSSB2 
purification 
At first, various common plasmid extraction methods such as the rapid boiling lysis 
method of Holmes and Quigley (1981) (section 2.9.1), electrophoresis of crude cell 
extracts by the Single Colony Final Sample Buffer method (D. Summers, personal 
communication, section 2.9.2) and the Qiagen plasmid mini preparation kit (section 
2.9.3) were used in an attempt to extract the linear plasmid, pBSSB2 from E. coli 
Top10 cells. However, none of these methods was found to yield a visible plasmid band 
following electrophoresis of the purified sample.  
  
3.3 Development and optimization of a method for the successful 
extraction of pBSSB2 
In preliminary experiments with the Taghavi method (1994) to purify pBSSB2 no band 
was visible in an agarose gel. The presence of the linear plasmid, however, could be 
detected by PCR using primers that amplified a 500bp region of the plasmid (Data not 
shown). It was concluded that the Taghavi method was not an efficient option for 
routine purification of the plasmid. It was clearly important that an efficient and reliable 
method for the purification of pBSSB2 was developed. Modifications were therefore 
made to the Taghavi method, with each step of the procedure being considered 
individually for optimization as discussed in the following sections. 
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3.3.1 Cell lysis 
Plasmid pBSSB2 is linear with proteins attached covalently at its 5’ ends. While 
designing a lysis solution it was argued that the linear plasmid could be more prone to 
denaturation if alkaline lysis was used because of its linear structure than it would be if 
it had a circular structure. Linear plasmid fragments would be lost more easily with 
chromosomal DNA fragments that arise following cell lysis. In addition, gentle cell 
lysis condition can also reduce shearing of plasmid DNA and enable recovery in its 
original form. 
In the Taghavi method, the lysis solution comprised 40mM Tris and 1% sodium 
dodecyl sulphate with its pH being adjusted to 12.6 with 5N NaOH. In the absence of 
lysozyme and sucrose this solution would cause rapid cell lysis. Rapid lysis could shear 
linear plasmid DNA. Additionally, the alkaline pH of the lysis solution would cause 
denaturation of not only chromosomal DNA but also of linear plasmid DNA strands. 
Subsequent renaturation would render both chromosomal and plasmid DNA insoluble 
and result in subsequent loss with cellular debris.  
It was, therefore, decided to use a lysis solution that contained lysozyme to digest the 
cell wall and a non-ionic detergent, Triton-X, in place of SDS, to achieve gentle cell 
lysis in the presence of sucrose that provided an osmotically balanced environment in 
which lysis could occur. The pH of the lysis solution was also maintained near to 
neutral (pH 8.0) in order to prevent denaturation and possible insolubilization of 
pBSSB2.  
In the optimized method (Table 3.2), a single colony of E. coli (SGB33) containing 
pBSSB2 was inoculated into 2L of L-broth containing kanamycin (30 µg ml
-1
) and 
grown overnight at 37°C and 120 rpm on an orbital shaker. Cells were harvested and 
resuspended in a solution containing 2% Triton X-100, 60mM EDTA and 50mM Tris, 
pH 8.0 (Table 3.2, step: 1). For every 250 ml of culture, 5 ml of resuspension solution 
was used. Cells were then incubated with gentle agitation at 37°C for 1 hour in lysis 
solution containing lysozyme (1mg ml
-1
), sucrose (10%), 50mM Tris (pH 8.0) and 
0.5M  EDTA (Table 3.2, step: 2).  
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3.3.2 Removal of cell debris 
In the Taghavi method, cell debris was directly removed from the cell lysate using 4M 
NaCl and phenol-chloroform (1:1, water saturated, pH 4.8). pBSSB2 is believed to 
have proteins attached to the 5´ termini (Baker et al., 2007b). There is a danger that any 
protein removal step, such as salt precipitation or phenol: chloroform: isoamylalcohol 
treatment, would lead to the loss of the linear plasmid. A protease treatment was 
therefore included prior to salt precipitation with 4M NaCl and treatment with phenol: 
chloroform: isoamylalcohol.  
Cell lysates were incubated with gentle agitation in the presence of proteinase K 
(200µg ml
-1
) for 1hr at 37°C.  Salt precipitation was done using 4M NaCl and 
centrifugation at 21,000 rcf (SS34 rotor, Sorvall) at 4°C for 15 min. This was followed 
by three extractions with phenol: chloroform: isoamylalcohol to ensure complete 
removal of proteins (Table 3.2, step: 3).  
3.3.3 Precipitation of DNA 
No optimization was done for this step. Following a clearing spin (12,000 rcf at 4°C in 
a SS34 rotor, Sorvall, for 30 minutes), DNA was precipitated from the supernatant 
using two volumes of absolute ethanol (Table 3.2, step: 4). The precipitated DNA was 
washed three times with ice-cold 70% ethanol (Table 3.2, step: 5) and resuspended in 
TE (10mM Tris-HCl, 1mM EDTA, pH 8.0) (Table 3.2, step: 6).  
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Table 3.2. Linear plasmid purification method developed in the present study 
Ingredient Final concentration/ value 
Step 1: Cell resuspension solution 
Triton X-100 2% (v/v) 
EDTA 60mM 
Tris-HCl 50mM, pH8.0 
Step 2: Lysis solution 
Lysozyme 1 mg ml
-1
 
sucrose    10% (v/v) 
Tris (pH 8.0) 50mM 
EDTA 0.5M   
Incubation at 37°C for 1hr with gentle agitation (40-50 rpm on an orbital shaker) 
Step 3: Removal of proteins and cell debris 
Proteinase K  200µg ml
-1
 
Incubation for 1hr at 37°C with gentle agitation (40-50rpm on an orbital shaker) 
NaCl 4M 
Centrifugation at 21,000  g at 4°C for 15 min 
3 extractions with phenol: chloroform: isoamylalcohol (25:24:1) 
1 extraction with chloroform: isoamylalcohol (24:1) 
Step 4: Precipitation of DNA using absolute ethanol 
Step 5: Wash of precipitated plasmid with ethanol (70%) 
Step 6: Resuspension of plasmid DNA in TE 
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3.4 Gel electrophoresis of extracted pBSSB2 
pBSSB2 purified from 2L culture of SGB33, which is E. coli Top10 (Invitrogen) 
transformed with pBSSB2 (Baker et al., 2007b) was resuspended in 1-3ml Tris EDTA. 
Five µl of the extracted DNA was resolved in a 0.5% agarose gel and stained with 
ethidium bromide (100µg ml
-1
) before visualization (Figure 3.1). A linear ladder (λ 
DNA mono cut mix; N3019S, NEB) was run simultaneously for estimation of size. 
Based on the ladder, the size of the linear plasmid band was about 28kb as expected. 
Once the plasmid DNA was visualized in agarose gel, its concentration was measured 
using a ND-1000 spectrophotometer (Nanodrop). It was found to be about 200ng µl
-1
. 
The yield from the optimized method was highly reproducible and was about 200-
500µg from a 2L culture. When this purified DNA was used as a template for PCR, the 
success of the PCR was variable unless the template was diluted about 1000 fold (data 
not shown). It was assumed that the sample was possibly contaminated with chemicals 
used during purification.  
                                           Lane:             1         2          
 
                                                  
                                              
                                              
 
 
 
 
 
Figure 3.1: Purification of pBSSB2 by an optimized method. pBSSB2 was resolved in a 
0.5% agarose gel. Lane 1: λ DNA mono cut mix (NEB), lane 2: Purified pBSSB2 
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A PCR purification column (Qiagen) was used to further purify the plasmid DNA, 
following the manufacturer’s recommendations. Columns used for bacterial total DNA 
extraction in the DNeasy Blood and Tissue kit (Qiagen) were also used successfully for 
further purification of extracted pBSSB2. This yielded highly purified plasmid suitable 
for PCR and restriction digestion.  
When plasmid preparation was carried out using the optimized method, but with the 
proteinase K step omitted to account for any effect of this on the efficiency of 
extraction, no plasmid DNA was obtained. This proved that the protease treatment was 
crucial for the extraction of pBSSB2 to be successful. 
 
3.5  Restriction digestion of purified pBSSB2  
In order to confirm the restriction profile of purified pBSSB2, the extracted plasmid 
was digested with EcoRV and PmeI. Figure 3.2 shows the restriction pattern obtained. 
Alongside the gel images are predicted restriction patterns for pBSSB2 generated by 
the NEB cutter software (http://tools.neb.com/NEBcutter2/) when the linear plasmid is 
digested by the same enzymes.  With PmeI, three bands corresponding to expected 
sizes of about 14kb, 9kb and 5 kb were obtained (Figure 3.2, lane 3). EcoRV yielded 
the expected bands of approximately 13kb, 7.5kb, 3.4kb, 1.8kb, 1.3kb, 500bp and 
400bp (Figure 3.2, lane 2). The generation of bands of expected sizes provided further 
evidence in support of the fact that the purified DNA was pBSSB2.  
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                                                           Lanes:        1              2              3     
  
  
 
 
 
 
 
 
 
Figure 3.2. Restriction digestion profile of pBSSB2 with EcoRV and PmeI to confirm 
its identity. The digested DNA was resolved in a 1% agarose gel. A software (NEB 
cutter) generated profile is also shown in order to indicate expected sizes of bands for 
the digestion. 
 
3.6  Treatment of purified pBSSB2 with λ exonuclease  
The linear plasmid pBBS2 has a protein attached covalently to its 5' end (Baker et al., 
2007b). When treated with proteinase K, the majority of the peptide bonds would be 
expected to be hydrolysed. However, the amino acid attached to the DNA backbone 
would not be removed since the bond between an amino acid and DNA would not be 
recognized by a peptidase. Since, the smallest peptide hydrolysed by proteinase K is a 
tetra-peptide (Kraus et al., 1976), a protease treatment would leave at least a tetra-
peptide at the linear plasmid 5’ termini. Owing to the presence of this amino acid cap, 
the purified DNA would be expected to be resistant to treatment with λ exonuclease, a 
pBSSB2+EcoRV   pBSSB2+PmeI 
539bp 
442bp 
 
14.3kb 
13.3kb 
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5' phosphate specific exodeoxyribonuclease. However, this treatment should hydrolyse 
any contaminating chromosomal DNA. A linearized pUC18 was used as control for the 
exonuclease digestion since it should be sensitive. It was observed that the purified 
plasmid was still resistant to λ exonuclease (Figure 3.4).  
 
 
 
 
 
 
 
 
Figure 3.3. Lambda exonuclease treatment on pBSSB2 with pUC18 as control. The 
ladder is Hyperladder I from Bioline. 
 
3.7 PCR amplification of pBSSB2 specific regions 
To further confirm the identity of the linear plasmid, an amplicon specific for a 500bp 
region of pBSSB2 was amplified using primers (P2_INRP and P2_INLP, Table 2.4) 
that annealed to the linear plasmid template. The 500bp amplicon was successfully 
amplifiable. Subsequently it was sequenced which proved that the linear plasmid was 
present in the sample (Figure 3.4). 
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Figure 3.4. Amplification of a 500bp region present in pBSSB2. Lane 1: Hyperladder I 
(Bioline), Lane 2: 500bp amplicon 
 
3.8 Retransformation of purified pBSSB2 
Purified pBSSB2 was re-transformed into commercially available chemically 
competent E. coli (XLI-Blue, Agilent technologies) following the manufacturer’s 
recommendations. Transformant colonies were selected on L-agar with kanamycin 
(25µg ml
-1
) at 37°C overnight.  The transformation efficiency, at 5 cfu µg
-1
, was very 
low. To confirm the presence of pBSSB2 in the colonies, a colony PCR was carried out 
using primers specific for a 500bp region of pBSSB2. Generation of the expected 
amplicon proved that the colony contained the linear plasmid (data not shown).  
 
3.9 Discussion 
An initial objective of the present investigation was to develop a method for the routine 
purification of the linear plasmid pBSSB2. In earlier studies by Baker et al. (2007b) 
pBSSB2 was isolated using the Taghavi method (1994). However, this method was not 
reproducible and gave yield of the linear plasmid which was so poor that Southern 
blotting was necessary to reveal plasmid bands (S. Baker, personal communication). 
Use of the Taghavi method in the present study yielded no visible plasmid band on an 
agarose gel, even though the presence of the plasmid was indicated by PCR 
amplification of a pBSSB2-specific amplicon. This prompted literature review of 
methods commonly used for linear plasmid purification. As discussed previously, linear 
plasmids of several bacterial genera (viz. Streptomyces, Borrelia, Rhodococcus, 
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5kb 
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600bp 
 
400bp 
 
 
500bp 
Lane:      1           2 
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Mycabacterium and Nocardia) have been purified by using pulsed-field gel 
electrophoresis. The major drawback of PFGE is that it is technically demanding and 
time consuming (Tenover et al., 1997). Since the Taghavi method used by Baker et al. 
(2007b) was successful in isolating the linear plasmid, albeit at a low concentration, 
attention was given to optimization of the existing protocol.  
Each step of the Taghavi method was considered for further modifications. For 
optimization of lysis conditions, several methods were taken into consideration. It was 
anticipated that in methods based on alkaline lysis of cells (e.g. the Qiagen plasmid 
extraction kit) alkaline pH breaks the hydrogen bonds between linear plasmid strands 
causing complete separation. In these methods, linear plasmid strands behave similarly 
to sheared linear chromosomal fragments and are subsequently lost with cell debris. A 
similar situation arises in the boiling lysis STET protocol (Holmes and Quigley, 1981), 
in which linear plasmid strands are separated owing to breakdown of hydrogen bonds 
following the heat treatment. Finally, in the Taghavi method (1994), alkaline condition 
causes denaturation of linear plasmid strands and incorporation of the DNA into 
insoluble aggregates. Denatured strands behave like sheared, chromosomal fragments 
that are lost during the subsequent salt precipitation step. In all these methods, loss of 
linear plasmids is further enhanced by the absence of any protease treatment. In the 
present study, changes were made to the composition of the cell lysis solution through 
the incorporation of lysozyme aimed at cell wall breakdown, use of a non-ionic 
detergent (Triton-X) for cell lysis and inclusion of sucrose in order to maintain an 
osmotically balanced environment. The pH of the lysis solution was also set at 8.0 
instead of an alkaline 12.0. This near-neutral pH would prevent separation of linear 
plasmid strands.  
In the purification of a 43kb linear plasmid from Streptomyces rimosus, Chardon-
Lauriaux et al (1986) found that it was necessary to carry out a ‘soft lysis’ including a 
protease treatment during extraction. Their method also avoided use of alkaline 
conditions in order to successfully purify the linear DNA. Although there was no direct 
evidence that gentle lysis facilitated pBSSB2 extraction in the present study, the 
rationale for designing the lysis solution is concordant with that favoured by Chardon-
Lauriaux et al (1986).  
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Another key change was the addition of a proteinase K treatment step. It was assumed 
that linear plasmid would be lost with cellular proteins if the protein cap was not 
removed first before cellular protein removal treatment. When pBSSB2 was purified 
using the modified method, but with the proteinase K treatment step omitted, there was 
no pBSSB2-specific band visible in an agarose gel, in contrast to a bright band present 
for the proteinase K treated sample. It was evident that the omission of this step in the 
Taghavi method (Taghavi et al., 1994) resulted in loss of most of the linear plasmid 
through the denaturation of the terminal protein attached to its 5' end during the phenol-
chloroform-isoamylalcohol treatment and its precipitation with cell debris during the 
subsequent clearing spin.  
The optimized method was similar to that used by Kemble and Baszczynski (1987) for 
the extraction of linear mitochondrial plasmids of sorghum and maize. As with the 
present work, omitting a proteinase K treatment failed to yield any linear plasmid DNA. 
The authors also found that conducting the complete protocol without any protease 
treatment but including such a treatment just prior to gel electrophoresis, did not show 
any plasmid band in agarose gel. From their study, it can be concluded that gentle cell 
lysis alone is not sufficient for purification of linear plasmids but that a protease 
treatment is also crucial. 
The optimized method developed in the present work is rapid, reproducible and simple. 
It can be used routinely for purification of linear plasmids such as pBSSB2. The 
resulting DNA can be used for all experimental work, either as a template for PCR or 
for restriction digestion following an added column purification step.  
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4.1 Introduction 
Preliminary analysis of the linear plasmid pBSSB2 was primarily through bioinformatic 
approaches (Baker et al., 2007b). Experimental investigation into replication and its control 
has not hitherto been carried out. One of the objectives of the present study was to identify 
regions of the linear plasmid pBSSB2 that are associated with replication.  
The only indication of the location of the origin of replication is based on sequence analysis 
of pBSSB2 (Baker et al., 2007b). According to this analysis, a GC skew lies immediately 
upstream of ORF017 and is close to 11000bp in the linear plasmid map. A GC skew is 
usually associated with the origin of replication (Picardeau et al. 2000). This assumption is 
further supported by the direction of transcription of most of the ORFs which, if the origin 
were located as suggested (Baker et al., 2007b), are transcribed in the same direction as the 
movement of the replication fork. No short direct repeats that could be associated with 
control of replication by titrating away rep proteins were found by these authors in this 
region.  
The central regions of Streptomyces linear plasmids can replicate in circular mode when their 
telomeres are deleted (Chang and Cohen, 1994; Hiratsu et al., 2000; Redenbach et al., 1999; 
Shiffman and Cohen, 1992). Based on this finding, and concerns that working directly with a 
linear plasmid or a linear derivative may pose difficulty with manipulations such as 
transformation, it was decided to construct a library containing 4-6 kb overlapping fragments 
of pBSSB2 in a circular vector (pUC18) and to screen these plasmids for their ability to 
replicate from the linear plasmid sequence.  
Plasmid pUC18 carries a ColE1-like replicon, which requires DNA polymerase I to initiate 
replication (Kingsbury and Helinski, 1970). Huang and Chen (2008) showed that DNA 
polymerase I is not required for replication of the Streptomyces chromosome, the native form 
of which is linear (Lin et al., 1993; Chen, 1996). It has been proposed that replication of the 
Streptomyces chromosome and linear plasmids occur by similar mechanisms (Qin and Cohen, 
1998). The structure of pBSSB2 is similar to Streptomyces linear plasmids (Baker et al., 
2007b) so it seems reasonable to suppose that replication of pBSSB2 will also be polymerase 
I independent. In this study a DNA polymerase I mutant of Escherichia coli (BR825) is used 
to screen for replication of plasmids containing pBSSB2 fragments in pUC18. In this host, in 
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the absence of DNA polymerase I, the pUC18 replicon would be inactive. Any replication 
that occurs in this host must therefore be driven by a linear plasmid replicon.  
 
4.2. Construction of a pBSSB2 library in pUC18  
Overlapping regions of pBSSB2 were cloned into pUC18 to generate circular derivatives 
which could be used to screen replication function of the linear plasmid. Fragments were 
amplified using EcoRI and BamHI tailed primers (Table 2.4) and the MasterAmp
TM
 Extra 
Long DNA polymerase (Section 2.10.3). PCR amplicons were ligated to pUC18 using EcoRI 
and BamHI restriction sites. Digestion, drop dialysis and ligation were carried out according 
to sections 2.13, 2.16 and 2.15, respectively.  
Table 4.1 shows the start and end nucleotide co-ordinates of pBSSB2 used to generate 
fragments to be cloned in pUC18. Fragments were named RP2 to RP10. The terminal 
inverted repeat (TIR) of pBSSB2 is about 1230bp (Baker et al., 2007b). The fragment (RP3) 
amplified from the left end of the plasmid started from position 1419bp which excluded the 
TIR. For the right end, sequence similarity was found to the phase II flagellin gene for 
ORF031 and to the fljA repressor for ORF032 (Baker et al., 2007b). The cloned fragment 
(RP10) closest to the right terminus began at 18230bp and ended upstream of ORF031 (start 
position 23,683bp). A schematic map of the overlapping fragments used in this study is 
shown in figure 4.1.  
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Table 4.1 Nucleotide co-ordinates of linear plasmid fragments inserted into pUC18  
Construct name 
Starting 
nucleotide  
Ending 
nucleotide  
RP2 10068 14073 
RP3 1419 6015 
RP4 4594 9106 
RP5 6954  11514 
RP6 9549 13595 
RP7 11350 15933 
RP8 12494 18090 
RP9 15938 20493 
RP10 18230 22957 
 
 
 
 
 
 
 
 
 
Figure 4.1 Fragments of pBSSB2 cloned into pUC18. The name and size of each fragment is 
shown. The pBSSB2 genetic map is adapted from Baker et al., 2007b. The arrows indicate 
ORFs and direction of transcription. The star shows the position of the GC skew. A 
restriction digestion map is also shown.  
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After construction of the pUC18 library (Figure 4.1), the clones were validated by size 
confirmation following restriction digestion (Figure 4.2) and by sequencing of the ends of the 
inserted fragments.   
 
 
 
 
 
 
Figure 4.2. Linear plasmid library. Lane 1: Supercoiled ladder (NEB), Lane2: Blank, Lane 3: 
pUC18, Lanes 4-12: pRP2-pRP10 
 
 
 
 
 
 
 
 
Figure 4.3. Validation of cloned fragments RP2-RP10 by restriction digestion. EcoRI and 
BamHI were used for confirmation of insert sizes. pUC18 was used as a control and was 
digested with each enzyme separately to confirm enzymatic activity of each. Uncut pUC18 
contains the vector incubated in the reaction mixture minus restriction enzyme. 
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4.3 Identification of pBSSB2 replicon function in a circular mode 
In order to identify which of the pBSSB2 cloned fragments contained a replicon, pRP2-
pRP10 were individually transformed into BR825, a DNA polymerase I mutant in which the 
pUC18 replicon is inactive (Figure 4.10, step: 1). pUC18 (no insert) was used as a negative 
control and pREG531 (which contains a P1 origin of replication) was used as a positive 
control for replication. The optimized protocol (Section 2.18.2) was used for transformation 
of constructs and control plasmids into BR825. Triplicate assays were done for each construct 
and control.  
Colonies were observed only in the case of BR825 transformed with pRP7 and the positive 
control plasmid pREG531. There was no growth of BR825 transformed with pUC18 or with 
the other constructs containing amplicons of pBSSB2 (initially some colonies were obtained 
for pRP8 and pRP9 but upon repeated assays, this result was not reproducible).  
To confirm the presence of pRP7 in the BR825 transformants, five randomly picked colonies 
were inoculated individually into 10ml of L-broth containing carbenicillin (50µg ml
-1
) and 
incubated overnight at 37°C in a static incubator. Plasmid was purified using the QIAprep 
Spin Miniprep Kit (Qiagen) following the manufacturer’s recommendations (Figure 4.10, 
step: 2). About 5µl of purified plasmid was analysed by agarose gel electrophoresis.  
No plasmid band was visible in the gel (data not shown). However, the presence of pRP7 in 
the sample was suggested by successful PCR amplification of a 500bp fragment present 
within RP7 using primers described in Table 2.4 (Figure 4.4). The 500bp band was confirmed 
to contain linear plasmid sequence by sequencing. The amplification of the 500bp fragment, 
in spite of the lack of any visible plasmid band, suggested that pRP7 might replicate in 
BR825 with low copy number or that it had integrated into the chromosome. In order to 
further test for the presence of free pRP7, aliquots of the plasmid DNA preparations from the 
five different BR825 colonies were transformed into chemically competent XL1-Blue 
(Agilent technologies) cells following the manufacturer’s recommendations (Figure 4.10, 
step: 3).  XL1-Blue cells are polA
+
 and hence will allow plasmid replication from the pUC18 
replicon at high copy number. Transformed cells were spread on L-agar containing 
carbenicillin (50µg ml
-1
) and incubated at 37°C overnight.  
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Figure 4.4. Amplification of a 500bp RP7 product from strain BR825 transformed with pRP7. 
Lane 1 contains Hyperladder I (Bioline) used as a molecular weight marker; lane 2 shows the 
amplification using pBSSB2 as template and lane 3 shows the amplicon using one of the 
plasmid preparations as template. 
 
For each plasmid preparation that was transformed into XL1-Blue cells, one transformant 
colony was picked at random using a sterile toothpick and inoculated into an individual tube 
containing 10ml of L-broth and carbenicillin (50µg ml
-1
). The cultures were incubated 
overnight at 37°C at 120 rpm. The QIAprep Miniprep Kit (Qiagen) was used to purify 
plasmid DNA (Figure 4.10, step: 4) which was analysed in an agarose (1%) gel. Plasmids of 
two different sizes were identified from the transformants (Figure 4.5).  
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Figure 4.5. Plasmids extracted from XL1-Blue transformants following transformation with 
plasmid extracted from BR825 transformed with pRP7. Lane 1: Supercoiled ladder from 
Epicentre, Lane 2: pUC18 (2.6kb), Lane 3: pRP7 (4.5kb), Lane 4: Carry-over from lane 3, 
Lane 5 to 9: Plasmids extracted from transformants. 
 
The same experiment was repeated (Figure 4.10, step: 5) and another five transformants were 
picked for plasmid purification (Figure 4.6). A mixture of plasmid sizes was observed in a 
number of XL1-Blue transformants (Figure 4.6, Lanes 5, 7, 9 and 11). 
                      
 
 
 
 
Figure 4.6. Plasmids extracted from XL1-Blue transformants following transformation with 
plasmid extracted from BR825 transformed with pRP7. Lane 1: Hyperladder 1 (Bioline), 
Lane 2: pUC18, Lane 3: pRP7, Lane 4: Blank, Lane 5, 7, 9, 11 and 13: plasmids purified 
from XL1-Blue.  
 
The presence of plasmids of different sizes might be due to multiple transformation of BR825 
or XL1-Blue, or picking of XL1-Blue colonies founded by more than one cell. Finally, 
Lane:      1             2      3     4      5      6     7      8     9            
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rearrangements of the plasmid might occur in either BR825 or XL1-Blue after 
transformation. Considering the possibility that smaller plasmids were natural deletion 
derivatives of pRP7, it was decided to test plasmids of different sizes for their ability to 
generate BR825 transformants. The largest plasmid from the gels was named pMG1 (Figure 
4.5, lane 5) and the smallest named pMG6 (Figure 4.5, lane 7). These were purified using a 
QIAquick gel purification kit (Qiagen). Total plasmid DNA from the XL1-Blue transformant 
that contained the maximum number of plasmid bands (Figure 4.6, lane 9) was also used for 
transformation into BR825 to screen any of the plasmids of intermediate sizes that might 
contain the pBSSB2 replicon.  
Plasmids pMG1, pMG6 and the plasmid mixture were transformed individually into BR825, 
using pRP7 and pUC18 as positive and negative controls, respectively (Figure 4.10, step: 6). 
BR825 transformant colonies were observed with pMG1, the plasmid mixture and the 
positive control, pRP7. No colonies were observed for pMG6 or with the negative control 
plasmid, pUC18. Plasmid pMG1 appeared to be of similar size to pRP7. With the hope that a 
smaller plasmid derivative of pRP7 might be recovered by screening colonies transformed 
with the plasmid mix, fourteen transformants were picked and plasmids purified from these 
(Figure 4.10, step: 7). These fourteen plasmid samples were transformed individually into 
XL1-Blue (Figure 4.10, step: 8). Subsequently, plasmids purified from XL1-Blue (Figure 
4.10, step: 9) were resolved in agarose (1%) gel (Figure 4.7). Plasmids of several different 
sizes were observed in the different colonies.  
 
                  
 
 
 
Figure 4.7. Extraction of plasmid from XL1-Blue colonies transformed with plasmid 
preparations from BR825 transformed originally with pRP7. Lane 1: Hyperladder I (Bioline), 
Lane 2-13: Plasmids purified from twelve randomly-picked XL1-Blue transformants.  
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Samples from lanes 2, 5 and 11 were re-run and ten plasmid bands of different sizes were 
purified from the gel using the QIAquick gel purification kit (Qiagen) (Figure 4.10, step: 10). 
Each of these plasmids was transformed again into XL1-Blue in order to obtain transformants 
with unique plasmid sizes (Figure 4.8; Figure 4.10, step: 11-12).  
 
                            
 
 
 
 
 
Figure 4.8. Plasmids purified from XL1-Blue transformants transformed with plasmid bands 
cut out from gel carrying mixed plasmids. Lane 1: Hyperladder 1 (Bioline), Lane 2-11: 
Purified plasmids. 
 
Plasmids from lanes 6, 7, 9 and 10 (Figure 4.9) were selected for further study. These were 
designated pBR6, pBR7, pBR9 and pBR10. First they were digested with EcoRI and BamHI 
in order to determine the sizes of inserts (Figure 4.10, step: 13) (Figure 4.9). Upon digestion, 
it appeared that inserts were of two distinct sizes, about 4kb and 2kb. Three plasmids 
contained the smaller insert and one the larger insert.  All plasmids retained the pUC18 
backbone. The plasmids were transformed into BR825 to check for their ability to replicate in 
the polA mutant. Colonies were obtained for plasmids pBR6 and pBR9 only (Figure 4.8). 
Both of these plasmids contained inserts of approximately 2.0kb.  
 
 
 
 
 
10kb 
5kb 
2.5kb 
 
H
y
p
er
la
d
d
er
  
1
  
  
 
p
B
R
1
  
p
B
R
2
  
  
p
B
R
3
  
  
p
B
R
4
  
  
 
p
B
R
5
  
  
p
B
R
6
  
  
p
B
R
7
  
  
p
B
R
8
  
  
p
B
R
9
  
 
p
B
R
1
0
  
 
Characterization of the replication function of the linear plasmid, pBSSB2 
 
75 
 
 
 
 
 
 
 
 
Figure 4.9. Digestion of four plasmids from XL1-Blue transformants. Lane 1: Hyperladder 1 
(Bioline), Lane 2: undigested pUC18, Lane 3: pUC18 digested with EcoRI, Lane 4: pUC18 
digested with BamHI, Lane 5: pUC18 digested with EcoRI and BamHI, Lanes 6 and 9: 
Blank, Lane 7: pBR6, Lane 8: Digested pBR6, Lane 10: pBR7, Lane 11: Digested pBR7, 
Lane 12: pBR9, Lane 13: Digested pBR9, Lane 14: pBR10, Lane 15: Digested pBR10.   
 
M13/pUC18 sequencing primers were used in order to determine the exact nature of the 2kb 
inserts of plasmids pBR6 and pBR9 (Figure 4.10, step: 14). The insert retained a total of 
1.1kb of RP7 sequences in two fragments separated by a sequence of approximately 530bp 
with similarity to E. coli insertion sequence (IS1). It contained a 815bp sized region covering 
nucleotides 15119-15933 (nucleotides 3770-4584 of RP7) and a 285bp sized fragment 
spanning nucleotides 11350-11698 (nucleotides 1-349 of RP7) of pBSSB2. The 815bp 
pBSSB2 fragment was amplified by PCR from pBR6 plasmid and cloned in pUC18 using 
EcoRI and BamHI restriction sites (Figure 4.10, step: 15). The ability of the construct to 
replicate in BR825 was tested (Figure 4.10, step: 16).  Unfortunately, the plasmid failed to 
replicate in BR825.  
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Figure 4.10. Flow diagram of the steps undertaken to identify the region of pBSSB2 that 
drives replication using the pRP2-pRP10 library (continued in next page) 
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Figure 4.10. Flow diagram of the steps undertaken to identify the region of pBSSB2 that 
drives replication using the pRP2-pRP10 library (continuation from previous page) 
 
In the absence of autonomous replication driven by the 815bp sequence, attention was re-
directed towards pRP7. In order to further confirm the presence of an autonomous linear 
plasmid replicon in RP7 attempts were made to ligate fragment RP7 to a kanamycin cassette, 
with the assumption that this construct should be able to replicate independently. Fragment 
RP7 in pRP7 and a Km
r
 cassette cloned in pUC18 were individually digested out with EcoRI 
and BamHI. The digestion mix was treated with ligase and dialyzed.  
About 5µl of the dialyzed DNA was transformed directly into commercially prepared 
chemically competent XL1-Blue cells (Agilent technologies) following the manufacturer’s 
instructions. Transformed cells were spread on L-agar containing kanamycin (25µg ml
-1
) and 
incubated at 37°C overnight. A total of 300 randomly picked colonies were patched onto L-
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agar containing kanamycin (25µg ml
-1
) and carbenicillin (50µg ml
-1
) in separate plates. Those 
colonies that grew in the presence of kanamycin, but not in the presence of carbenicillin, 
were candidates to contain RP7 ligated to Km
r
, since cells with pUC18 religated to Km
r
 
would grow in the presence of both antibiotics, whereas those containing pUC18 ligated to 
RP7 would grow in the presence of carbenicillin only. Three colonies were found to grow in 
the presence of kanamycin only. These were individually inoculated into 10ml of L-broth 
containing kanamycin (25µg ml
-1
). Plasmid DNA was purified from each culture using the 
QIAprep Miniprep Kit (Qiagen) and the sample was analysed on agarose gel. Unfortunately, 
no plasmid bands were visible in the gel (data not shown). It was presumed that since pRP7 
replicated in BR825 with low copy number, the RP7-Km
r
 constructs might also replicate at a 
copy number too low for them to be visible on the gel.  
PCR was used to probe for the presence of the RP7-Km
r
 construct by amplifying the RP7 
(4.5kb) region, as well as junction regions between RP7 and Km
r
, including the antibiotic 
cassette (Figure 4.10). From the gel of the PCR products (Figure 4.11) it was observed that 
even though a single PCR product (4.5kb) was detectable for RP7, multiple PCR amplicons 
were detected when gradient PCR was used to amplify across the junctions of RP7 and the 
Km
r
 cassette. PCR was carried out at annealing temperatures ranging from 50°C to 65°C. The 
same PCR primers used to generate the Km
r
 for the ligation were used in this reaction. Even 
though a single band for Km
r
 has been obtained consistently in earlier reactions, multiple 
bands were obtained in the present PCR. Consequently, in the absence of a single band for 
Km
r
 and junction regions it was not possible to confirm the presence of the construct RP7-
Km
r
. 
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RP7, 4.5kb 
                   
 
                            
Total junction sequence, 2.5kb 
Figure 4.11. Theoretical construct RP7-Km
r
. The red arrows (E and F) indicate forward and 
reverse primers used to amplify fragment RP7 (region in yellow), black arrows (C and D) 
represent oligonucleotides used to amplify Km
r
 (region shown in green) and blue arrows (A 
and B) indicate right and left primers used to amplify across the junction of RP7 and Km
r
. 
 
                                                
 
 
 
 
 
 
 
Figure 4.12. PCR carried out to detect presence of a putative construct containing RP7 ligated 
to Km
r
. Plasmid DNA from two transformants (pS1 and pS2) believed to contain RP7-Km
r
 
were used as templates. Lane 1: Hyperladder I (Bioline), lane 2:  2.5kb junction amplicon 
(A+B), lane 3: Km
r
 amplicon (C+D), lane 4: RP7 amplicon (E+F). Lanes 2-4 use pS1 as 
template. Lanes 5, 6 and 7 use pS2 as template. Capital letters refer to primers shown in 
Figure 4.10.  
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4.4 Deletion analysis of fragment RP7  
In the absence of clear evidence for the construction of RP7-Km
r
 and consequently the 
inability to test it for autonomous replication, it was decided to use the DNA polymerase I 
mutant BR825 as the system to identify the basic replicon of the linear plasmid when inserted 
into a pUC18 vector. 
pRP7 had been shown to replicate in BR825 (polA). The next step was subcloning of RP7 to 
identify the minimal replicon. A deletion series of RP7 was generated by PCR using the high 
fidelity enzyme (Section 2.10.3). Deletions were generated from either end. After 
amplification of each fragment, it was cloned in pUC18 using EcoRI and BamHI restriction 
sites. Every construct was validated by restriction digestion and size validation in agarose gel. 
A schematic diagram showing the deletion series is shown in figure 4.12. Each construct was 
individually transformed into BR825 using the optimized protocol. Construct pRP7 and 
pUC18 were used as positive and negative controls for replication in the BR825 host, 
respectively.  
All deletion derivatives except one were unable to replicate. This deletion derivative was 
2831bp (nucleotides 12820 to 15649 of pBSSB2) and contained the left end of RP7 with 
1751bp deleted from the right end. The exclusion of even the first 144bp from the left end of 
RP7 prevented replication. 
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Figure 4.13. Deletion series of RP7 generated by PCR to identify the minimum replicon. The 
numbers represent nucleotide co-ordinates of RP7. The thick dark line represents RP7. All 
the other fragments are subclones of RP7 used to locate the basic replicon. Plasmids 
containing blue fragments failed to replicate in BR825. Only a plasmid containing the red 
fragment replicated successfully. Broad arrows represent open reading frames within RP7. 
  
4.5 Genetic analysis of fragment RP7  
According to annotations carried out by Baker et. al. (2007b), three ORFs (ORFs 018-020), 
are present in fragment RP7. In order to determine whether any of these ORFs is required for 
replication, a premature stop codon was introduced into each ORF in turn. Suitable primers 
were designed using the software Primer 3 available at http://frodo.wi.mit.edu/primer3/ so 
that they were present within the first one third of the total sequence. The primer sequence 
was designed to introduce a stop codon in the correct reading frame. 
In order to introduce nonsense mutations, the QuikChange II one-day site-directed 
mutagenesis protocol was used (Smith, 2007). The manufacturer’s instructions were 
followed, details of which can be found in section 2.20.2. The complete pRP7 construct was 
regenerated with a nonsense mutation in the reading frame of the targeted ORF. The 
amplified plasmids were transformed into chemically competent, commercially prepared 
RP7 
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XL1-Blue cells (Agilent technologies). Transformant colonies were spread on L-agar 
containing carbenicillin (50µg ml
-1
) and incubated at 37°C overnight. A single colony was 
picked and inoculated into 10ml L-broth containing carbenicillin (50µg ml
-1
). The culture 
was incubated at 37°C at 120 rpm overnight. The QIAprep Miniprep Kit (Qiagen) was used 
to purify plasmid from each culture. The size of purified construct was validated by agarose 
gel electrophoresis. The introduction of the desired mutation was confirmed by sequencing in 
each case.  
In the case of ORF018 a GAA triplet coding for glutamic acid at position 10 was changed to 
TAA, a non-sense mutation (Ochre) (Figure 4.14).  
 
 
 
 
 
 
 
 
 
 
Figure 4.14. Introduction of a stop codon in ORF018. An ochre mutation was introduced at 
the position indicated.  
 
For ORF019 a glutamic acid codon (GAA) was changed to a stop codon (TAA) (Figure 
4.15).  
Nucleic acid and amino acid sequences of ORF018  
 
                                                                                  Nucleic acid sequence: TAA 
                                                                                   Amino acid sequence:  Stop 
 
           Mutation 
Nucleic acid sequence: ATG CAA TCT TTT CAA AAG ATT GCG GTT GAA ACT GCT TTT AAT GCC  
Amino acid sequence:   Met     Q       S      F      Q       K       I       A       V      E       T       A       F     N      A        
 
Nucleic acid sequence: GGT GAC TCT TAC TGG TCG CAT GAA TAT TTT GCA CAT AGT AAT AAT  
Amino acid sequence:      G      D      S      Y      W      S      H       E      Y       F      A       H      S       N      N       
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Insertion of a stop codon in ORF020 was achieved by changing a leucine codon, TTG, to a 
TAG amber codon (Figure 4.16). (The mutagenesis was carried out before the deletion 
analysis (Figure 4.10) and showed that ORF020 was not required for replication.) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.15. Introduction of a stop codon in ORF019. An ochre mutation was introduced at 
the position indicated. 
 
 
Nucleotide sequence of ORF019  
Nucleic acid sequence: ATG GCA AAA GTT AAT GCA AAA GGT TTA AAA ACA TAT AAC CAT 
Amino acid sequence:   Met    A       K       V      N      A       K       G      L       K      T       Y      N      H  
Nucleic acid sequence: CAG GGT TTT TTA ACT TCA AAC TCA GGA GCA AAC AGC AGT GAT 
Amino acid sequence:     Q       G      F      L       T      S       N       S      G       A       N       S       S       D  
Nucleic acid sequence: AGT CCT CTA TAC CCA ACA CAA GAA GAT GCT TAT TAT ATC GAT 
Amino acid sequence:      S       P      L      Y       P       T       Q       E      D       A     Y      Y       I       D  
Nucleic acid sequence: GCC TGG TCA GGT ATA GAG ATT ACA GAT CCA AAT CCT GCA AAA 
Amino acid sequence:     A      W      S        G      I        E       I       T       D       P      N       P      A       K  
Nucleic acid sequence: CTT GTT AAA GAT ATA GAG GAA GGT GTA TAC GAT AAA GTT CAT 
Amino acid sequence:     L      V      K       D       I        E       E       G      V      Y       D      K       V     H 
Nucleic acid sequence: TTC CCT ACA AAA AGA TTT CTT AAC GAT TTA AAA GTG AAA GAT 
Amino acid sequence:     F       P       T       K       R      F       L      N      D      L       K      V       K      D  
Nucleic acid sequence: CTT GCA GGT GGT TTA AAG AAA TTT AAT AAG CTT CAC GAG CTT 
Amino acid sequence:      L      A      G       G      L       K      K       F      N       K       L     H        E        L  
Nucleic acid sequence:  GAT GAA CAA CCG GAA GGT GAG CAC ………………  
Amino acid sequence:      D       E       Q       P        E       G       E       H    ………………     
                             Mutation 
            Nucleic acid sequence: TAA  
             Amino acid sequence: Stop 
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Figure 4.16. Introduction of a stop codon in ORF020. An amber mutation was introduced at 
the position indicated. 
  
Each plasmid with a mutation in ORF018, ORF019 or ORF020 was transformed into BR825 
to test its ability to replicate. pRP7 was used as positive control and pUC18 as negative 
control for replication. Transformant colonies were obtained for all three mutant plasmids, 
indicating that none of these ORFs encodes a protein product essential for replication.  
 
4.6 Analysis of RP7 for promoters, transcription terminators, ORFs and 
ribosome binding sites (RBS).  
 
4.6.1 Promoters  
When ORFs 018-020 were not found to play any role in replication of RP7, the 2831 bp 
sequence was analysed in order to identify regions that could be associated with replication. 
Nucleotide sequence of ORF020 
Nucleic acid sequence: ATG AAC ATA AAC AAC AAT AAG GAC AGA ATA AAA GAA ATA 
Amino acid sequence:   Met     N       I       N       N      N       K       D       R       I       K       E       I  
Nucleic acid sequence: GAG AGT CTT GGT GTA AGC GGG GAG GAA ACT CCC CTT ACT CCA 
Amino acid sequence:     E        S       L      G      V       S       G       E       E       T       P      L       T      P   
Nucleic acid sequence:  CCT GAT GGT ATT ATA GGA GCG ATT AAC GAG TTA AGG GAA  
Amino acid sequence:       P      D       G       I       I       G       A       I       N       E       L       R      E 
Nucleic acid sequence: GAA GAG TGT TCT CTT CCC GAT CCT TTG ………………………. 
Amino acid sequence:      E       E      C       S      L       P      D        P      L  ………………………. 
                                                                                          Mutation 
                                                              Nucleic acid sequence:            TAG 
                                                                Amino acid sequence:            Stop 
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A transcriptional analysis of pBSSB1 has been carried out at the Wellcome Trust Sanger 
Institute as part of PhD work of Chinyere Okoro. This analysis showed that most of the 
transcription was taking place from the strand in which ORFs 018-020 were present (Figure 
4.17). The sequence analysis described here is complementary to this RNA-seq study. 
 
 
 
 
 
 
 
Figure 4.17. Transcription profile from the RP7 region in pBSSB2. The green trace shows 
transcription from the region containing ORFs 017-019. The blue bars represent ORFs with 
the arrows pointing in the direction in which they are transcribed. The black bars show start 
and stop codons. The figure was constructed from data provided by Chinyere Okoro, a 
graduate student at the Wellcome Trust Sanger Institute, UK.  
 
Although the transcription profile indicates transcription of only the strand containing ORFs 
018 and 019, both strands of the 2831 bp sequence were scanned for potential promoters. The 
scan was carried out using software available at http://linux1.softberry.com/. Twelve 
promoters were predicted by this software; seven (promoters 1-7) were in the same strand as 
ORFs 018 and 019 and five (promoters 8-12) were in the complementary strand. Their 
sequences are shown in Table 4.2 and their positions within the 2831 bp fragment are shown 
in figure 4.18.  
Each promoter sequence was assessed for its similarity to the consensus sequences of 
TATAAT at the -10 Pribnow box and TTGACA at the -35 box, as well as the length of the 
intervening spacer. Invariants were particularly considered during analysis (Harley and 
Reynolds, 1987). In terms of these parameters, promoters 3 and 6 are good potential 
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promoters. All the other potential promoters in this strand have relatively poor matches to the 
consensus.  In the 2083 bp strand complementary to that containing ORFs 018 and 019, 
promoters 8 and 10 are good potential promoters.  Although the -10 and -35 sequences of 
promoter 9 conform closely to the consensus, the intervening spacer length of 22 bases is 
considered too long for this sequence to function effectively as a promoter.   
 
Table 4.2. Candidate promoters identified within the 2831 bp fragment using the 
program available at http://linus1.softberry.com/. 
Promoter 
number 
-35 
consensus
1
 
(TTGACA) 
-35 
sequence 
quality  
-10 
consensus
2 
(TATAAT) 
 
-10 
sequence 
quality 
Length of 
spacer 
(bp)
3
 
Transcription 
start base 
 
Promoters in the same strand as ORF018 and ORF019 
 
1 TGGACG Poor TATCGT Moderate  16 C 
2 TTGAAA Good GACTCT Poor 17 G 
3 GTGACA Good TAGAAT Good 18 T 
4 TTTCCA Moderate TATCAC Poor 21 A 
5 TTGATG Moderate TTTAAT Good 19 C 
6 TTGAAA Good TAATCT Good 16 G 
7 ATGCAA Moderate GAATAT Moderate 17 T 
 
Promoters in the complementary strand 
 
8 TTGAAA Good TTTAAT Good 16 T 
9 TTGTAA Good TATATT  Good 22 T 
10 TTATTA Moderate TTTAAT Good 18 C 
11 TTGACT Good TATTCT Moderate 22 C 
12 TTTTTA Poor TATATT Good 15 T 
1
In column 2, the bases that match with the expected -35 sequence are shown. 
2
In column 3, 
the bases of the putative promoter sequences are matched with the consensus TATAAT. The 
invariants for the -35 and -10 sequences are indicated by light blue and bold letters. 
3
The 
optimal spacer length between the -35 and -10 consensus is 17 ± 1 bp. 
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Figure 4.18. Positions of the potential promoters (arrowheads) in the two strands of the 2831 
bp fragment. The dark blue arrowheads indicate promoters in the same strand as ORFs018 
and 019. The red arrowheads represent promoters in the complementary strand. Annotated 
ORFs are shown by light blue arrows and transcription profile by green and red traces. ORFs 
018 and 019 are in the same strand from which the transcription pattern indicated by the 
green trace occurs.  
 
Based on the promoter search, promoters 3 and 6 in the same strand as ORFs 018 and 019, 
and promoters 8 and 10 in the complementary strand were considered as potential candidates 
for further investigation. 
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 4.6.2 Prediction of ORFs in 2083 bp fragment 
Having identified potential promoters, the sequence was next analysed for ORFs over and 
above those already identified, using the ORF finder tool available at 
www.ncbi.nlm.nih.gov/projects/gorf/, with default parameters. Six additional ORFs were 
found: five (ORFs A, B, C, D and E) in the same strand as ORFs 18 and 19, and two (ORFs F 
and G) in the complementary strand (Table 4.3; Figures 4.19 and 4.20). The sequences of 
ORFs A-G are given in figures 21-27. ORFs C, D and E are within ORF019 but have 
alternative start codons. The mutation that was introduced into ORF019 in fragment RP7 
would not have affected ORFs C, D and E because the start codons for these ORFs are 
downstream of the introduced mutation. 
Table 4.3. ORFs present in the 2831bp replication-competent region of RP7 
Frame Start and end 
nucleotide
2
 
Length (bp) ORF
1
 
 
ORFs in the same strand as ORFs 018 and 019 
 
+3 396, 698 313   18 
 
+1 850, 2784 1935 19 
 
+2 158, 358  201  A 
 
+2 182-358 177 B 
 
+1 1561, 2784 1223 C 
 
+1 1756, 2784 1029 D 
 
+1 1873-2784 912 E 
 
ORFs in the complementary strand as ORFs 018 and 019 
 
+3 2409-1207 1203 F 
 
+1 
 
2195-1425 771 G 
    
1
ORFs A-G have been identified using ORF finder tool available at 
www.ncbi.nlm.nih.gov/projects/gorf/ using default parameters. 
2
The numbers represent 
nucleotide co-ordinates of the 2831 bp derivative of RP7 (see Figure 4.19 and 4.20). 
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Figure 4.19. Promoters (dark blue arrowheads), transcription profile (green peaks) and ORFs 
(light blue arrows) present in the strand that contains ORFs 018 and 019 of the 2831 bp 
fragment of pBSSB2 that could support replication in a circular derivative. The numbers on 
the left indicate reading frames.  
 
 
 
1                          3                                                      6 
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Figure 4.20. ORFs in the 2830 bp fragment in the strand complementary to that containing 
ORFs 018 and 019. The red arrowhead pairs indicate possible promoters. ORFs F and G are 
represented by solid red arrows. Transcription from this strand is indicated by the red curved 
line underneath the green peaks; numbers on the right indicate reading frames.   
 
 
 
Figure 4.21. Nucleotide sequence of ORF A (highlighted in blue). The putative Shine- 
Dalgarno sequence is highlighted in yellow and promoter 1 is shown in green.  
 
 
 
Figure 4.22. The nucleotide sequence of ORF B (highlighted in blue). Promoter 1 is shown 
highlighted in green.  
TGTTCACGAACTGGACGGAACGGACAAGCTCTGTATCGTCATTCCTAATCGTGTAGAACTGCAAAACAAAGAG
CATAAAGACCTGCTCGAAATGCAGTTTGAAAATGTCCCCTACATGAAGAAGCGAGTCTCTTACTCTCGTGCCT
ACGGCATGGGTGTAACTATCTATTCGGAAGGTACAGGCTTACCGAACCTGGGGATCACTCGCCAGGAGTTCGA
CGGTGTAGCTAAATACATTCATAAACGAATCGAAAAACACATTGCTGATATGAAAGCAAAAGAGAAGGCATAA
CTTATGAGCAAAGAAAAAAAATTCATGGCTTGATGATATGCAATCTTTTCAAAAGATTGCGGTTGAAACTGCT
TTTAATGCCGGTGACTCTTACTGGTCGCATG 
TGTTCACGAACTGGACGGAACGGACAAGCTCTGTATCGTCATTCCTAATCGTGTAGAACTGCAAAACAAAGAGC
ATAAAGACCTGCTCGAAATGCAGTTTGAAAATGTCCCCTACATGAAGAAGCGAGTCTCTTACTCTCGTGCCTAC
GGCATGGGTGTAACTATCTATTCGGAAGGTACAGGCTTACCGAACCTGGGGATCACTCGCCAGGAGTTCGACGG
TGTAGCTAAATACATTCATAAACGAATCGAAAAACACATTGCTGATATGAAAGCAAAAGAGAAGGCATAACTTA
TGAGCAAAGAAAAAAAATTCATGGCTTGATGATATGCAATCTTTTCAAAAGATTGCGGTTGAAACTGCTTTTAA
TGCCGGTGACTCTTACTGGTCGCATG 
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Figure 4.23. The nucleotide sequence of ORF C (highlighted in blue). The SD sequence is 
shown in yellow. 
 
 
 
 
 
 
 
 
Figure 4.24. The nucleotide sequence of ORF D (highlighted in blue).  
 
 
AAAGATAACAAAGTAAGAACGATTGTTGAAAACCAGATAAATATGGCTTTGGCAGCGGCTGGGATAGAAGCAACGGTAA
CCCTTGGTTCTTTACAAGAGGAAATTGGTGCGACAGATGAAATTAAATCAGAAAAATTAAAAAAAGAAGCAGAAGAAAA
TAATAAGCCTCTTGCTGATGTAGCACAAGAACATATCAATGACGAATCTCTTGATGATGAAGAAATTTCCGACTCTTTA
ATGCAACATGGAAATCTTTCAGAACAATCCATAGAAAAACTTGAGTCTATAATTAATAAAACAGCATTTGACAGTAATG
AACAAGTAAGAAGAAAACAGGCTCAGATAAAAGAGCTAATGGCTGAACTTGTCGAAAGAGAACAGGAATTACAAGCTAT
TAATAAAGGTATTCTTTATGAAGCAAAATATATTCAAACTAAAAACCTGTTGAATGAAACTTCCAGAAAGCTTGAATCT
GTAAATAAAGAACTTGAAGAAGCAAATAAACTAAATGACGATTTCAATGAAAAAATAATTGAAAACACTAATACTATTT
CTAATCTTAATGATGAATTAGCGAGAGAAAGAAAATATAACGAAGAACAAGAATTACAACTTAACCAGTTAGAAAAAGA
ACTTGAAACCGAAAAAAATATAAATGCGGAAAACTCAGCACTCATTACAACCCTTACCGACAAGAATACTGTTTTAGCA
GCTAACCTTGAACTTGAGCAAGGTAAGACGGCAGAACTGACAGCCGAAAATGCAGAACTTAAAGAGAAGCATAAAGTTG
AGATCGCCACTCTTCGTAGTGAGTTCGCTCAGAAACTGGTTAAATACCGTAAAAACTTTGTGGCTCGTGTTAAAAACAA
AGTGGCAACGGCTGTTGAACATGCAATACAGGCATTTAGAGATAATGAATTACCTTCATTACTTAAAGATGCAACAACC
AAAGCTGTTAGTGAATATAAATTAAAAGAATTGCCTGGAAAACTTAGAAAAGTAAGAGAGGAAGAAGCCAAAAAATCAG
AGAAAGAAATTAAAGCATTAACAAACGATGTTTCAACATTGAAGACTAATGTAAATACTTTAACGGCTGATAAAGATAC
ATTGCAGAAAGATTTTGACGAATTGTTTAATGCAAGCAAAGAAAAAGCAACGGAAATGAATAATGAAATTGCTCGTCTT
AAAGAAATTCTTAAAAGCAATGGAATAAACCCTGATGGTGATAACTCACCAAAAAAGCCTAAAAATGACAATAAGATAT
AAGGGGTGACTTATGAACATAAACAACAATAAGGACAGAATAAAAGAAA 
GACGAATCTCTTGATGATGAAGAAATTTCCGACTCTTTAATGCAACATGGAAATCTTTCAGAACAATCCATAGAAAAACT
TGAGTCTATAATTAATAAAACAGCATTTGACAGTAATGAACAAGTAAGAAGAAAACAGGCTCAGATAAAAGAGCTAATGG
CTGAACTTGTCGAAAGAGAACAGGAATTACAAGCTATTAATAAAGGTATTCTTTATGAAGCAAAATATATTCAAACTAAA
AACCTGTTGAATGAAACTTCCAGAAAGCTTGAATCTGTAAATAAAGAACTTGAAGAAGCAAATAAACTAAATGACGATTT
CAATGAAAAAATAATTGAAAACACTAATACTATTTCTAATCTTAATGATGAATTAGCGAGAGAAAGAAAATATAACGAAG
AACAAGAATTACAACTTAACCAGTTAGAAAAAGAACTTGAAACCGAAAAAAATATAAATGCGGAAAACTCAGCACTCATT
ACAACCCTTACCGACAAGAATACTGTTTTAGCAGCTAACCTTGAACTTGAGCAAGGTAAGACGGCAGAACTGACAGCCGA
AAATGCAGAACTTAAAGAGAAGCATAAAGTTGAGATCGCCACTCTTCGTAGTGAGTTCGCTCAGAAACTGGTTAAATACC
GTAAAAACTTTGTGGCTCGTGTTAAAAACAAAGTGGCAACGGCTGTTGAACATGCAATACAGGCATTTAGAGATAATGAA
TTACCTTCATTACTTAAAGATGCAACAACCAAAGCTGTTAGTGAATATAAATTAAAAGAATTGCCTGGAAAACTTAGAAA
AGTAAGAGAGGAAGAAGCCAAAAAATCAGAGAAAGAAATTAAAGCATTAACAAACGATGTTTCAACATTGAAGACTAATG
TAAATACTTTAACGGCTGATAAAGATACATTGCAGAAAGATTTTGACGAATTGTTTAATGCAAGCAAAGAAAAAGCAACG
GAAATGAATAATGAAATTGCTCGTCTTAAAGAAATTCTTAAAAGCAATGGAATAAACCCTGATGGTGATAACTCACCAAA
AAAGCCTAAAAATGACAATAAGATATAAGGGGTGACTTATGAACATAAACAACAATAAGGACAGAATAAAAGAAA 
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Figure 4.25. Nucleotide sequence of ORF E in blue with the putative SD in yellow. 
 
 
 
 
 
 
 
 
 
 
Figure 4.26. The sequence of ORF F highlighted in blue. The ribosome binding site is 
indicated in yellow, promoter sequences in green and the sequences involved in termination 
of transcription in pink. 
 
TTCTGCAATGTATCTTTATCAGCCGTTAAAGTATTTACATTAGTCTTCAATGTTGAAACATCGTTTGTTAATG
CTTTAATTTCTTTCTCTGATTTTTTGGCTTCTTCCTCTCTTACTTTTCTAAGTTTTCCAGGCAATTCTTTTAA
TTTATATTCACTAACAGCTTTGGTTGTTGCATCTTTAAGTAATGAAGGTAATTCATTATCTCTAAATGCCTGT
ATTGCATGTTCAACAGCCGTTGCCACTTTGTTTTTAACACGAGCCACAAAGTTTTTACGGTATTTAACCAGTT
TCTGAGCGAACTCACTACGAAGAGTGGCGATCTCAACTTTATGCTTCTCTTTAAGTTCTGCATTTTCGGCTGT
CAGTTCTGCCGTCTTACCTTGCTCAAGTTCAAGGTTAGCTGCTAAAACAGTATTCTTGTCGGTAAGGGTTGTA
ATGAGTGCTGAGTTTTCCGCATTTATATTTTTTTCGGTTTCAAGTTCTTTTTCTAACTGGTTAAGTTGTAATT
CTTGTTCTTCGTTATATTTTCTTTCTCTCGCTAATTCATCATTAAGATTAGAAATAGTATTAGTGTTTTCAAT
TATTTTTTCATTGAAATCGTCATTTAGTTTATTTGCTTCTTCAAGTTCTTTATTTACAGATTCAAGCTTTCTG
GAAGTTTCATTCAACAGGTTTTTAGTTTGAATATATTTTGCTTCATAAAGAATACCTTTATTAATAGCTTGTA
ATTCCTGTTCTCTTTCGACAAGTTCAGCCATTAGCTCTTTTATCTGAGCCTGTTTTCTTCTTACTTGTTCATT
ACTGTCAAATGCTGTTTTATTAATTATAGACTCAAGTTTTTCTATGGATTGTTCTGAAAGATTTCCATGTTGC
ATTAAAGAGTCGGAAATTTCTTCATCATCAAGAGATTCGTCATTGATATGTTCTTGTGCTACATCAGCAAGAG
GCTTATTATTTTCTTCTGCTTCTTTTTTTAATTTTTCTGATTTAATTTCATCTGTCGCACCAATTTCCTCTTG
TAAAGAACCAAGGGTTACCGTTGCTTCTATCCCAGCCGCTGCCAAAGCCATATTTATCTGGTTTTCAACAATC
GTTCTTACTTTGTTATCTTTTAGTAATAAAGCAGCATTGACAATTCTTTTATTAGGATTTGCTGCATTTATAA
ATGGAATAAACTCTCCTTTATCATTCGTTGAAACACCATAATTCTTATCAGTGATACAATGAGCAGAACGGAA
GAGGTGGAAATGGTCTGGAATTACATTTCCCAAATGATCTGTCTGGTTGCGGTGAATCCCCCAGGCAAGCACA
CTTTGCAGACCTTTATTGACTATAATCTGTGGTTTTCTACCGCTATTCTGTTCTTTTCTGAATATAAAATCGG
GGTGAGAGATTTCTCTTATGATAATTTCCCTGGTTTTTGATTGTAGGTGCTTAGGAACACCATCAAGATAAAA
GACAAAGTGCTCACCTTCCGGTTGTTCATCAAGCTCGTGAAGCTTATTAAATTTCTTT 
AAACAGGCTCAGATAAAAGAGCTAATGGCTGAACTTGTCGAAAGAGAACAGGAATTACAAGCTATTAATAAAGG
TATTCTTTATGAAGCAAAATATATTCAAACTAAAAACCTGTTGAATGAAACTTCCAGAAAGCTTGAATCTGTAA
ATAAAGAACTTGAAGAAGCAAATAAACTAAATGACGATTTCAATGAAAAAATAATTGAAAACACTAATACTATT
TCTAATCTTAATGATGAATTAGCGAGAGAAAGAAAATATAACGAAGAACAAGAATTACAACTTAACCAGTTAGA
AAAAGAACTTGAAACCGAAAAAAATATAAATGCGGAAAACTCAGCACTCATTACAACCCTTACCGACAAGAATA
CTGTTTTAGCAGCTAACCTTGAACTTGAGCAAGGTAAGACGGCAGAACTGACAGCCGAAAATGCAGAACTTAAA
GAGAAGCATAAAGTTGAGATCGCCACTCTTCGTAGTGAGTTCGCTCAGAAACTGGTTAAATACCGTAAAAACTT
TGTGGCTCGTGTTAAAAACAAAGTGGCAACGGCTGTTGAACATGCAATACAGGCATTTAGAGATAATGAATTAC
CTTCATTACTTAAAGATGCAACAACCAAAGCTGTTAGTGAATATAAATTAAAAGAATTGCCTGGAAAACTTAGA
AAAGTAAGAGAGGAAGAAGCCAAAAAATCAGAGAAAGAAATTAAAGCATTAACAAACGATGTTTCAACATTGAA
GACTAATGTAAATACTTTAACGGCTGATAAAGATACATTGCAGAAAGATTTTGACGAATTGTTTAATGCAAGCA
AAGAAAAAGCAACGGAAATGAATAATGAAATTGCTCGTCTTAAAGAAATTCTTAAAAGCAATGGAATAAACCCT
GATGGTGATAACTCACCAAAAAAGCCTAAAAATGACAATAAGATATAAGGGGTGACTTATGAACATAAACAACA
ATAAGGACAGAATAAAAGAAA 
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Figure 4.27. Nucleotide sequence of ORF G in blue. The SD sequence is in yellow.  
 
Based on the relative positions of the candidate promoters (3 and 6) and the ORFs in the 
strand containing ORFs 018 and 019, it appeared that promoter 3, which is 67 bases upstream 
of the start codon of ORF019, could be a potential promoter for ORFs 019, C, D and E.  
In the complementary strand, promoter 8 could potentially transcribe ORFs F and G. 
Promoter 8 is 144 bases upstream of the start codon of ORF F (Figure 4.26) and 358 bases 
upstream of ORF G (Figure 4.27). Thus Promoter 8 can potentially direct transcription of an 
mRNA containing ORF F and ORF G. On the other hand, promoter 9 is contained within 
ORF G and cannot prime its transcription. At this stage both ORFs F and G are potential 
candidates for encoding rep protein, with ORF F being a stronger candidate because of its 
proximity to promoter 8.  
 
4.6.3 Ribosome binding sites 
In order to predict which of the ORFs were likely to be expressed, the sequences were 
analysed further to identify putative Shine-Dalgarno sequences upstream (<10 bp) of the 
TTCTGCAATGTATCTTTATCAGCCGTTAAAGTATTTACATTAGTCTTCAATGTTGAAACATCGTTTGTTAATGCT
TTAATTTCTTTCTCTGATTTTTTGGCTTCTTCCTCTCTTACTTTTCTAAGTTTTCCAGGCAATTCTTTTAATTTA
TATTCACTAACAGCTTTGGTTGTTGCATCTTTAAGTAATGAAGGTAATTCATTATCTCTAAATGCCTGTATTGCA
TGTTCAACAGCCGTTGCCACTTTGTTTTTAACACGAGCCACAAAGTTTTTACGGTATTTAACCAGTTTCTGAGCG
AACTCACTACGAAGAGTGGCGATCTCAACTTTATGCTTCTCTTTAAGTTCTGCATTTTCGGCTGTCAGTTCTGCC
GTCTTACCTTGCTCAAGTTCAAGGTTAGCTGCTAAAACAGTATTCTTGTCGGTAAGGGTTGTAATGAGTGCTGAG
TTTTCCGCATTTATATTTTTTTCGGTTTCAAGTTCTTTTTCTAACTGGTTAAGTTGTAATTCTTGTTCTTCGTTA
TATTTTCTTTCTCTCGCTAATTCATCATTAAGATTAGAAATAGTATTAGTGTTTTCAATTATTTTTTCATTGAAA
TCGTCATTTAGTTTATTTGCTTCTTCAAGTTCTTTATTTACAGATTCAAGCTTTCTGGAAGTTTCATTCAACAGG
TTTTTAGTTTGAATATATTTTGCTTCATAAAGAATACCTTTATTAATAGCTTGTAATTCCTGTTCTCTTTCGACA
AGTTCAGCCATTAGCTCTTTTATCTGAGCCTGTTTTCTTCTTACTTGTTCATTACTGTCAAATGCTGTTTTATTA
ATTATAGACTCAAGTTTTTCTATGGATTGTTCTGAAAGATTTCCATGTTGCATTAAAGAGTCGGAAATTTCTTCA
TCATCAAGAGATTCGTCATTGATATGTTCTTGTGCTACATCAGCAAGAGGCTTATTATTTTCTTCTGCTTCTTTT
TTTAATTTTTCTGATTTAATTTCATCTGTCGCACCAATTTCCTCTTGTAAAGAACCAAGGGTTACCGTTGCTTCT
ATCCCAGCCGCTGCCAAAGCCATATTTATCTGGTTTTCAACAATCGTTCTTACTTTGTTATCTTTTAGTAATAAA
GCAGCATTGACAATTCTTTTATTAGGATTTGCTGCATTTATAAATGGAATAAACTCTCCTTTATCATTCGTTGAA
ACACCATAATTCTTATCAGTGATACAATGAGCAGAACGGAAGAGGTGGAAATGGTCTGGAATTACATTTCCCAAA
TGATCTGTCTGGTTGCGGTGAATCCCCCAGGCAAGCACACTTTGCAGACCTTTATTGACTATAATCTGTGGTTTT
CTACCGCTATTCTGTTCTTTTCTGAATATAAAATCGGGGTGAGAGATTTCTCTTATGATAATTTCCCTGGTTTTT
GATTGTAGGTGCTTAGGAACACCATCAAGATAAAAGACAAAGTGCTCACCTTCCGGTTGTTCATCAAGCTCGTGA
AGCTTATTAAATTTCTTT 
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ORFs and similar to the conserved E. coli SD sequence (AGGAGG). A candidate SD 
sequence, AAAGAC, was identified adjacent to the start of ORF A (Figure 4.21). No putative 
SD could be identified for ORF B (Figure 4.22) or D (Figure 4.24). A candidate SD sequence 
of GAAAAC was found adjacent to ORF C (Figure 4.23). The sequence AAAAGA could act 
as a SD sequence for translation of ORF E (Figure 4.25). In case of ORF F a candidate Shine-
Dalgarno of AAATGC was found (Figure 4.26). Scanning the sequences upstream of ORF G 
also indicated a potential SD sequence of GTAAGG (Figure 4.27). On the basis of the 
finding of candidate SD sequences, it appears that ORFs A, C, E-G could be potentially 
translated.  
 
4.6.4 Transcription terminators 
Intrinsic terminators of transcription were searched by looking for GC-rich sequences that 
were followed by T-rich segments (Farnham and Platt, 1981; reviewed by Platt, 1986; Wilson 
and Hippel, 1995). Alternatively, rho-dependent terminators were searched by looking for C-
rich regions (reviewed by Richardson and Greenblatt, 1996). The sequence immediately 
adjacent to the termination codon of ORF A/B was not significantly GC rich to allow 
conventional termination of transcription. However, a relatively GC rich sequence 
(GCTGCTCATGTCGTCAC) that was followed by a region containing 13 A+T was found 
380 bases downstream of promoter 1. This GC rich sequence can potentially form a stem-
and-loop structure consisting of two GC bonds that could help in termination of transcription 
of any transcript from promoter 1 (Figure 4.28). 
 
 
 
 
 
 
Figure 4.28: Candidate transcription termination sequence for transcript from promoter 1.  
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In case of the complementary strand to that containing ORFs 018 and 019, a sequence 
(TTGTAGGTGCTTAGGAACACCATCAAG) immediately adjacent of the termination 
codon of ORF F, followed by a string of 6 pyrimidines (mostly A’s), could act as a potential 
transcription terminator (highlighted in pink in figure 4.23). The mfold software 
(www.mfold.rna.albany.edu) predicted a stem-and-loop structure with four GC- bonds and 
four AU bonds (Figure 4.29).  This could act as a potential transcription terminator for both 
ORFs F and G.  
 
 
 
 
 
 
 
 
Figure 4.29. A potential stem-and-loop terminator structure downstream of ORF F and G. GC 
bonds are shown in red. 
 
4.6.5 Candidate replication initiator protein genes based on sequence analysis 
In section 4.4, it was found that deletion of the first 144 bp from the left end abolished 
replication driven by the 2831 bp sequence. Deletion of 144 bases deletes promoter 1. 
Promoter 1 which is located 99 bp downstream of the end at which the deletion was made 
may actually play a role in transcription from this end. Further analysis indicates that ORF A 
starts 52 bases and ORF B starts 76 bases downstream of the -10 box of promoter 1 (Figure 
4.18 and 4.19, respectively). Based on the deletion analysis and in the absence of a putative 
SD sequence for ORF B, ORF A is proposed to be a more likely candidate for translation of a 
putative rep protein than ORF B in the strand that contains ORF 019.  
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In the complementary strand, considering the position of promoter 8, the presence of a 
candidate SD sequences and the presence of a candidate terminator of transcription, it seems 
possible that either ORF F or ORF G might be a suitable candidate for further investigation as 
an initiator of replication or rep protein. 
 
4.6.6 Alternative hypothesis based on possible candidates for RNA initiators of 
replication 
ORF019 has already been experimentally demonstrated not to be involved in replication. The 
other alternative is priming of replication by RNA which would not require translation to take 
place. However, this would indicate transcription of a potential anti-transcript (repressor of 
replication) from the RP2 region (the region conferring incompatibility) that would bind to 
the transcript to inhibit replication from the RNA primer. When the RP7 sequence was 
aligned at http://blast.ncbi.nlm.nih.gov/with the RP2 region, no alignment was found. Also, 
no candidate promoter and transcription terminator sequences could be identified in RP2. In 
the present sequence analysis promoter 3 in the same strand as ORF 019 and promoter 10 in 
the complementary strand are both potential promoters. Transcription terminator sequences 
have also been identified in both strands. It is possible that promoter 3 may transcribe a 
replication initiator RNA as in the case of ColE1. The transcript from promoter 10 could 
potentially function as a regulator of initiation of replication by binding to the initiator. 
Northern blot for RNA profile or alternatively qPCR could be done to identify the presence 
of the candidate RNAs. The hypothesis that replication might be initiated by RNA however 
needs to be tested in future studies.  
 
4.7 Identification of pBSSB2 regions which exert plasmid incompatibility 
The phenomenon in which one plasmid is lost owing to the presence of a second plasmid 
with similar replicon or similar stability functions in the same host is termed plasmid 
incompatibility. It was expected that by identifying a fragment in the pBSSB2 library that 
exerts incompatibility to the parental plasmid, a region that carries the origin of replication or 
replication control elements or alternatively a region that carries information for stability 
function might be found. When two plasmids carrying similar replicons co-exist in a host 
Characterization of the replication function of the linear plasmid, pBSSB2 
 
97 
 
cell, they are regulated as a single pool instead of as separate plasmids. With time, one of the 
plasmids may be lost from the population as its copy number may drift downwards and not be 
corrected.  
Vectorial incompatibility may occur when a cloned fragment from a test plasmid is present in 
an unrelated (and normally compatible) vector and is present at a high copy number in a cell 
also containing the test plasmid (Novick, 1987). Specific regions of the test plasmid when 
cloned cause destabilization of the test plasmid owing to incompatibility (Novick, 1987). 
Typically these regions will be those involved in the regulation of replication (e.g. producing 
a trans-acting repressor or a site which titrates a Rep protein). Cross-reaction between 
stability (e.g. par) functions can also cause incompatibility.  
In order to identify incompatibility determinants, the pRP2-pRP10 library of pBSSB2 
fragments cloned in pUC18 was used in incompatibility assays. Cells harbouring the linear 
plasmid were made electrocompetent following the procedure outlined in section 2.18.1. 
Constructs pRP2-pRP10 were individually introduced by electroporation. Transformed cells 
were spread on L-agar containing kanamycin (25µg ml
-1
) and carbenicillin (50µg ml
-1
) to 
select for both plasmids. As a negative control the vector backbone of pUC18 was also tested 
for incompatibility to pBSSB2.  
A total of 50 transformants was picked for each construct and streaked onto L-agar 
containing carbenicillin only to select for the pUC18 derivative plasmids. Plates were 
incubated at 37°C overnight. Fifty colonies from each plate were streaked the next day on L-
agar containing carbenicillin and L-agar with kanamycin. Plates were incubated at 37°C 
overnight. The percentage of Km
r
 colonies (i.e. those that contained the linear plasmid) 
compared to the number of carbenicillin resistant colonies was then scored. Since selection 
was maintained for only the circular constructs, and pBSSB2 is stable over the length of the 
experiment in the presence of pUC18 (Baker et al., 2007b), the percentage loss of pBSSB2 
provides a measure of incompatibility exerted by the insert in the circular plasmid. The assay 
was done in triplicate for each construct and control (Figure 4.30).  
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Figure 4.30. Incompatibility between pBSSB2 and constructs pRP2 to pRP10. pUC18 was 
used as a control to check its compatibility with pBSSB2. The results are the averages of at 
least three assays ± S.D. The % for pRP2 and pRP6 is zero. 
 
The result of the assay showed that pRP3-pRP5 and pRP7-pRP9 were compatible with the 
linear plasmid. With the exception of pRP4, 100% of the transformed cells retained the linear 
plasmid. With pRP4 and pRP10, 76% and 71.1% of the colonies retained the linear plasmid, 
respectively, whereas pRP2 and pRP6 showed strong incompatibility. Fragment RP2 includes 
most of RP6. In the linear plasmid map, RP2 (10068bp-14073bp) and RP7 (11350bp-
15933bp) overlap (Figure 4.33). It was decided to use pRP2 as the starting point for 
identification of the incompatibility region in a deletion analysis.  
 
 
 
 
 
 
Figure 4.31. Map showing position of fragments RP2, RP6 and RP7. Fragment RP2 includes 
most of RP6 and overlaps with fragment RP7. 
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4.8 Generation of RP2 deletion derivatives to identify the minimum region 
conferring incompatibility 
In the initial analysis of RP2 deletion derivatives a rapid test for incompatibility was adopted. 
The circular derivative was transformed into cells containing the linear plasmid and 
incompatibility was scored based on the presence or absence of transformant colonies in 
plates (L-agar) containing antibiotic selecting for both the linear and the circular plasmids. 
The justification for the rapid assay was the fact that no transformant colonies had been found 
on plates containing carbenicillin and kanamycin when a pBSSB2-containing strain was 
transformed with pRP2 or pRP6.   
 
Sub-sections of RP2 were amplified and cloned into pUC18 to identify the minimum region 
conferring incompatibility. PCR (MasterAmp PCR kit, Section 2.10.3) was used to generate a 
set of deletions extending from both ends of RP2 (Figure 4.34). Oligonucleotides used for 
PCR are detailed in section 2.8. PCR primers were tailed with EcoRI and BamHI recognition 
sites. Using these restriction sites, each PCR product was cloned in pUC18. Each construct 
was checked by agarose gel electrophoresis following digestion with EcoRI and BamHI (data 
not shown). Further confirmation was obtained by sequencing of the insert. Following 
validation of a construct, it was transformed into electrocompetent DH5α cells containing 
pBSSB2. Transformant colonies were spread on L-agar containing both carbenicillin and 
kanamycin. pUC18 was used as a negative control and pRP2 as positive control for the 
incompatibility assay. Following transformation the absence of colonies on agar containing 
both carbenicillin and kanamycin was taken as evidence of incompatibility. The pattern of 
incompatibility exhibited by the deletion series is shown in Figure 4.32 in which 
incompatible fragments are indicated by blue lines and compatible fragments by black lines. 
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Figure 4.32. RP2 deletion series to identify minimum region expressing incompatibility 
against pBSSB2. The blue lines indicate fragments that exerted incompatibility, whereas the 
black lines represent fragments that were compatible with pBSSB2. The numbers indicate the 
nucleotide positions within RP2. 
 
Subsequently a more thorough incompatibility analysis was performed with selected 
constructs. Each construct (pRP2, its deletion derivatives and pUC18 control) was 
transformed into pBSSB2-containing cells and transformant colonies were selected on L-agar 
with carbenicillin (50µg ml
-1
). A total of ten colonies were picked randomly from this plate 
and streaked onto L-agar in the absence of selection. The plate was incubated at 37°C 
overnight. Ten colonies were picked and transferred to L-agar without selection.  This 
process was repeated once again.  Finally, a total of 100 colonies were picked and replica-
plated using sterile toothpicks onto L-agar containing carbenicillin and L-agar with 
kanamycin. The pattern of antibiotic resistance indicated which plasmids(s) had been retained 
(Figure 4.33).  
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Figure 4.33. Plasmid profile of cells transformed with linear plasmid and pRP2 deletion 
derivatives after growth in the absence of selection. Blue bars indicate proportion of colonies 
containing only the circular plasmid; pink bars indicate proportion of cells containing 
pBSSB2 and green bars represent colonies with both plasmids. Results are averages of three 
assays ± S.D. 
It was observed that in most cases when incompatibility occurred, the circular pUC18-based 
plasmid was retained preferentially. This is expected since, in this experiment, 
incompatibility is directional, i.e. it is possible for the pUC18 derivative to repress replication 
of pBSSB2, but not vice versa. Exceptions were pRP2DelA and pRP2DelDRev where 
significant numbers of cells containing only the linear plasmid were recovered. 
 
4.9 Sequence analysis of the minimum region of incompatibility 
Control of plasmid replication can be mediated by antisense RNA, protein and iterons 
(Summers, 1996). When the 179bp sequence responsible for RP2-mediated incompatibility 
was analysed using an ORF finder tool available at 
http://www.ncbi.nlm.nih.gov/projects/gorf/, no complete ORF was found. The only possible 
candidate as element for incompatibility therefore was an RNA or iterons. However, an 
insignificant level of transcription was observed from the region containing RP2 (Figure 4.31, 
RP2 is immediately to the left of ORF017). The 179bp sequence was analysed by eye. A six 
base pair imperfect repeat, (G/T) (G/A) TGTT was found within this sequence (Figure 4.34). 
   % with circular 
plasmid 
    % with linear 
plasmid 
    % with both 
plasmids 
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It is possible that these repeats might act as iterons that bind a hypothetical replication 
initiator protein, titrating the latter away from events leading to initiation of replication.  
 
Figure 4.34. 179bp of RP2 deletion series sufficient to cause incompatibility. Location of this 
sequence in linear plasmid map is shown. 
 
4.10 Interaction of incompatibility and replication functions 
Replication of pRP7 in a polA host indicated that fragment RP7 carries information for 
replication of the linear plasmid in a circular mode. But the very low copy number and the 
inability to isolate a colony containing fragment RP7 ligated to Km
r
 cassette provided 
evidence that replication from fragment RP7 is inefficient. It was speculated that if the region 
of RP2 containing the incompatibility function of the linear plasmid was joined to RP7, 
replication might be better regulated. 
Using PCR the region of the linear plasmid including both RP2 and RP7 was amplified using 
the left EcoRI tailed primer used originally to generate RP2 and the right BamHI tailed 
primer used originally to generate RP7 (Table 4, Section 2.8). This single fragment, 
designated RP27, was cloned in pUC18 using EcoRI and BamHI. The construct was 
validated by restriction digestion and sequencing. The plasmid (pRP27) was transformed into 
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the E. coli DNA polymerase I mutant, BR825. pRP7 and pUC18 were used as positive and 
negative controls, respectively. The optimized transformation method designed for BR825 
was followed. Transformant colonies were selected at 37°C on L-agar containing 
carbenicillin. No colonies were obtained from the pRP27 transformation. The control 
plasmids behaved as expected with pRP7 resulting in a lawn of growth and no colonies with 
pUC18. This experiment was repeated with pRP27 purified from ten different, randomly-
picked transformant colonies from the initial transformation plate and repeating the 
transformation using each plasmid on its own as well as combining the ten plasmids in a 
mixture and using an aliquot for transformation. This was done to exclude the possibility of a 
chance mutation in the pRP27 construct initially tested. However, the same failure to obtain 
transformants was observed in every case. Clearly the presence of the incompatibility region 
was inhibiting replication from the RP7 origin.  
 
In order to investigate whether the inhibitory effect of the RP2 inc determinant also occurs in 
trans, the RP2 region was cloned separately in a low copy number vector, pFH450. The 
resulting construct was designated pFHRP2. pFH450 contains a high copy number, DNA 
polymerase I-dependent ColEI origin, a low copy number, DNA polymerase I-independent 
P1 origin and  a chloramphenicol resistance cassette. Hence pFH450 is able to replicate in the 
polA mutant strain, BR825. In BR825 pFH450 replicates from the low copy number P1 origin 
(the ColEI origin being non-functional). The plasmids used and the results of transformation 
into BR825 in this experiment are shown in Table 4.4. 
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Table 4.4 The influence of fragment RP2 on RP7 when present in cis or in trans 
Name of 
plasmid(s) 
transformed 
into BR825 
Purpose of the 
experiment 
Presence of transformants in BR825 
LA+Carbenicillin LA+Chloramphenicol 
pRP7 Positive control for 
pBSSB2 replication in 
circular mode 
>300
1
  ND
2
 
pFH450 Positive control for 
pFH450 replication  
ND >300 
pUC18 Negative control for 
pUC18 replication in 
BR825 
0 ND 
pFHRP2 and 
pRP7 
Effect of RP2 on RP7 
when present in trans 
0 >300
1
  
pRP27 Investigate effect on 
replication from RP7 by 
RP2 in cis 
0 ND 
1
 >300 refers to the number of colonies in a plate spread with 100µl of transformants. 
2
Not done 
 
 
It was seen that pRP7 and pFHRP2 replicated in BR825, whereas pUC18 did not. When 
pRP7 and pFHRP2 were transformed sequentially in either order, pRP7 did not replicate 
when pFHRP2 was present in the same host (BR825). pRP27 failed to replicate. Thus, 
absence of transformants was observed when RP2 and RP7 were present together in the same 
cell, either in the same plasmid or in different plasmids. From this observation it was 
concluded that the inhibitory effect of RP2 on replication from RP7 occurred both in cis and 
in trans.  
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4.11 Discussion  
Since its identification and isolation by Baker et al. (2007b), the linear plasmid pBSSB2 has 
previously only been characterized by sequence analysis. The GC skew (Picardeau et al., 
2000) (G-C/G+C) lies upstream of ORF017 and this region has been proposed to contain the 
origin of replication (Picardeau et al., 2000). No direct repeats or iterons were found in this 
region (Baker et al., 2007b).  
One of the major objectives of the present study was a functional analysis of pBSSB2 
replication. To map the basic replicon it was decided to work with circular derivatives of 
pUC18 containing inserts from the linear plasmid. Working with circular plasmids was 
expected to be technically easier. For example transformation efficiency would be higher for 
circular than for linear plasmids. A search of the pertinent literature revealed that there are 
both advantages and disadvantages of using circular derivatives of a linear plasmid or 
chromosome. For example, it has been reported that linear plasmids pSLA2, pSLA2-L, SCP1 
and pSCL from the well characterized Streptomyces group can replicate as a circle from a 
central origin when their telomeres are deleted (Chang and Cohen, 1994; Hiratsu et al., 2000; 
Redenbach et al., 1999; Shiffman and Cohen, 1992). In the Streptomyces linear plasmid 
pSCL mutations that inhibited replication in a linear mode also rendered replication of the 
circular mode non-functional (Shiffman and Cohen, 1992). Such an observation indicated 
that these two modes require the same gene products for replication. Linear plasmids from 
Rhodococcus and Mycobacterium also replicate from centrally located loci and have similar 
structure to pBSSB2 (Warren et. al., 2004; Picardeau et al., 2000). However, inefficient 
replication of circular derivatives of plasmids that are linear in their native state has been 
reported previously (Zakrzewska-Czerwinska and Schrempf, 1992; Chang et. al., 1996; Qin 
and Cohen, 2003; Beaurepaire and Chaconas, 2005; Xu et al., 2006). Linear plasmid lp17 of 
Borrelia burgdorferi has also been found to replicate more efficiently in a linear mode than in 
a circular mode. The circular derivative exhibited reduced stability with no detectable 
plasmid following 50 generations (Beaurepaire and Chaconas, 2005). The reason for the 
effect of topology on replication is not always clear but differences in supercoiling between 
circular and linear replicons can potentially influence melting of the replication origin, 
formation of essential secondary structure or transcription (Alverson et al., 2003). 
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Since most previous investigation of linear plasmid replicons have been based on 
experiments with circular derivatives, it was decided to adopt this approach in order to look 
for pBSSB2 replicon. 
Upon working with circular derivatives, only one region of pBSSB2, RP7, was able to rescue 
replication of pUC18 in a polA mutant. Formally this could be due to: 
1. Presence of sufficient pBSSB2 information in pRP7 to enable replication in a circular 
mode. 
2. Integration of the construct into the chromosome. 
3. Activation of the pUC18 origin by information contained in RP7 that enabled 
replication in BR825. 
Purification of pRP7 from XL1-Blue transformed with plasmid preparation purified from 
BR825 made it unlikely that pRP7 had integrated into the chromosome.  It also seems 
unlikely (although not impossible) that only one of the pRP2-pRP10 plasmid series would 
have been capable of integration.  
Some of the BR825 transformants were found to contain a pRP7 derivative that had 
undergone rearrangement and contained 815bp of linear plasmid sequence. This 815bp 
cloned in pUC18 could not drive replication of the resultant construct in BR825. This 
suggested that presence of the insertion sequence exerted some influence on replication of the 
construct. It is possible that the insertion sequence enabled integration of the plasmid into the 
host chromosome, where it replicated with the chromosome but this was not investigated 
further. 
From the transformation of pRP7 into BR825 it could not be concluded whether RP7 
contained functions required for pBSSB2 replication in a circular mode or whether it 
somehow activated the pUC18 origin. An attempt was made to resolve the question by 
ligating RP7 to a kanamycin cassette (Km
r
). If the resultant construct was replicated from 
RP7 this construct should be viable. Unfortunately, exhaustive attempts to obtain an 
autonomously replicating construct proved futile. The possibility that information contained 
in RP7 activated the pUC18 origin cannot therefore be excluded.  
Deletion analysis of RP7 identified a 2830bp fragment which supported replication of a 
pUC18 derivative in a polA mutant. A 144bp deletion from the left end rendered RP7 non-
replicating, indicating that this region is essential for RP7 function. The smallest replicating 
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fragment carries ORF018 and ORF 019 of pBSSB2. Mutagenesis studies showed that neither 
of these ORFs is essential for replication. However, analysis of transcription data generated at 
the Wellcome Trust Sanger Institute (Hinxton, UK) indicated significant transcription of the 
region containing ORFs 017, 018 and 019 (Figure 4.14). Upon sequence analysis, three ORFs 
in the same strand as that containing ORF 019 (ORFs A, C and E) and two in the 
complementary strand (ORFs F and G) are potential candidates for rep-protein encoding 
ORFs in future investigations. An alternative hypothesis of RNA primed replication has also 
been proposed. This hypothesis also needs to be tested in future studies.  
Incompatibility assays and deletion walking on fragment RP2 identified a 179bp region 
exerting incompatibility, just 331bp from the boundary of RP7. Fragment RP2 contained the 
GC skew (Baker et al., 2007b), which had previously been cited as evidence that this region 
contained the origin of replication. On the other hand, the incompatibility phenotype would 
also be consistent with being (or encoding) a repressor of replication. This can be by the 
production of a repressor (antisense RNA or protein) or by DNA direct repeats or iterons 
titrating a Rep protein. The absence of a complete ORF sequence made the production of a 
repressor protein unlikely. The four 6bp imperfect repeats in RP2 may be acting as 
incompatibility determinants possibly by titrating a Rep protein. In any case these data show 
that additional sequences outside of RP7 play a role in regulation of replication in the native 
linear plasmid. Requirement for sequences in addition to the Rep gene and iterons has been 
demonstrated for other linear plasmids viz. pSLA2 (Chang et al., 1996). In case of SLP2 
efficient replication as a circular derivative requires additional 47bp sequences upstream of 
23-mer iterons. Inclusion of these sequences increased the transformation efficiency by about 
1000 fold (Xu et al., 2006). The ability of RP2 to inhibit replication from RP7 also provided 
evidence against the hypothesis that RP7 simply activates the pUC18 origin. The presence of 
iterons, if confirmed, would favour a Rep protein as the initiator of replication rather than 
pre-primer RNA.  
Based on comparison with other linear plasmids with similar structural features to pBSSB2, 
the encoding of an initiator protein in region RP7 is plausible. The origin of replication seems 
likely to lie in fragment RP2. Control of replication is possibly regulated by iterons in RP2. In 
the event that the origin of replication is contained in fragment RP2, it is possible that a 
secondary origin-like sequence drives circular plasmid replication from RP7. The Rep-iteron 
organisation would be similar to that found for pSLA2 (Chang et al., 1996), SCP1 
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(Redenbach et al., 1999), pSCL1 (Huang et al., 2003), SLP2 (Wu and Roy, 1993), pCLP 
(Picardeau et al., 2000) and pRHL3 (De Mot et al., 1997).  
Based on the findings related to pBSSB2 replication, the following hypothesis can be put 
forward: 
1. Fragment RP7 encodes an initiator of replication and fragment RP2 contains the 
origin of replication as well as a replication repressor.  
2. In the linear plasmid the RP27 region, i.e. combined RP7 and RP2, constitutes the 
basic replicon.  
3. It is possible that the circularity of the pRP27 derivative represses replication. Hence 
the inviability of pRP27.  
4. When the repressor and origin containing region (RP2) is omitted, replication of a 
circular plasmid is activated through an origin-like sequence in RP7. 
5. Owing to the absence of the true origin in RP7 and because of its topology, replication 
driven by this fragment is inefficient, hence the low copy number of pRP7.  
In the present study, the putative Rep protein is yet to be identified. Binding assays of any 
putative Rep protein with incompatibility determinants within RP2 could provide further 
supporting evidence of the role of iterons in replication control. Future studies also need to be 
carried out in order to identify elements associated with plasmid replication at the telomeres.  
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5.1 Introduction 
 
In order to ensure that plasmids are passed efficiently to daughter cells, stability 
function(s) must be present in the plasmid, particularly when the copy number of the 
plasmid is low and random distribution would lead to plasmid-free cells at high 
frequency.  
 
Three mechanisms commonly used by low-copy number plasmids to ensure 
segregational stability are: 
 
1. Partitioning systems that distribute plasmids actively into daughter cells e.g. the 
partitioning system of F plasmid (Ogura and Hiraga, 1983).  
2. Toxin - antitoxin systems which code for a stable toxin and an unstable 
antitoxin. Plasmid-free cells are killed by the toxin. Plasmid - containing cells 
are viable as only these contain the antitoxin. An example of this is the hok-sok 
system in plasmid R1 (Gerdes et al., 1990). 
3. Plasmid multimer resolution systems which convert multimers to monomers by 
site-specific recombination. This increases number of available plasmid entities 
to be partitioned during cell division. An example is the Cre-lox system of P1 
(Sternberg and Hamilton, 1981). 
 
Because of their structure, multimer formation due to recombination between linear 
plasmids is not a threat. The presence of a partitioning system, a post-segregational 
killing system, or both, is more likely for a linear plasmid. One of the major objectives 
of the present investigation was to identify and characterize regions involved with 
stable inheritance of pBSSB2.  
 
Limited studies have been conducted on stability functions of linear plasmids. Of these 
the stability functions of the linear plasmid pCLP of Mycobacterium celatum have been 
investigated in circular derivatives (Dantec et al., 2001). Similarly circular plasmids 
have been used to identify the region(s) carrying pBSSB2 stability function(s). This 
makes the assumption that partition and replication functions are not interlinked and 
identification of stability determinants is possible in a circular vector not carrying the 
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linear plasmid replicon. The independence of replication and stability functions is 
supported by a number of studies in circular plasmids. The parS cis-acting site of P1 
has been shown to stabilize heterologous replicons (Austin and Abeles, 1983; Austin et 
al., 1986). P1 can stabilize mini-F plasmids that do not contain any partition region 
(Austin and Abeles, 1983). Plasmid F par/sop can stabilize oriC plasmids that lack 
stability functions (Ogura and Hiraga, 1983). The hok/sok system of R1 has also been 
shown to be independent of the replicon (Boe et. al., 1987; Gerdes, 1988; Gerdes et al., 
1985). This system stabilizes F and R1 plasmids about 50-100 fold and high copy 
number plasmids such as p15A and pBR322 1000-10,000 fold. Based on these 
observations, it was assumed that linear plasmid stability functions should also function 
independently of replication mechanisms. In other words, stability functions of 
pBSSB2 would be expected to stabilize an unstable heterologous circular replicon.  
 
5.2 Identification of regions containing stability functions of pBSSB2 
Mutations in pcnB (plasmid copy number control gene) decrease the copy number of 
ColE1 (Lopilato et al., 1986). pcnB codes for a poly(A) polymerase (Cao and Sarkar, 
1992), which polyadenylates RNAI. The RNAI antisense suppressor of replication 
initiation is initially degraded by ribonuclease E (Tomcsanyi and Apirion, 1985; Lin-
Chao and Cohen, 1991) and the polyadenylated cleaved product undergoes rapid 
degradation (Xu et al., 1993). In the absence of polyadenylation, RNAI undergoes slow 
decay and the copy number of ColE1-like plasmids is reduced. Copy number reduction 
in a pcnB mutant means that pUC18 is lost more rapidly. To maintain itself in the host 
population an additional stability system becomes necessary. The linear plasmid library 
pRP2-pRP10 was used to identify regions that carried stability functions. This screen 
envisages that the presence of a pBSSB2 stability function in any of these pUC18 
derivatives will improve their stability in a pcnB host.  
 
Each construct was transformed into the pcnB mutant and stability was tested using the 
assay described by Martin et al. (1987). In this method, 8 transformant colonies were 
picked randomly and streaked onto L-agar containing carbenicillin. The plate was 
incubated at 37°C overnight. In the next step 8 colonies were randomly picked and 
plated onto L-agar without carbenicillin. This procedure was repeated once more. A 
total of 64 colonies were picked from the final L-agar plate after incubation overnight 
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at 37°C and patched onto L-agar with and without selection. The number of colonies 
that grew in the presence and absence of selection was used to calculate the percentage 
of cells that retained the plasmid. In this assay, pUC18 was used as a negative control.  
 
In the case of pUC18, 59% of cells retained the plasmid (Figure 5.1). All constructs 
carrying regions of pBSSB2, with the exception of pRP2 and pRP4, had a smaller 
percentage of cells retaining the plasmid when compared to pUC18. It is notable that 
the presence of the inserts often reduces stability further. This may be explained by the 
added metabolic load imposed by the larger plasmid.  Construct pRP2 showed variable 
stability (74%) with a high standard deviation. pRP4 (93.75%) was consistently highly 
stable. It was clear that fragment RP4 contributed to the stabilization of pUC18 in the 
pcnB host and may therefore play a role in the stability of pBSSB2.  It was decided to 
work primarily with fragment RP4. pRP2 was also included in further stability assays 
for comparison.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.1 Stability of constructs pRP2 to pRP10 in a pcnB mutant. Vertical bars show 
average percentage of cells retaining a construct ± standard deviation (S.D.) of at least 
three independent experiments. The dotted line shows the cut-off value and corresponds 
to the percentage of cells retaining pUC18.  
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5.3 Further analysis of stability functions in regions RP2 and RP4 
In a further analysis of pBSSB2 stability functions an unstable bi-replicon plasmid, 
pFH450 (Hayes, 1998), was used. This plasmid carries the medium copy number ColE1 
replicon, and a low copy number P1 replicon, but no stability function. It was used as a 
cloning vector to clone the fragments RP2 and RP4 that had stabilized pUC18 in the 
pcnB mutant. In wild-type E. coli, this vector replicates from the ColE1 replicon and 
random distribution is sufficient to ensure stable maintenance. However, in a DNA 
polymerase I mutant (BR825), the ColE1 replicon is non-functional and replication 
proceeds from the low copy number P1 replicon which leads to segregational 
instability. However, presence of a pBSSB2 stability function would be expected to 
stabilize the vector. This also helped to overcome any concern that RP2 or RP4 raised 
the copy number and hence stability of pUC18 in the pcnB mutant rather than 
independently assisting stable inheritance.   
 
RP2 and RP4 were individually cloned in pFH450. The same PCR primers that were 
used to generate RP2 and RP4 amplicons for cloning into pUC18 were used for 
amplification and insertion of these fragments into pFH450, except that instead of 
EcoRI tailed primers, SacI tailed primers were used. BamHI and SacI restriction sites 
were used for cloning. Ligated DNA was transformed into commercially available 
chemically competent XL1 - Blue cells according to the manufacturer’s instructions 
(Agilent technologies). Transformed cells were spread on L-agar containing 
chloramphenicol (10µg ml
-1
) and incubated at 37°C overnight. About five 
transformants were randomly selected and grown in L-broth containing 
chloramphenicol (10µg ml
-1
) at 37°C overnight. Extracted plasmid was analysed by gel 
electrophoresis following digestion with BamHI and SacI. Confirmation of the insert 
was further obtained by DNA sequencing.  
 
Having obtained pFH450 clones containing RP2 (designated pFHRP2) or RP4 
(designated pFHRP4), their stability was assayed in a DNA polymerase I mutant 
(BR825). The optimized protocol for transformation into BR825 (section 2.18.2) was 
employed to introduce pFHRP2 or pFHRP4. pREG531 (that contained the partition 
cassette of plasmid TP228 inserted in pFH450) was used as a positive control. The 
stability assay was performed as described in section 5.1, with the exception that 
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chloramphenicol was used instead of carbenicillin and pFH450 was used instead of 
pUC18 as a negative control.   
 
Figure 5.2 shows the percentage of cells that retained the plasmid after growth for about 
25 generations without antibiotic selection. In case of the positive control, pREG531, 
66% of the colonies retained the plasmid, as opposed to 8% in case of the negative 
control, pFH450. Fragment RP4 in plasmid pFHRP4 increased the stability of pFH450 
such that 83% of the colonies retained the plasmid. In contrast, no significant stability 
was conferred by pRP2 which was retained by only 3% of the colonies. In fact, the 
presence of fragment RP2 reduced the stability of the negative control further, possibly 
through increased metabolic load on the host. Since fragment RP2 exhibited variable 
stability in the pcnB mutant system and did not stabilize pFH450, it was decided to 
focus primarily on fragment RP4 which increased stability in both assays. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.2 Stability of plasmid pFH450 and derivatives containing fragments RP4 and 
RP2. The result is the mean ± S.D. of at least three independent assays. The dotted line 
is the cut-off value for the experiment and corresponds to the percentage of cells 
retaining the negative control, pFH450. 
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5.4 Deletion analysis of fragment RP4 to identify minimum region 
necessary for stability 
Fragment RP4 is approximately 4.5 kb. An initial deletion analysis to identify the 
minimum region essential for stability was made by restriction digestion. The 
restriction map for RP4 shows the presence of a HindIII site within the sequence. 
Another HindIII site is present within the multiple cloning site of pUC18. A HindIII 
digestion of pRP4 would therefore remove about 2.3kb of RP4 sequence as shown in 
Figure 5.3. This would leave approximately 2.2kb of RP4 sequence attached to the 
vector backbone.  
 
 
 
 
 
 
 
 
 
 
 
Figure 5.3 Schematic diagram of pRP4. HindIII sites within RP4 (indicated by box) and 
within the MCS of pUC18 (black lines) are indicated. For simplicity pUC18 sequence 
has been shown by straight lines.  
 
pRP4 was digested with HindIII and the digestion mix was run on an agarose (1%) gel. 
The DNA band corresponding to pUC18 plus the remaining 2.2kb RP4 sequence was 
purified from the gel using the Qiagen gel purification kit (Qiagen). The purified DNA 
was self-ligated, drop dialyzed and transformed into chemically competent XL1 Blue 
cells following the manufacturer’s recommendations (Agilent technologies). The 
resultant pRP4 derivative was named pRP4HindIII. Plasmid DNA was prepared from 
white XL1 - Blue colonies using the Qiagen mini prep plasmid purification kit 
(Qiagen). Purified plasmid was analysed on an agarose (1%) gel for size confirmation.  
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Plasmid stability assays in a pcnB host were carried out as detailed in section 5.2 
comparing the stability of pRP4HindIII with pRP4 as a positive control and pUC18 as 
negative control. It was found that fragment RP4HindIII still stabilized a circular 
plasmid (Figure 5.4).  The position of fragment RP4HindIII (2.2kb) in the linear 
plasmid map is shown in figure 5.5.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.4 Stability of pRP4HindIII as compared to pRP4 and pUC18. The results are 
the means ± S.D. of at least three independent assays. The dotted line represents the 
percentage of cells retaining the negative control, pUC18. 
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             RP4HindIII fragment 
 
Figure 5.5. The location of the RP4HindIII region within pBSSB1 DNA sequence. The 
black box represents RP4HindIII. The pBSSB2 genetic map is taken from Baker et. al., 
2007b. The arrows indicate pBSSB2 ORFs and point in the direction in which they are 
transcribed. The star shows the position of the GC skew. A size scale is also shown in 
the diagram including selected restriction sites. 
 
 
Since RP4HindIII was sufficient to confer stability to pUC18 in pcnB mutant, it was 
used as the basis for further deletion studies in order to identify the minimum fragment 
containing the stability function.  
A series of deletions of RP4HindIII (Figure 5.6) was generated by PCR, using primers 
listed in Table 2.4. The designation and nucleotides covered by each PCR product is 
indicated in figure 5.6. For PCR reactions the Expand Long Template PCR (Roche) 
system detailed in section 2.10.4 was used. Each PCR product was cloned in pUC18 
using EcoRI and BamHI restriction sites. Ligated DNA was subjected to drop dialysis 
before transformation into chemically competent E. coli XLI-Blue cells. Transformant 
colonies were grown in L-agar containing carbenicillin (50 µg ml
-1
) and also containing 
X-gal (300µg ml
-1
) and IPTG (0.3mM) for blue-white screening. Five white colonies 
were screened for the presence of the desired plasmids. Constructs were validated by 
both restriction digestion and sequencing.  
All constructs were tested in triplicate in stability assays in the pcnB mutant (Figure 
5.7). The deletion analysis showed that all deletions from the right end of RP4HindIII 
(constructs Del1, 2 and 3, figure 5.6) reduced stabilization of the circular plasmid. 
Deletions of up to 1173bp from the left end (construct DelB, figure 5.6) still enabled 
RP4HindIII to stabilize a circular derivative. This indicated that the right end of the 
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fragment was necessary for stability functions in the circular mode. A 1023 bp 
fragment (DelB, figure 5.6) was the smallest that contained pBSSB2 stability function. 
A further 73bp deletion from the 5’ end of this minimum fragment removed the 
stabilization effect. On the other hand, a further 40bp deletion from the 3’ end also 
reduced stability function.  
 
 
 
 
 
 
 
 
 
 
Figure 5.6 Deletion derivatives of the RP4HindIII 2.2kb fragment. Numbers indicate 
nucleotide co-ordinates, taking the start nucleotide of the left end of RP4HindIII to 
have a co-ordinate of 1. Blue lines indicate fragments that were stable and black lines 
indicate those that were unstable in a pcnB mutant.  
 
 
 
 
 
 
 
 
 
 
Figure 5.7. Stability of RP4HindIII deletion series. Results are the average ± S.D. of at 
least three independent assays. Del1-4, DelA, DelB and Del3,4Fwd are deletion 
derivatives. pUC18 and pRP4HindIII were negative and positive controls, respectively.  
The dotted line indicates the cut-off value for instability and corresponds to the 
percentage for pUC18. 
 
RP4HindIII 
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5.5 Mutational analysis of the pBSSB2 stability region  
 
Sequence analysis of RP4HindIII indicated the presence of ORF07, ORF08 and ORF09 
(Figure 5.6). In order to investigate the potential role of these ORFs in stability, stop 
codons were introduced into each by site directed mutagenesis. Oligonucleotides used 
to introduce the desired base changes are listed in table 2.4. Site-directed mutagenesis 
was carried out according to the overlap extension method (Ho et al. 1989) outlined in 
section 2.20.1. For PCR, the Expand Long Template PCR system described in section 
2.10.4 was used. Amplicons with the desired base change were inserted into pUC18 
using EcoRI and BamHI restriction sites. Ligated DNA was transformed into 
chemically competent E. coli XL1-blue cells.  Blue-white screening was used to 
identify transformants containing inserts. Plasmid DNA was extracted from selected 
white colonies using the QIAprep miniprep plasmid kit (Qiagen).  Extracted plasmids 
were validated for the correct insert by sequencing.  
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5.5.1 Engineering a stop codon in ORFs 07 
 
The original sequence and mutation introduced in ORF07 are shown in figure 5.8. 
 
Nucleic acid sequence:   1   ATG ATA AAG AGA TAC AGT GAA AGA CTT GCA GAA CTG GAA CTA CTA  
Amino acid sequence:      1      M       I      K       R      Y       S       E        R       L      A       E       L       E       L     L       
Nucleic acid sequence:  46 CAA AAC AGG CTG TTG CTG TCG TTC CGA ACG GAT GAC GAC GAT TAT  
Amino acid sequence:    16     Q      N      R       L       L       L      S       F      R       T      D       D      D       D     Y                   
Nucleic acid sequence:  91 ATT TTA TCT GTA TGC CGT CAA ATC AGC GAT ACA GGG CTA AAT CTC  
Amino acid sequence:    31     I      L      S      V      C       R       Q       I       S       D       T       G       L      N      L                     
Nucleic acid sequence: 136  AAA TAC AGT AAT ACA GAT TAT ATT TTC CAT TAT ATA AAC TGT TGC 
Amino acid sequence:    46     K      Y       S      N       T       D     Y        I      F       H      Y      I        N      C      C            
Nucleic acid sequence: 181 TCT TAC CAC AGA GAA CCC AGT TTT ATT GTG ATT GGT TTA CTG TTG 
Amino acid sequence:    61    S      Y      H        R       E       P      S       F       I       V       I       G      L       L      L           
                                                                                                                                Changed to TAG 
Nucleic acid sequence: 226  TCA TTA CAG GCT AAA AAA ACG GTC ATG GCA TAC AGA TTA TTT AAG 
Amino acid sequence:    76     S       L      Q       A       K      K       T       V      M      A      Y*     R       L      F      K        
                                                                                                                               Changed to  Stop 
Nucleic acid sequence: 271 AAG CTG TAT ATA GAT AAA AAA GAT AGC CAC AGC TTA ACT GAC AAC 
Amino acid sequence:    91    K       L      Y       I        D      K       K      D       S       H       S      L        T      D      N        
Nucleic acid sequence: 116 ATT CAA AGA ACG GCT GGT AGT TTA CTG ACT GTT ATG AAC AGA AAG  
Amino acid sequence:  106      I       Q       R       T       A      G       S       L       L      T       V     M      N        R      K              
Nucleic acid sequence: 161 GAT AGT GCA GCT TGA 
Amino acid sequence:  121     D      S      A      A    Stop 
 
Figure 5.8 DNA and corresponding amino acid sequence of ORF07. The altered DNA 
sequence and amino acid are indicated by arrows. Y* corresponds to the amino acid tyrosine.  
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5.5.2 Introduction of nonsense mutation in ORF08 
 
The DNA and amino acid sequences corresponding to ORF08 and the mutation 
introduced are shown in figure 5.9.  
 
DNA sequence:           1   ATG AGA AAA GAA CTC TTT GAC GAC CTG ATC GAG AGT GTT AAC GAA  
Amino acid sequence:   1     M       R       K       E       L      F      D      D       L       I        E       S      V       N      E               
DNA sequence:          46  GCC GTA GCC ATC AAA CGG GGT CTT GTA GCC CCA GCT CGT GTT ACG 
Amino acid sequence: 16    A      V       A       I       K       R      G       L      V       A      P       A      R      V      T                    
DNA sequence:           91 ACT TTT GAG ATG CCC GAT GTG AAA GCT ATC CGC ACG AAA GCG AAG 
Amino acid sequence: 31     T      F       E      M      P       D      V      K       A       I       R       T      K       A       K        
                                                                                                    Changed to TAG 
 
DNA sequence:          136 CTC AAA CAA AAT GAG TTT GCC CAG GTA GTG GGT GTC TCC CCT TCT  
Amino acid sequence:  46     L      K      Q      N       E       F       A      Q*     V      V      G      V      S       P       S                      
                                                     
                                                                                                    Changed to Stop 
DNA sequence:         181 CTG GTG CAA GCC TGG GAA CAG CAA AAG AGA ACA CCC ACC GGC AGC  
Amino acid sequence: 72    L      V      Q      A      W       E       Q       Q       K       R       T       P       T       G       S                    
DNA sequence:        246  AGT CTT AAA CTG TTG CGG GTC ATT GAA AAG CAT CCT GAC ATG CTT  
Amino acid sequence: 97    S       L      K       L      L       R       V      I       E       K       H      P       D      M      L      
DNA sequence:           291 AAC CTG TTC AGA ACA GCA TAA 
Amino acid sequence: 112    N       L      F       R       T       A    Stop 
 
Figure 5.9. DNA and amino acid sequences of ORF08. The position in which mutation 
was introduced is indicated by asterisk. Q* represents the amino acid glutamine, which 
was changed to a stop code by the introduced mutation.  
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5.5.3 Introduction of stop code in ORF09 
 
The wild-type sequence of ORF09 and position mutated is shown in figure 5.10.  
 
DNA sequence:           1  ATG AAT TTA CTA CAC TTC ATT GAA ACC AAA GTC TTT CAG AGA GTA ATC  
Amino acid sequence:  1     M      N       L      L      H       F       I       E       T       K      V      F       Q       R      V       I        
DNA sequence:         49 GAT GGA TTG CTT TCA CCC GAC GAA CTC CGG GAG TTT CAG GAA GTG TTA  
Amino acid sequence: 17   D      G       L      L      S       P       D       E      L       R       E       F      Q       E       V      L        
DNA sequence:        97 AGG CAA GAT CCT ACC GCT GGC GAT ACC ATA TCA GGT ACG GGC GGT TGC  
Amino acid sequence: 39   R      Q       D      P       T      A      G       D       T       I       S       G       T       G      G      C        
DNA sequence:        145 CGT AAG ATT CGC TGG GCT TTG CCT GGT ATG GGT AAA AGT GGT GGT ATC  
Amino acid sequence: 49    R      K        I       R      W      A      L      P      G       M      G      K       S      G       G      I         
DNA sequence:        193  AGG GTC ATA TAC TAC TAT CTG ACA GCA GAT AAC GAA GTA TTC CTT CTT  
Amino acid sequence: 77     R       V       I       Y      Y      Y       L       T       A      D       N      E      V       F       L      L        
DNA sequence:       241  ATA GCT TAT CCC AAG AAC GAG AAA GAC AAT CTC ACT AAT GCT GAA AAG  
Amino acid sequence: 81    I       A      Y      P       K      N       E       K       D      N       L      T      N       A      E       K        
                                                      Changed to TAG 
DNA sequence:      289 AAC CAG TTG AAG AAA GCC GTA GAA GGT ATA GAG CAA GCC TCC CAG GAG 
Amino acid sequence: 97 N      Q       L      K*     K       A      V       E       G       I       E       Q       A     S        Q      E        
                                                     Changed to Stop  
DNA sequence:      337     GCA AGG GGG AAG AAA TGA 
Amino acid sequence: 113     A      R       G       K      K    Stop  
 
Figure 5.10. The nucleotide and amino acid sequences of ORF09 showing the 
introduction of mutation. The codon AAG that normally codes for lysine was changed 
to a stop code by introduction of the mutation.  
 
 
5.6 Role of ORFs 07-09 in pBSSB2 stability 
 
The stability of pRP4HindIII derivatives with ORFs 07-09 individually mutated was 
assayed in a pcnB mutant as described previously. Construct pRP4HindIII was used as 
positive control and pUC18 was used as negative control. The stability assay indicated 
that 97% of the colonies retained pRP4HindIII. The corresponding percentages of 
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colonies containing the plasmids were 89 and 100 for plasmids containing mutant 
ORF07 and ORF08, respectively. These values were significantly higher than the 58% 
plasmid-containing colonies in the case of the negative control, pUC18. A plasmid 
containing a mutation in ORF09 had 64% plasmid-containing colonies which is 
comparable with the 58% for pUC18 (Figure 5.17). It was therefore concluded that 
ORF09 is necessary for stabilization of the circular derivative and by implication the 
linear plasmid, pBSSB2. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.11. Stability assay of constructs with ORFs 07-09 mutated. Stability assays 
were performed in triplicate for each plasmid. The dotted line indicates the percentage 
for the negative control, pUC18. 
 
In summary, the minimum region required to stabilize a circular derivative was a 1023 
bp fragment of pBSSB2. This region was obtained by deletions from the left end of 
RP4HindIII. Any deletion from the right end reduced stability of the circular plasmid. 
This indicated that information contained in the right end was necessary for 
stabilization functions. On the other hand, mutagenesis studies showed that mutation of 
ORF09 affected stability of pRP4HindIII. ORF09 is present at the right end of the 
fragment RP4HindIII (Figure 5.6). The result of the mutagenesis experiment is, 
therefore, consistent with that of the deletion analysis.  
 
 
 
Stability function of pBSSB2 
 
124 
 
5.7. Characterization of the RP4 stability function 
 
Of two possible plasmid stability systems, viz. partitioning system and toxin-antitoxin, 
the latter seemed more likely for RP4 since only one ORF is required. In partitioning 
systems, two ORFs are usually involved, coding for ATPase and DNA-binding 
proteins. On the other hand, in a toxin-antitoxin system, the antitoxin can either be 
protein or RNA. In the latter case, therefore, it is possible to have either one ORF and 
one transcript, or two protein - coding ORFs. It was therefore hypothesized that the 
stability system contained in RP4HindIII is possibly a toxin-antitoxin system and that 
ORF09 was a potential toxin.  
 
In order to test the hypothesis, ORF09 was cloned in an expression vector, pBAD18 
(Guzman et al., 1995). Plasmid pBAD18 carries the promoter of the arabinose operon, 
PBAD, a multiple cloning site, a pBR322 origin of replication and chloramphenicol 
resistance marker.  
 
Oligonucleotide primers tailed with EcoRI and PstI restriction sites (section 2.10.4) 
were used to amplify ORF09 from pBSSB2. The restriction sites were used to clone 
ORF09 in the pBAD18 vector. The presence of the insert was validated by 
amplification of the insert using the original pair of primers and by sequencing. The 
construct was designated pBAD18-ORF09.  
 
For the toxicity assay, E. coli XLI-Blue containing pBAD18-ORF09 was grown 
overnight in L-broth at 37°C. An aliquot of overnight culture (250-300µl) was 
transferred to 50ml fresh L-broth medium and allowed to grow to OD600 ≈ 0.3. The 
culture was then split into two. Two conditions were set up: one in which cells 
containing pBAD18-ORF09 were grown in L-broth plus glucose (0.2%) to repress PBAD 
promoter, and one in which arabinose (0.2%) was added to the L-broth so that the 
arabinose promoter was induced and ORF09 was expressed. The time the culture was 
split was t=0 (Figure 5.12). Cultures were also set up in which pBAD18 was contained 
in the host to control for the possibility of any toxic effect of the vector itself. As a 
measure of growth OD600 was read 30min, 60min, 90min and 150min. Samples were 
taken simultaneously for estimation of viable counts.  
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Figure 5.12 shows the growth of cultures containing the vector pBAD18 and pBAD18-
ORF09 grown in the presence of glucose or arabinose. The cultures containing 
pBAD18 showed a similar pattern of growth in the presence of glucose and arabinose 
(Figure 5.12). This showed that no toxic effect was exerted by the vector alone. 
Compared to cells containing the vector only, those containing pBAD18-ORF09 
exhibited a reduced rate of increase in OD when arabinose was present. This effect was 
not seen when the culture was supplemented with glucose rather than arabinose. This 
indicated that some growth-inhibitory effect was exerted by the product of ORF09.  
 
In order to find out the effect of ORF09 expression on cell viability, duplicate samples 
collected during the growth experiment were diluted and spread on L-agar without 
additional glucose or arabinose. Plates were incubated at 37°C overnight and viable 
counts were determined. Figure 5.20 shows the viable counts obtained for samples of 
cultures containing pBAD18 or pBAD18-ORF09 grown in L-broth supplemented with 
glucose (0.2%) or arabinose (0.2%).   
 
In the presence of glucose, similar viable counts were observed for cells containing 
either pBAD18 or pBAD18-ORF09. However, in the presence of arabinose, the pattern 
changed remarkably for pBAD18-ORF09. Viable counts for cells containing pBAD18-
ORF09 were 10
4
-fold less after 30 minutes in the culture supplemented with arabinose. 
Thus, the expression of ORF09 resulted in the death but not lysis of most of the cells 
within 30minutes of induction.  
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Figure 5.12. Growth of cultures containing pBAD18 or pBAD18-ORF09 in the 
presence of glucose (0.2%) or arabinose (0.2%). The red and the purple lines 
correspond to cells containing pBAD18 and pBAD18-ORF09, respectively, grown in 
L-broth containing glucose. Green and blue lines represent cells containing pBAD18 
and pBAD18-ORF09, respectively, grown in L-broth with arabinose. All assays were 
performed in triplicate and results are expressed as average ±S.D. 
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Figure 5.13. Growth of cultures containing pBAD18 and pBAD18-ORF09 in the 
presence of glucose or arabinose. Viable counts (cfu ml
-1
) of samples from cultures of 
XL1-Blue containing pBAD18 grown in L-broth with glucose (green) or arabinose 
(red) and pBAD18-ORF09 grown in L-broth containing glucose (purple) or arabinose 
(Blue).  
 
5.8. The effect of ORF09 expression on cell morphology 
 
In order to observe any changes in cell morphology due to the expression of ORF09, 
culture samples (5µl approx.) of E. coli XLI-Blue containing pBAD18 or pBAD18- 
ORF09 grown in L-broth with glucose (0.2% final concentration) or arabinose (0.2% 
final concentration) were embedded in molten, slightly cooled agarose (1% w/v) in 
phosphate buffer saline (PBS) and observed under the phase contrast microscope 
(Figure 5.14). 
 
There was no change in cell morphology when E. coli XL1-Blue transformed with 
pBAD18 was grown for 30 minutes in L-broth containing glucose (Figure 5.14) (a) or 
arabinose (Figure 5.14) (b). In case of cells containing pBAD18-ORF09, no 
morphological change was evident following growth for 30 minutes in the presence of 
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glucose (Figure 5.14) (c). However, after induction with arabinose for 30 minutes, cells 
were larger and many appeared to be ‘empty’ or ‘ghost cells’ (Figure 5.14) (d). Such 
cells were visible within half an hour of the induction of ORF09 expression. A 
magnified image of cells with altered morphology is also shown in Figure 5.14 (e) and 
(f).   
 
 
 
 
                                                                                                                                           
 
                                                                
  
 
 
 
                                                                                      
     
                                                                                           
 
 
 
 
 
 
 
 
Figure 5.14. Phase contrast micrographs of E. coli XL1-Blue cells containing pBAD18 
grown in L-broth with glucose (a) or arabinose (b), and pBAD18-ORF09 grown in L-
broth containing glucose (c) or arabinose (d). Images were taken after 30min of growth 
in the presence of glucose or arabinose. Enlarged images of cells with altered 
morphology are shown in (e) and (f).   
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5.9. Possible candidates for an antitoxin  
 
Mutation of ORF09 reduces the stability of pRP4HindIII, indicating that the ORF plays 
a role in stabilization of the circular plasmid by the 1023 bp region of pBSSB2. 
Furthermore, ectopic expression of ORF09 from an expression vector (pBAD18) 
dramatically reduces viability of the host. These observations support the hypothesis 
that the product of ORF09 is the toxin component of a toxin-antitoxin system. In most 
toxin antitoxin systems, the antitoxin gene precedes the toxin gene (Hayes, 2003). 
ORFs 07 and 08 are down-stream of ORF09 in fragment RP4HindIII, and it has been 
shown experimentally that they are not required for the stabilization of a circular 
plasmid. Further sequence analysis of the 1023 bp fragment was performed to identify a 
candidate for the antitoxin.  
 
5.9.1 Promoter search in the 1023 bp stability region 
An antitoxin can either be a protein or a countertranscript. For the expression of either, 
a promoter is required. Promoter search software http://linux1.softberry.com/ was used 
to find promoters in the 1023 bp RP4 sequence. Details of the potential promoters are 
presented in Table 5.1 and a schematic diagram showing the positions of the promoters 
within the 1023 bp fragment are shown in figure 5.15.  
 
Table 5.1. Promoter prediction for the 1023 bp RP4 region  
Serial -35 
sequence 
Position -10 
sequence 
Position Spacing Transcription 
start nucleotide 
Promoters in the complementary strand to that containing ORF09 
1 TTATCA 31-36 TAATAC 52-57 15 T 
2 TTGTCT 461-466 TAAGCT 482-487 15 G 
3 TTGATA 870-875 GATAAT 890-895 14 G 
Promoters in the same strand as that containing ORF09 
4 TTGAAA 892-897 TAACCT 914-919 16 A 
5 TTGCCG 435-440 TTGCCT 457-462 16 T 
6 TTCATT 126-131 TAATAT 146-151 14 A 
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Figure 5.15. Potential promoters within the 1023 bp fragment carrying the toxin-
antitoxin locus of pBSSB2 
 
Promoter 6 is 143 bases upstream of the translation start codon of ORF09. It is possible 
that this promoter transcribes the toxin mRNA. The -10 box, TAATAT, conforms 
closely to the consensus TATAAT. However, the -35 sequence of TTCATT differs 
significantly from the consensus TTGACA. The spacer length of 14 bases is short. In 
spite of a weak -35 sequence and a short spacer length, promoter 6 may be the promoter 
for ORF09 mRNA since this is the only predicted promoter close to this ORF. Intrinsic 
terminators of transcription were searched by looking for GC-rich sequences that were 
followed by T-rich segments (Farnham and Platt, 1981; reviewed by Platt, 1986; 
Wilson and Hippel, 1995). In the absence of these parameters, rho-dependent 
terminators were searched by looking for C-rich regions (reviewed by Richardson and 
Greenblatt, 1996). However, no candidate transcription termination sequences could be 
found for the proposed toxin transcript (Figure 5.16).  
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Figure 5.16. Nucleotide sequence containing putative promoter for pBSSB2 toxin. The 
putative -35 and -10 sequences are shown in bold and underlined, the proposed Shine-
Dalgarno sequence is shown in blue and ORF09 is highlighted in yellow.    
 
 
The RNA-seq transcription analysis carried out at the Wellcome Trust Sanger Institute 
by Chinyere Okoro was used for additional information. This analysis indicated 
transcription from one strand only (Figure 5.17). The positions of the promoters were 
aligned with the transcription profile in order to evaluate the likelihood that a promoter 
was functional. 
 
 
 
 
 
 -35                 -10   
TTCATTATCAGGAAATAAATTAATATCAATATGTACCAGTTATGTTTCTGGATATACGGCTTACCCA
CTTAAAAGAACGGTTAACTTATCATCAAAAATGGCTTGCAACTCTTACACAGTACCACTAAGATAGA
CTCAT ACAGTGTGCGAGTGAGATAGAGTTAAGGGGATGAATTTACTACACTTCATTGAAACCAAA 
GTCTTTCAGAGAGTAATCGATGGATTGCTTTCACCCGACGAACTCCGGGAGTTTCAGGAAGTGTTAA
GGCAAGATCCTACCGCTGGCGATACCATATCAGGTACGGGCGGTTGCCGTAAGATTCGCTGGGCTTT
GCCTGGTATGGGTAAAAGTGGTGGTATCAGGGTCATATACTACTATCTGACAGCAGATAACGAAGTA
TTCCTTCTTATAGCTTATCCCAAGAACGAGAAAGACAATCTCACTAATGCTGAAAAGAACCAGTTGA
AGAAAGCCGTAGAAGGTATAGAGCAAGCCTCCCAGGAGGCAAGGGGGAAGAAATGAGAAAAGAACTC
TTTGACGACCTGATCGAGAGTGTTAACGAAGCCGTAGCCATCAAACGGGGTCTTGTAGCCCCAGCTC 
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Figure 5.17. Putative promoters in relation to the RNA-seq transcription pattern 
obtained for the 1023 bp RP4 derivative carrying the toxin antitoxin locus of pBSSB2. 
The blue graph on pink background represents the transcription pattern from the same 
strand that contains ORF09; each pair of grey arrowhead indicates a putative promoter. 
The position of ORF09 has been shown with a dark blue arrow in order to compare the 
relative positions of the promoters with respect to this ORF.  
 
 
The antitoxin can be a countertranscript that can bind to the toxin mRNA and prevent 
its synthesis. For this to occur, the countertranscript must be complementary to the 
toxin mRNA at least over some of its sequence. Looking at the promoters in the anti-
sense strand (complementary to the strand containing ORF09) in Table 5.1 and Fig. 
5.17, promoters 1 and 2 were obvious candidates for further analysis because they were 
present either upstream (promoter 1) or within the sequence (promoter 2) of the region 
complementary to ORF09. Promoter 3 is downstream of the region complementary to 
ORF09 and is therefore unlikely to be a potential candidate for synthesis of a candidate 
countertranscript.  
 
For promoter 1 the -35 sequence, TTATCA, and the -10 sequence, TAATAC, were 
significantly different from the consensus (TTGACA for the -35 and TATAAT for the -
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10). In addition the spacer length between the -35 and the -10 sequences of 15 bp in 
size was shorter than the optimum of 17 bp. Because of the poor match to the consensus 
sequences, spacer length and its position, which is significantly upstream of the region 
concerned, it was not considered to be a strong candidate promoter for a 
countertranscript.  
 
Promoter 2 lies within the region complementary to ORF09 (Figure 5.18). When 
compared to the consensus (TATAAT) the -10 box, TAAGCT, has the invariants 
(Harley and Reynolds, 1987) at 1
st
, 2
nd
 and 6
th
 positions conserved. The -35 sequence of 
TTGTCT has the invariants (Harley and Reynolds, 1987) at 1
st
 to 3
rd
 positions 
conserved compared to the consensus TTGACA. The spacer length of 15 bp is, 
however, short for a functional promoter. Because of its strong -10 sequence, promoter 
2 was considered a stronger candidate for further analysis than promoter 1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.18. Promoter 2, a candidate promoter for antitoxin countertranscript formation. 
 
 
A GC- rich region with the sequence CCCGGAGTTCGTCGGG (651-667 bp) followed 
by a relatively AT rich region might act as a transcription terminator for this promoter 
Putative ORF09 promoter 
Putative antisense 
promoter 
5’-TATTGATATTAATTTATTTCCTGATAATGAATGAGTGATAACAATTAAAA-3’ 
3’-ATAACTATAATTAAATAAAGGACTATTACTTACTCACTATTGTTAATTTT-5’ 
5’-GTGAGATTGTCTTTCTCGTTCTTGGGATAAGCTATAA-3’ 
3’-CACTCTAACAGAAAGAGCAAGAACCCTATTCGATATT-5’ 
-35                                      -10 
 -10                                  -35 
ORF09 
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(Figure 5.19). Secondary structure prediction indicated that the GC rich region can 
form a stem-and-loop region consisting of four GC bonds in the stem (Figure 5.20). 
 
 
 
 
 
Figure 5.19. Possible transcription termination sequence (bold and underlined) for 
transcription initiated from promoter 2 (highlighted in blue). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5.20. Secondary structure of possible terminator of transcription from promoter 
2. GC bonds are indicated in red. 
 
 
A countertranscript from promoter 2 might bind to the toxin mRNA and inhibit 
translation. For this to happen, the region of the toxin that is complementary to the anti-
toxin RNA has to be accessible for the antitoxin to bind. It was, therefore, necessary to 
study the secondary structure of the toxin mRNA to estimate how likely it would be for 
a countertranscript to bind to it. The secondary structure of the toxin was predicted 
using the software available at http://mfold.rna.albany.edu (Figure 5.21).  
 
TTGTCTTTCTCGTTCTTGGGATAAGCTATAAGAAGGAATACTTCGTTATCTGCTGTCAGATAGTAGTA
TATGACCCTGATACCACCACTTTTACCCATACCAGGCAAAGCCCAGCGAATCTTACGGCAACCGCCCG
TACCTGATATGGTATCGCCAGCGGTAGGATCTTGCCTTAACACTTCCTGAAACTCCCGGAGTTCGTCG
GGTGAAAGCAAT 
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Figure 5.21. Predicted secondary structure for the ORF09 transcript. 
 
 
The putative countertranscript from promoter 2 is 175 bases. The program mfold 
(www.mfold.rna.albany.edu) was used to predict the secondary structure of this 
putative anti-sense RNA (Figure 5.22). It was found that the antisense RNA also forms 
stem-loop structures as has also been observed with the sok RNA of R1 (Section 
1.4.2.2, figure 1.12).  
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Figure 5.22. Predicted secondary structure for candidate antitoxin transcript. GC bonds 
are shown in red. 
 
 
Figure 5.23 shows the region of the predicted toxin mRNA which is complementary to 
the putative antitoxin transcript from promoter 2. According to this figure, the part of 
the toxin mRNA which is complementary to the candidate countertranscript is involved 
in the formation of extensive stem and loop structures. It is possible that initial 
interaction between the toxin and the candidate antitoxin occurs through loops.  
 
The possibility that the suggested countertranscript binds to the toxin mRNA needs to 
be tested in future studies. qPCR could be done to determine whether the 
countertranscript is actually synthesized.  Introduction of mutation at promoter 2 
sequences could also determine whether this promoter is functional. If the promoter 
were functional, mutation would prevent transcription. In the absence of the antitoxin, a 
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reduction in viability of the host cells and a phenotype as was observed in section 5.8, 
figure 5.14 would be observed. 
 
 
 
 
Figure 5.23. Predicted secondary structure of pBSSB2 toxin. The region 
complememtary to hypothetical countertranscript is enlarged.  
 
 
5.9.2 Prediction of ORFs in the 1023 bp region  
 
Another option for an antitoxin is that it could be a protein. The ORFs located in both 
the strands were analysed with a view to finding a protein anti-toxin using the ORF 
finder tool available at www.ncbi.nlm.nih.gov/gorf gorf.html. Bacterial code was 
selected under the ‘Genetic Code’ option. Other parameters were kept at default. ORFs 
found using this tool are shown in Table 5.2. Two ORFs, v and vi, were present in this 
strand. The nucleotide sequences of these ORFs are shown in figures 5.23 and 5.24. 
The relative positions of these ORFs and putative promoters identified in this strand are 
indicated in figure 5.25.  
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Table 5.2. ORFs identified within the 1023 bp fragment as identified by the 
program at http://www.ncbi.nlm.nih.gov/gorf/gorf.html. 
 
ORF 
designation 
Position Size (bp) Reading 
frame 
Shine-Dalgarno 
sequence 
ORFs in the strand complementary to that with ORF09 
i 114-455  342 +3 None 
ii 122-484  363 +2 None  
iii 132-455  132 +3 None 
iv 530-646  117 +2 AGATAG 
ORFs in the strand that contains the toxin 
v 5-112  108 +2 None 
ORF09 295-648  354 +1 AGAGTT 
vi 466-648  183 +1 None 
ORF08 645-935  291 +3 GGGGAA 
 
 
 
 
Figure 5.23. Nucleotide sequence of ORF v. The nucleotide sequence is highlighted in 
blue. 
 
 
 
 
 
 
Figure 5.24. Nucleotide sequence of ORF vi. The nucleotide sequence is highlighted in 
blue. 
 
 
 
 
TTAAATGGGGTTCGTGGTTTTACTTCATAAGTGCAATCAAAGTATTCCAGGAATAAATTTACTCTTTC
TTTGTTGTCTCGGATTCTTAATACCATATTTATCTCCTTTTTAA 
GATCCTACCGCTGGCGATACCATATCAGGTACGGGCGGTTGCCGTAAGATTCGCTGGGCTTTGCCTGG
TATGGGTAAAAGTGGTGGTATCAGGGTCATATACTACTATCTGACAGCAGATAACGAAGTATTCCTTC
TTATAGCTTATCCCAAGAACGAGAAAGACAATCTCACTAATGCTGAAAAGAACCAGTTGAAGAAAGCC
GTAGAAGGTATAGAGCAAGCCTCCCAGGAGGCAAGGGGGAAGAAATGA GAAAAGAACTCT TTGA CG 
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Figure 5.25. ORFs in the same strand as ORF09. The hollow square and the red box 
represent the 1023 bp fragment. The coloured arrows indicate ORFs. The numbers on 
the left that follow the ‘+’ sign are the reading frames of the ORFs. The grey arrowhead 
pairs indicate the predicted promoters. 
 
 
ORF v was only four bases away from the end ligated to pUC18 MCS. This was too 
short to look for SD sequence. ORF vi, which is in the same reading frame as ORF09 
(Figure 5.25), can also be transcribed from promoter 6. Although, no putative Shine-
Dalgarno sequence could be detected <10 bp of the start codon of ORF vi (Figure 5.24) 
the possibility that ORF vi is translated cannot be ruled out. Translation of ORF vi 
would support the transcription pattern obtained for this region at the Sanger Institute 
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which indicates transcription from one strand only. However, whether ORF vi is 
translated needs to be determined in future studies. 
 
The nucleotide sequences of the ORFs in the complementary strand are shown in 
figures 5.26-5.29.  
 
 
 
 
 
 
Figure 5.26. Nucleotide sequence of ORF I highlighted in blue. 
 
 
 
 
 
 
Figure 5.27. Nucleotide sequence of ORF ii highlighted in blue.  
 
 
 
 
 
 
Figure 5.28. Nucleotide sequence of ORF iii highlighted in blue.  
 
 
 
 
 
Figure 5.29. Nucleotide sequence of ORF iv highlighted in blue. The putative SD 
sequence is highlighted in yellow. The -35 and -10 sequences are in bold and 
underlined. 
AATAAAGCCCCAGTAAAGGGGCTTATGCTGTTCTGAACAGGTTAAGCATGTCAGGATGCTTTTCAA
TGACCCGCAACAGTTTAAGACTGCTGCCGGTGGGTGTTCTCTTTTGCTGTTCCCAGGCTTGCACCA
GAGAAGGGGAGACACCCACTACCTGGGCAAACTCATTTTGTTTGAGCTTCGCTTTCGTGCGGATAG
CTTTCACATCGGGCATCTCAAAAGTCGTAACACGAGCTGGGGCTACAAGACCCCGTTTGATGGCTA
CGGCTTCGTTAACACTCTCGATCAGGTCGTCAAAGAGTTCTTTTCTCATTTCTTCCCCCTTGCCTC
CTGGGAGGCTTGCTCTATACCTTCTACGGCTTTCTTCAACTGGTTCTTTTCAGCATTAGTGAGATT 
GTTAAGCATGTCAGGATGCTTTTCAATGACCCGCAACAGTTTAAGACTGCTGCCGGTGGGTGTTCTC
TTTTGCTGTTCCCAGGCTTGCACCAGAGAAGGGGAGACACCCACTACCTGGGCAAACTCATTTTGTT
TGAGCTTCGCTTTCGTGCGGATAGCTTTCACATCGGGCATCTCAAAAGTCGTAACACGAGCTGGGGC
TACAAGACCCCGTTTGATGGCTACGGCTTCGTTAACACTCTCGATCAGGTCGTCAAAGAGTTCTTTT
CTCATTTCTTCCCCCTTGCCTCCTGGGAGGCTTGCTCTATACCTTCTACGGCTTTCTTCAACTGGTT
CTTTTCAGCATTAGTGAGATTGTCTTTCTCGTTCTTGGGATAAGCTATAAGAAGGAATACTTCGTTA 
TCAGGATGCTTTTCAATGACCCGCAACAGTTTAAGACTGCTGCCGGTGGGTGTTCTCTTTTGCTGTTC
CCAGGCTTGCACCAGAGAAGGGGAGACACCCACTACCTGGGCAAACTCATTTTGTTTGAGCTTCGCTT
TCGTGCGGATAGCTTTCACATCGGGCATCTCAAAAGTCGTAACACGAGCTGGGGCTACAAGACCCCGT
TTGATGGCTACGGCTTCGTTAACACTCTCGATCAGGTCGTCAAAGAGTTCTTTTCTCATTTCTTCCCC
CTTGCCTCCTGGGAGGCTTGCTCTATACCTTCTACGGCTTTCTTCAACTGGTTCTTTTCAGCATTAGT
GAGATTGTCTTTCT 
 -35                  -10 
TTGTCTTTCTCGTTCTTGGGATAAGCTATAAGAAGGAATACTTCGTTATCTGCTGTCAGATAGTAGT 
ATATGACCCTGATACCACCACTTTTACCCATACCAGGCAAAGCCCAGCGAATCTTACGGCAACCGCC
CGTACCTGATATGGTATCGCCAGCGGTAGGATCTTGCCTTAACACTTCCTGAAACTCCCGGAGTTCG
TCGGGTGAAAGCAATCCATCGAT 
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The relative positions of the ORFs and promoters in the complementary strand are 
shown in figure 5.30. 
 
 
 
 
Figure 5.30. ORFs identified within the 1023 bp fragment carrying the toxin-antitoxin 
locus of pBSSB2. The hollow square and the red box represent the 1023 bp fragment. 
The coloured arrows indicate ORFs. The numbers on the left that follow the ‘+’ sign 
are the reading frames of the ORFs. The grey arrowhead pairs indicate predicted 
promoters. 
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With respect to ORFs identified within the complementary strand (Table 5.2), only 
ORF iv had a putative RBS (the sequence AGATAG six bases upstream of the start 
codon; Figure 5.29). This could be a potential candidate for encoding a protein 
antitoxin. Promoter 2, which is immediately upstream with its -10 Pribnow box 37 
bases upstream of the start codon of ORF iv could potentially act as a promoter for 
transcription of ORF iv.  The relative positions of ORF iv and 09 are indicated in figure 
5.31.  
 
 
Figure 5.31. Position of ORF iv relative to the toxin ORF09. The solid blue bar 
represents the 1023 bp fragment carrying the toxin-antitoxin locus. The light blue 
arrowhead pairs are the -35 and -10 consensus of promoters. The green and blue arrows 
indicate ORFs iv and 09, respectively.  
 
 
Based on the sequence analysis described above, it appears that either the transcript 
from promoter 2 or the translation of the same transcript (ORF iv) could be potential 
candidates for the antitoxin. Future studies will need to be carried out to determine the 
validity of these hypotheses. 
  
 
5.9.3 BLAST analysis of nucleotide and protein sequences  
 
A search for sequence similarity and simple structure prediction was done using the 
software at http://www.sbg.bio.ic.ac.uk/~phyre/ to predict the structure of both the 
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toxin and the candidate antitoxin. This software uses amino acid sequence as input. A 
psi blast carried out by the same software indicated similarity of the toxin sequence to 
RelE like proteins. The relEB is a chromosomal toxin-antitoxin locus found in E. coli. 
The RelE protein toxin inhibits translation through mRNA cleavage and its activity is 
inhibited by binding of the RelB protein antitoxin (reviewed by Gerdes, 2005).  A 
screenshot of the hits with similarities is shown in (Figure 5.32).   
 
 
Figure 5.32. Selected results of psi blast of the ORF09 sequence at http:// www. sbg. 
bio.ic.ac.uk /~phyre/. 
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The same software also searches for similarity between the predicted folding pattern of 
the query sequence with folding patterns deposited for other proteins in the database. 
The putative secondary structure indicated here is predicted with 60% probability for 
the toxin and was drawn by analysing the possible folding patterns of the toxin and 
comparison with the folding patterns deposited for other proteins in the database. The 
folding indicating the greatest match with existing protein information in the database 
is shown here (Figure 5.33).  
 
 
 
 
Figure 5.33. A proposed secondary structures of the toxin encoded by the 1023 bp RP4 
derivative of pBSSB2. This structure was derived with 60% probability based on the 
similarity of its folding pattern with RelE-like bacterial chromosomal toxin. 
 
 
The amino acid sequence of the candidate antitoxin did not show any significant match 
with any other protein in the database. The only folding similarity was with a human 
signalling protein and the structure output was provided with a 10% probability only. 
Because there was no similarity to bacterial proteins, this structure was not taken into 
consideration.  
Future studies need to be conducted to investigate whether the candidate ORF 
suggested for the protein antitoxin is functional. If it is, then introduction of a 
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premature nonsense mutation into the ORF would be expected to generate the same 
phenotype as ectopic overexpression of the ORF09 toxin.  
 
5.10 Discussion 
This chapter constitutes the first report of the identification and preliminary 
characterization of a stability function of plasmid pBSSB2. Using plasmid vectors that 
were either unstable naturally (pFH450) or were rendered unstable because of the 
genotype of their host (pUC18 in pcnB mutant), fragment RP4, covering nucleotide 
4594-9106 of pBSSB2, was found to contain a stability function. Upon further deletion 
studies, the stability function was found to be contained in a 1023 bp fragment spanning 
nucleotides 7236 to 8258 in the pBSSB2 genetic map. This region contained three 
ORFs but a mutational analysis revealed that only one (ORF09) was required to confer 
stability on a circular plasmid.  
 
Since a partitioning system would most likely require two ORFs, one coding for an 
ATPase and the other for a DNA-binding protein, it was hypothesized that the stability 
function was a toxin - antitoxin system. This hypothesis was tested by ectopic 
expression of ORF09. It was found that cultures that over-expressed ORF09 contained 
mostly non-viable cells. These cells appeared to be devoid of cytoplasmic contents 
when viewed using a phase contrast microscope. Cells showing a central clearing with 
condensed poles as a result of the effect of a toxin were coined ‘Ghost cells’ by Gerdes, 
(1986). A psi blast carried out at http://www.sbg.bio.ic.ac.uk/~phyre/ indicated 
similarity to RelE-like cytotoxic translation inhibitors (E-value = 2e-27). The relEB is a 
chromosomal toxin antitoxin locus found in E. coli.  The protein toxin, RelE, degrades 
mRNA and inhibits translation. As with pBSSB2, a toxin - antitoxin system has also 
been found as the stability determinant in the linear plasmid, pCLP, of M. celatum 
(Dantec et al., 2001). The plasmid pCLP system is similar to PemI - PemK of E. coli 
plasmid R100 (Tsuchimoto et al., 1988). The pem operon of M. celatum encodes 98 
and 84 amino acid peptides that act as PemK (toxin) and PemI (antitoxin), respectively. 
When M. smegmatis was transformed with the shuttle vector pMIP12 containing the 
373bp pemK gene, it was unable to grow on selective medium. Growth was restored 
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when a point mutation was introduced into the pemK gene. Like RelE, the toxin 
component of pCLP is also an endoribonuclease. No similarity was, however, found 
between the nucleotide sequences of ORF09 of pBSSB2 and the PemK of pCLP 
(Accession number: AF312688.1).  
The absence of any toxicity resulting from mutations of ORFs 07 and 08 seemed to 
discount them as antitoxins A candidate ORF (ORF vi) in the same strand as that 
containing ORF09 and a potential countertranscript or a putative protein antitoxin in the 
strand complementary to that containing ORF 09 has been identified are proposed as 
candidates for the antitoxin in future investigations. Transcription of the candidate 
antisense RNA could potentially prevent transcription of ORF09 mRNA and hence stop 
translation of the toxin. Alternatively, translation of a candidate ORF can lead to the 
production of a candidate antitoxin. ORF09 shows similarity to RelE-like toxins. The 
antitoxin of RelE is the protein RelB. Thus a protein antitoxin for ORF09 toxin might 
be expected.  However, at present there is no evidence that either the promoter or the 
putative protein antitoxins from either strand (translated from ORF vi or ORF iv) is 
functional and these hypotheses need to be tested in future studies.  
In the present study, an unsuccessful attempt was made to knock out ORF09 in the 
parental linear plasmid using the lambda red recombinase method (Datsenko and 
Wanner, 2000). A chloramphenicol marker flanked by sequences specific for ORF09 
was amplified by PCR and transformed into E. coli cells containing pBSSB2, with the 
expectation that the marker will insert into ORF09 sequence due to homologous 
recombination between the flanking sequences and the corresponding sequences in the 
linear plasmid. Although chloramphenicol resistant colonies were obtained, they did 
not contain the cassette in the right position. This was determined by amplifying a 
region containing the cassette. Colonies containing the cassette in the right position 
were expected to give an amplicon that was about a kb longer than the negative control 
that did not contain the cassette. In the absence of the right sized amplicon, it was 
concluded that the cassette had inserted in a different location and that no conclusion 
could be drawn from this experiment.  
In addition to a toxin-antitoxin system a partitioning system is found in most plasmids. 
The partitioning system ensures that the daughter plasmids are distributed evenly 
during cell division. The toxin - antitoxin system is more likely to be a secondary 
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system that leads to death of cells not containing the plasmid on rare occasions when 
the partitioning system has failed. A similar arrangement is expected for pBSSB2. 
Sequencing and annotation of the pBSSB2 genome was done at the Wellcome Trust 
Sanger Institute and the sequence is deposited at the National Centre for Biotechnology 
Information (accession number AM419040). The annotation suggests that ORF017 
possibly codes for a nucleotide binding protein that has similarity to ATPase-like ParA 
protein. The sequence has homology to the sequence of other bacterial plasmid 
partitioning systems such as those from Vibrio caribbenthicus (63% homology) and 
Corynebacterium glutamicum (51% homology) (Baker et al., 2007b). The function of 
the ParA homolog in pBSSB2 and neighbouring sequence has not been investigated in 
detail in the present study. However, fragment RP2, which contained ORF017, 
exhibited some improvement in stability when inserted into pUC18 into a pcnB mutant. 
As with the M. celatum pCLP linear plasmid ParA homolog (Dantec and Picardeau, 
2001), fragment RP2 is also located immediately adjacent to the RP7 replicon region. 
However, studies with fragment RP2 cloned in pFH450 did not provide support for the 
hypothesis that it contains stability function. Consequently work on this fragment was 
discontinued. Further studies with this fragment may yet reveal a partitioning function 
in pBSSB2.   It is possible that a partitioning function of a linear plasmid might not 
effectively stabilize a circular plasmid.  
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 6 
Discussion and  
Future work 
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6.1 Introduction 
This study focussed on the replication and stability functions of the linear plasmid, 
pBSSB1. The medical significance of studying pBSSB1 lies in the fact that it carries 
the gene for a flagellar antigen, H:z66. H:z66 is a phase II antigen in some S. Typhi 
Indonesian isolates that also express the H:d or H:j phase I antigen.  Flagella are 
important for salmonella pathogenesis and understanding the biology of pBSSB1 will 
aid in the understanding of the epidemiology of typhoid in the Indonesian archipelago. 
 
6.2 A method for the purification of protein-capped linear plasmids 
An initial objective of the study was the development of a method for the purification 
of the linear plasmid. The method used by Baker et al. (2007b) suffered from extreme 
lack of reproducibility. It also gave a very poor yield of the linear plasmid, such that 
detection of the plasmid required Southern blotting of gels (Stephen Baker, personal 
Communication). It was therefore important to develop a more efficient method to 
purify pBSSB2. According to the existing literature, PFGE and a variety of extraction 
protocols have been employed for extraction of linear plasmids (section 3.1). There is 
no standard protocol for linear plasmid purification. Conventional plasmid purification 
protocols do not always include a proteinase K treatment. For linear plasmids with 
covalently attached protein this would lead to loss of linear plasmids during any 
phenol-chloroform step used for the removal of cellular proteins. Column based 
methods also do not normally include a protease treatment step and linear plasmid 
DNA may be lost with cellular debris during the clearing spin. Any plasmid left in the 
supernatant that binds to the column may be removed during the subsequent medium-
salt wash for the removal of protein, RNA and other impurities.  
 
The method developed in this study, which owes its success to the inclusion of a 
proteinase K treatment step, gives good yield of pBSSB2. The optimized method has 
been used routinely for the purification of the linear plasmid during the course of the 
study. This method should be suitable for purification of protein-capped linear plasmids 
in general. This method is similar to that used by Baszczynski and Kemble (1987) for 
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the extraction of linear mitochondrial plasmids that had similar structural features to 
pBSSB2 and were purified from sorghum and maize.  
 
6.3 Replication of pBSSB2 
In this study, although a 2831bp region has been found to be sufficient for replication 
of pBSSB2 in a circular mode (albeit inefficiently), a candidate Rep protein or initiator 
RNA has not been identified. Candidate ORFs have been proposed for further 
investigation upon sequence analysis. An alternative hypothesis based on initiation of 
replication by RNA primer has also been proposed. However, the hypothesis for both 
the candidate ORFs and the potential RNA primer need to be tested in future studies.  
 
An adjacent 176bp region has also been found to exert incompatibility against pBSSB2 
when present in a circular multicopy plasmid. Based on bioinformatic approaches and 
finding of a GC skew, a putative origin of replication was previously suggested to be 
located upstream of ORF017 (Baker et al., 2007b). The ORF017 initiation codon lies 
about 300bp outside of the 2831bp fragment (Figure 6.1). It was found that although 
the putative origin of replication identified by Baker et al., (2007b) lies outside of the 
minimum replication region it is actually contained within the incompatibility region, 
which lies upstream of ORF017 (Figure 6.1).   
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Figure 6.1 Schematic diagram showing the minimum region of amplicon RP7 that can 
drive replication of a circular pBSSB2 derivative and the region of amplicon RP2 
conferring incompatibility functions in a circular mode.  
 
The fact that the GC skew lies within the region conferring incompatibility supports the 
possibility that the origin of replication of pBSSB2, in addition to regulatory iterons, 
lies within this region. On the other hand, the ability of pRP7 (a circular plasmid 
containing the RP7 region) to replicate points to the possibility that this fragment 
carries the information for the initiator (e.g. a Rep protein). Hence, RP27 (combination 
of RP2 and RP7) must contain the actual basic replicon for the linear plasmid. 
However, this region is not sufficient to support replication in the circular mode. In the 
absence of RP2, repression of replication in the circular mode is removed and pRP7 
probably replication from an origin-like sequence within RP7. RP7-supported 
replication is inefficient and this would be consistent with the need to use a secondary 
origin. In plasmid pSLA1 the presence of a locus, rlrA, which is required for replication 
in a linear mode has been found to be inhibitory to this function in the circular mode 
(Qin et al., 2003). At least in this respect the function of RP2 is analogous to rlrA. 
 
 
Incompatibility locus 
(10840-11018bp), 
contains GC skew 
Replicon 
(12820-15649bp) 
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Incompatibility regions carry either information for a repressor (often RNA) or the 
origin or sites that titrate Rep protein. Four putative 6bp imperfect repeats were found 
in the 176 bp region conferring incompatibility against the parental plasmid. These 
short repeats were significantly different from the 21-mer iterons present in the well-
characterized linear plasmid pSLA2 (Huang et al., 2003). Future studies need to be 
carried out to find out whether the 6bp imperfect repeats found in this study contribute 
to titration of a hypothetical Rep protein.  
 
As the components of the minimum replicon of the pBSSB2 circular derivative still 
remain enigmatic, it is pertinent to consider what the basic replicons of linear plasmids 
with structures similar to pBSSB2 contain. It was found that in Streptomyces linear 
plasmids with protein-capped 5' termini, the basic replicon usually contains one or 
more genes required for replication (Huang et al., 2003). For example, in plasmid 
pSLA1, two genes (rep1 and rep2) and two 21-mer iterons are required for replication 
in a circular mode (Huang et al., 2003). Looking at the sequence of the 2831bp 
fragment of pBSSB2, four candidate ORFs (120, 201, 213 and 1224bp) still remain to 
be tested as encoding potential Rep proteins. An initial attempt made to insert a stop 
codon in the 1224bp ORF was unsuccessful but could not be repeated owing to time 
constraints. Direct repeats and two ORFs have also been found in the basic replicon of 
the linear plasmid SCP1 (Redenbach et al., 1993). The Rep-iteron structure also exists 
in the minimum replicon of the linear plasmid, pSHK1 (Zhang et al., 2009). Based on 
these findings it is hypothesized that one of the four hitherto untested ORFs might 
encode a Rep protein for pBSSB2 replication. 
 
An interesting previous report identified two origins of replication in the plasmid 
pFRL1 from the Streptomyces sp. FR1 (Zhang et al., 2010). One of these origins can 
propagate in the circular mode. The other can propagate in the linear mode with the aid 
of additional loci containing the genes rlrA/rorA. In the case of pBSSB2 only one 
region has been found to support replication of a circular vector that is otherwise unable 
to replicate in the selected host. The possibility of another replicon which supports 
linear, but not circular, plasmid replication cannot be excluded. It is possible that the 
experimental approach used in the present investigation was not able to identify all 
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linear plasmid origins. Putting together all the information available at this stage, one 
possible model is that the 2831bp region encodes a Rep protein and the adjacent 176bp 
region contains the origin of replication and regulatory elements required for control of 
replication by titrating Rep protein (Figure 6.2). 
 
  
 
 
 
 
Figure 6.2. A tentative model for replication and its control in pBSSB2 
 
6.4 Future work necessary to characterize the pBSSB2 basic replicon 
Future work on replication functions of pBSSB2 will need to focus primarily on 
determining whether a Rep protein or initiator RNA is involved in initiation of 
replication. Binding studies of a Rep protein to the direct repeats identified in this study 
could test whether they act as iterons in the regulation of pBSSB2 replication. In the 
event that an initiator RNA is involved, the role of RP2 in exerting incompatibility will 
also need to be determined. An alternative possibility is that the replicon for pBSSB2 
may be similar to the ‘Rep-noncoding sequence’ configuration of some linear plasmids 
including plasmid pSLA1-L from Str. rochei (Hiratsu et al., 2000), pSCL2 from S. 
clavuligerus (Wu et al., 2006), pRL2, pRL4 and pFRL2 (Zhang et al., 2009), pCLP 
from Mycobacterium celatum linear plasmid and pRHL3 from Rhodococcus 
erythropolis (De Mot et al., 1997).  
 
 
 Position of ori 
and iterons 
 Iterons 
Minimum region necessary for replication in circular mode 
Excess Rep proteins are 
titrated by the iterons 
Putative Rep protein initiates 
replication by binding to ori 
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6.5 Stability function of pBSSB2 
The present study has identified a potential toxin-antitoxin system from pBSSB2 that is 
able to stabilize an otherwise unstable circular plasmid. It is proposed that 
postsegregational killing contributes to the stabilization of pBSSB2 in linear mode. 
Very little progress has been made so far in studying linear plasmid stability systems. 
The only report that exists describes a toxin-antitoxin system in the linear plasmid 
pCLP of Mycobacterium celatum (Dantec and Picardeau, 2001). This is similar to PemI 
- PemK system of E. coli plasmid R100. The authors have shown that transformation of 
M. smegmatis with the pemK gene in a shuttle vector pMIP12 kills host cells. 
Confirmation that death of cells was occurring due to the presence of pemK was 
obtained when a point mutation in this gene restored growth of host cells. PemK is an 
endoribonuclease and degrades mRNA, inhibiting protein synthesis and eventually 
leading to death of host cells (Zhang et al., 2004). In the present study, although the 
toxicity of the product of ORF09 has been experimentally demonstrated, the mode of 
action of the toxin has not been investigated.  
 
Plasmid toxin-antitoxin systems are usually found in addition to a partitioning system. 
Whilst the former ensures that plasmid-free cells are killed, the latter minimises the 
probability of their formation. Thus, it is expected that a partitioning system exists in 
pBSSB2 but remains to be identified. The sequence similarity of ORF017 (obtained 
through the blast program at www.ncbi.nlm.nih.gov/blast) to bacterial ParA genes 
indicates the possibility of a partitioning system in pBSSB2. However, no sequence 
similarity to ParB has been identified. Fragment RP2, containing ORF017 and 
ORF018, was unable to stabilize an unstable circular plasmid. This may indicate this is 
not a par locus or that the information contained in RP2 is not sufficient for partitioning 
function. Further assays combining regions adjacent to RP2 in order to look for 
partitioning functions was not pursued due to lack of time. Finally it is possible that 
RP2 (or some other region of pBSSB2) does encode a partitioning system but that this 
is non-functional in a circular plasmid.  
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The testing of the toxin-antitoxin system, as well as any potential role of ORF017 and 
other associated ORFs in plasmid partitioning, remains to be investigated for a linear 
plasmid. If both postsegregational killing and partitioning systems exist in pBSSB2, 
knocking-out of ORF09, that codes for the toxin, may not significantly reduce the 
stability of pBSSB2, since a partitioning system alone might be sufficient to ensure 
proper distribution of the plasmid at most cell divisions. If ORF017 plays a role in 
partitioning, its knock-out should reduce stability of pBSSB2 although plasmid-free 
cells might still be killed by the toxin-antitoxin system. Simultaneous knockout of both 
ORF09 and of ORF017 and comparison of the segregational stability with the parental 
plasmid, as well as the effect of individual knock-outs, should be attempted to 
understand the role of ORF017 in pBSSB2 stability. In addition systematic deletions of 
each annotated ORF of pBSSB2, and testing of each derivative for stability, may help 
to identify any other regions involved with stability of pBSSB2.  
 
The mechanism of action of ORF09 and identification of the antitoxin also remain the 
subjects of future studies. Future studies are necessary to identify the putative antitoxin. 
The antitoxin has not yet been identified but a candidate countertranscript and two 
potential ORFs have been proposed for future studies. A possible way of testing the 
candidate antitoxin is through construction of a lacZ fusion to the toxin gene and 
exploring the effect of putative regulator transcripts on lacZ expression. Further 
characterization of a hypothetical antitoxin may be achieved through RT-PCR, qPCR 
methods and mutagenesis analysis.  
 
6.6 Conclusion  
In conclusion, this study has been successful in developing a method for the 
purification of protein-capped linear plasmids with good yield and reproducibility. The 
study has also identified the minimum replicon and an additional incompatibility region 
which function in a circular plasmid. It is hypothesized that the initiator of replication 
lies in the minimum replicon whereas the incompatibility region is associated with 
control of replication as well as containing the origin of replication. In addition, a toxin-
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antitoxin system capable of stabilizing a circular unstable vector has also been found. A 
figure summarizing the findings from this study is shown (Figure 6.3).  
An important point to bear in mind is that all work in this study has involved circular 
derivatives of pBSSB2. It is possible that there are differences in the requirements for 
replication in circular and linear modes. Whether the basic replicon identified in this 
study suffices to support replication in a linear mode, and hence in pBSSB2, is the 
major question to be answered in future phases of this study. This can be achieved 
through reconstruction of a linear plasmid using the minimum region identified for 
replication, incompatibility and stability regions identified in this study. Controlled 
replication and stable maintenance of this linear construct will provide evidence as to 
whether these components are sufficient for replication in the linear mode or whether 
additional loci are necessary.  
The next step of this study would be to test whether the regions identified in this study 
also function in a linear mode. For this it is necessary to reconstruct a linear plasmid 
using pBSSB2 telomeres, the basic replicon identified in this study and the toxin-
antitoxin module that would potentially stabilize the construct. 
 
 
 
 
 
 
Figure 6.3. Overview of the regions associated with replication and stability of pBSSB2 
identified in this study. 
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